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RNA decay is an important mechanism in regulating steady state mRNA levels and 
thus in orchestrating gene expression to match the changing requirements of a cell. This 
study is concerned with the molecular mechanisms of three processes in the two branches of 
mRNA decay: Firstly, the interactions that give rise to phase separation leading to processing 
body (P-body) formation are studied. Secondly, we investigate the assembly pathway of the 
heteroheptameric LSm1-7 complex that interacts with the 3’ end of mRNAs in preparation of 
5’-3’ decay. The third and main project is aimed to elucidate the interplay between structure, 
dynamics and function in the scavenger decapping enzyme DcpS that performs the last 
catalytic step in 3’-5’ mRNA decay.  
Components of the eukaryotic mRNA decay machinery can accumulate in small 
cytoplasmic foci named processing bodies (P-bodies).These result from a phase transition 
process and have been observed in many eukaryotic species, yet the molecular mechanisms 
of their formation remain largely unknown.  
In this work, we combine biophysical methods with microscopy to demonstrate that a 
minimal set of mRNA degradation machinery from S. pombe can undergo phase transition in 
vitro. The interactions permitting the formation of indefinitely expanding intermolecular 
networks is the contact between multiple helical leucine-rich motifs occurring in Dcp2 and 
Pdc1 and the LSm domain of Edc3. Interfering with this interaction blocks protein clustering 
in vitro and in vivo. Additionally, we describe the structure of the Pdc1 Ge-1C domain and its 
binding to the decapping complex as an additional interaction within P-bodies.  
LSm proteins are a varied protein family that is homologous to the Sm proteins in 
splicing These form a heteroheptameric ring around small nuclear RNA. The nuclear LSm2–
8 (like Sm) complex and the cytoplasmic LSm1–7 complex play a central role in mRNA 
splicing and degradation, respectively. In contrast to the assembly pathway of the Sm 
complex, the assembly of the LSm complex is, has not been intensely studied yet.  
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Here, we solved the 2.5 Å-resolution structure of the LSm assembly intermediate that 
contains LSm5, LSm6, and LSm7. The three monomers display the canonical Sm fold and 
arrange into a hexameric LSm657–657 ring. We show that the order of the LSm proteins 
within the ring is consistent with the order of the related SmE, SmF, and SmG proteins in the 
heptameric Sm ring. Nonetheless, differences in RNA binding pockets prevent the prediction 
of the nucleotide binding preferences of the LSm complexes.  
Using high-resolution NMR spectroscopy, we confirm that LSm5, LSm6, and LSm7 
also assemble into a 60-kDa hexameric ring in solution and observe that the LSm domains 
adopt different angles depending on the number of monomers in the ring. With a combination 
of pull-down and NMR experiments, we show that the LSm657 complex can incorporate 
LSm23 in order to assemble further towards native LSm rings. In summary, our results 
identify LSm657 as a plastic and functional building block on the assembly route towards the 
LSm1–7 and LSm2–8 complexes. 
The scavenger decapping enzyme (DcpS) hydrolyzes the 5’ cap structure of short 
capped mRNAs that are the product of the 3' to 5' mRNA decay pathway. Degradation of 
these fragments is important, as they otherwise could compete for translation initiation 
machinery.  
Here, we solved the crystal structure of the yeast DcpS enzyme in complex with 
m7GDP. The 80 kDa homodimer consists of an N-terminal and a C-terminal domain, where 
the two catalytic sites are located in between these domains. In the asymmetric 
enzyme:substrate complex one active site is arranged in a catalytically active conformation 
around the substrate, whereas the second active site adepts an open and unproductive 
state. 
The static structure indicates that protein dynamics are essential for substrate 
recognition and product release. Using methyl TROSY NMR spectroscopy and ITC, we show 
that DcpS can interact with two substrate molecules in a sequential manner. The first 
nanomolar binding event results in a change of the symmetric apo homodimer into a highly 
asymmetric DcpS:substrate complex. The newly formed open binding site in this complex 
can then recruit a second substrate with micromolar affinity. Using longitudinal exchange 
experiments we show that this second binding event leads to DcpS domain flipping motions, 
where the second binding site closes and the first one opens. These dynamics increase with 
increasing substrate excess and are up to two orders of magnitude faster than the catalytic 
rate. To correlate these motions with function, we designed a mutant enzyme where the 
flipping motions are reduced. Interestingly, this more static enzyme displays increased 
catalytic activity. Our results thus indicate that DcpS flipping motions that are required for 
 III 
 
product release can be disadvantageous for catalysis if they are much faster than substrate 
turnover. In summary, we present an example of how protein motions in enzyme complexes 
can modulate activity. 
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mRNA Abbau ist ein wichtiger Mechanismus, um die Gleichgewichtskonzentrationen 
von mRNAs zu regulieren und somit die Expression von Genen an die variablen Bedürfnisse 
einer Zelle anzupassen. Diese Arbeit beschäftigt sich mit den molekularen Mechanismen von 
drei Prozessen in den beiden Teilen des mRNA Abbaus: Zunächst werden die Interaktionen, 
die zu einer Phasentrennung und der Bildung von processing bodies (P-bodies) führen, 
untersucht. Zweitens wird der Assemblierungsweg des heteroheptameren LSm1-7 
Komplexes, der vor dem 5’-3’ Abbau mit dem 3’ Ende von mRNAs interagiert, erforscht. Das 
Hauptprojekt zielt darauf ab, das Zusammenwirken von Struktur, Dynamik und Funktion des 
Dcs1p Enzyms, das den letzten Schritt im 3’-5’ Abbau katalysiert, zu beleuchten.  
In Eukaryoten können sich Komponenten des 5’-3’ mRNA Abbauweges in P-bodies, 
kleinen zytoplasmatischen Foken, ansammeln indem sie eine Phasentrennung durchlaufen. 
Diese Foki sind in vielen eukaryotischen Spezies beobachtet worden, allerdings sind die 
molekularen Mechanismen, die ihrem Zustandekommen zugrunde liegen, größtenteils noch 
unbekannt. In dieser Arbeit kombinieren wir verschiedene biophysikalische und 
struktubiolgische Methoden mit Mikroskopie und zeigen, dass eine kleine Anzahl an 
Komponenten der mRNA Abbaumaschinerie aus S. pombe ausreichend ist, um in vitroeine 
Phasentrennung zu erreichen. Die Interaktion, die es erlaubt unbegrenzte intermolekulare 
Netzwerke auszubilden ist die Bindung von kurzen Leucin-reichen Motiven (HLMs) aus Dcp2 
und Pdc1 an die LSm Domäne von Edc3. Störung dieser Interaktion führt dazu, dass sowohl 
in vitro als auch in vivo die Anhäufung dieser Proteine verhindert wird. Wir charakterisieren 
außerdem die Struktur der Pdc1 Ge-1C Domäne und ihre Interaktion mit dem Dcp1/Dcp2 
Komplex, die ebenfalls in P-bodies stattfindet. 
LSm Proteine sind eine diverse Proteinfamilie, die homolog zu den Sm Proteinen aus 
dem Spleißosom ist. Der nukleäre LSm2-8 Komplex und der cytoplasmatische LSm1-7 
Komplex sind jeweils zentral für das Spleißen und den Abbau von mRNA. Im Gegensatz zu 
den Sm Proteinen ist der Assemblierungsweg der LSm Proteinen jedoch noch wenig 
verstanden.  
 In dieser Arbeit haben wir die Struktur eines LSm Assemblierungsintermediats bei 
einer Auflösung von 2.5Å gelöst, das LSm5, LSm6 und LSm7 enthält. Die drei Monomere 
weisen eine kanonischen LSm Faltung auf und bilden zusammen einen hexameren LSm657-
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657 Ring. Wir zeigen, dass die Reihenfolge der Monomere im Ring konsistent mit der 
Reihenfolge der verwandten SmE, SmF und SmG proteine im heptameren Sm Ring ist. 
Allerdings verhindern Unterschiede in der RNA Bindestelle die Vorhersage der 
Nukleotidbindung der LSm Komplexe.  
Mittels hochauflösender NMR Spektroskopie bestätigen wir, dass LSm5, LSm6 und 
LSm7 auch in Lösung einen 60kDa großen hexameren ring bilden und beobachten, dass die 
LSm Domänen abhängig von der Anzahl der Monomere im Ring andere Winkel annehmen. 
Wir zeigen außerdem mit einer Kombination von NMR und Pull-down Experimenten, dass 
der LSm657 Komplex LSm23 inkorporieren kann und sich damit weiter in Richtung der 
nativen LSm Ringe entwickelt. Insgesamt identifizieren unsere Ergebnisse den LSm657 
Komplex als ein plastisches und funktionales Assemblierungsintermediat der LSm1-7 und 
LSm2-8 Ringe.  
Das Scavenger Decapping Enzym katalysiert die Hydrolyse der 5’ Cap Struktur an 
kurzen mRNA Abbauprodukten, die aus dem 3’-5’ Abbauweg hervorgehen. Diese Fragmente 
müssen abgebaut werden, da sie ansonsten unproduktiv Bestandteile der 
Translationsmaschinerie binden können.  
Wir haben die Struktur des Scavenger Decapping Enzyms aus Hefe in Komplex mit 
seinem Inhibitor m7GDP gelöst. Das 80kDa große Homodimer besteht aus einer N- und einer 
C-terminalen Domäne, die beiden aktiven Zentren befinden sich in den beiden Spalten 
zwischen den Domänen. In diesem asymmetrischen Enzym:Inhibitor Komplex umschließt ein 
aktives Zentrum ein Molekül m7GDP in einem geschlossenen, aktiven Zustand, während das 
andere eine offene und inaktive Konformation annimmt.  
Die statische Struktur des Proteins legt nahe, dass Konformationsänderungen im 
Protein für die Freisetzung des Produktes und die Erkennung des Substrates nötig sind. Wir 
zeigen mit TROSY NMR Spektroskopie und ITC, dass Dcs1p sequenziell zwei 
Substratmoleküle bindet. Die erste Bindung erfolgt mit nanomolarer Affinität und führt zu 
einer Konformationsänderung vom symmetrischen freien Protein zu einem asymmetrischen 
Enzym:Substrat Komplex. Die dabei entstehende offene Bindestelle interagiert mit 
micromolarer Affinität mit einem zweiten Substratmolekül. Mittels ZZ-Austausch 
Experimenten konnten wir zeigen, dass die zweite Bindung eine Klappbewegung der N-
terminalen Domäne hervorruft, die die zweite Bindestelle schließt und die erste öffnet. Diese 
Bewegungen nehmen mit steigender Substratkonzentration zu und liegen um bis zu zwei 
Größenordnungen über der beobachteten Katalyserate. Um die Zusammenhang zwischen 
dieser Bewegung und der Enzymfunktion zu etablieren, haben wir eine Mutante entworfen, in 
 VI 
 
der die Klappbewegungen langsamer sind als im Wildtyp. Interessanterweise weist dieses 
Protein eine erhöhte Katalyserate auf.  Unsere Ergebnisse deuten darauf hin, dass die 
Klappbewegungen, die für die Enzymfunktion notwendig sind, für die Aktivität des Enzyms 
von Nachteil sein können, wenn sie sehr viel schneller sind als der Substratumsatz. 
Zusammenfassend beschreiben wir hier ein neues Beispiel dafür, wie Proteinbewegungen 
die Aktivität eines Enzymes beeinflussen können. 
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Throughout life, cells are confronted with shiftingphysiological requirements depending 
on cell cycle, developmental stage or external requirements due to a changing environment. 
Reactions to these needs are brought about by changes in gene expression that differentially 
alter the abundance of RNAs and proteins,which in turn govern the structure and metabolic 
state of the cell. Gene expression has thus to be highly variable and tunable over space and 
time but at the same time remain tightly regulated to elicit a controlled response. In 
eukaryotes, a plethora of mechanisms exists that act on different cellular levels, such as 
control of DNA structure and modification, transcription, RNA splicing, translation and RNA 
and protein localization and stability. Together, the variety of gene expression mechanisms 
allows the integration of diverse sources of information and appropriate reactions to external 
signals. mRNA degradation is a central mechanism in gene expression, and is used by 
multiple regulatory pathways[1].  
 
Overall cytoplasmic mRNA concentrations depend on the steady state equilibrium 
between synthesis rate,which isdeterminedby transcription and splicing, and mRNA 
degradation. Total mRNA levels are kept at normal levels by co-regulating these two 
processes[2]. 
Half-lives of individual eukaryotic mRNAs vary between species. In yeast, half-lives 
range between 2-3 minutes and more than 90 minutes [3, 4], whereas in mammalian cells 
they range between 15 minutes and more than 24 hours[5].mRNA concentrations have to be 
tightly controlled by the cell in order to match the requirements for differential expression of a 
given gene at a given time and location in the organism.  
Eukaryotic mRNA degradation serves several purposes: Firstly, transcripts have to be 
routinely turned over. Secondly, it differentially targets transcripts for decay upon the need of 
up- or down-regulation of genes. Additionally, targeted degradation can be mediated by the 
action of miRNAs or siRNAs that promote either endonucleolytic cleavage with subsequent 
decay or recruitment of the decapping machinery. Both mechanisms target the transcripts for 
pathways of mRNA degradation. Thirdly, faulty transcripts have to be cleared from the cell to 
prevent synthesis of potentially deleterious protein variants or to release translation 
machinery that is unproductively trapped on a dysfunctional transcript. Surveillance pathways 
detect aberrant mRNAs and feed them into mechanisms of regular mRNA turnover. There 
are dedicated surveillance pathways to identify faulty transcripts containing premature stop 
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codons (Nonsense-mediated decay, NMD), transcripts that lack a stop codon (Non-stop 
decay, NSD) and transcripts with stalled ribosomes (No-go decay, NGD).  
 
Eukaryotic mRNA transcripts are protected from unspecific exoribonuclease activity at 
both ends. Their 5’ end is modified co-transcriptionally with a mRNA cap structure. This cap 
consists of a 7-methylated guanine nucleotide that is linked with the 5’ end of the transcript 
by a 5’-5’ triphosphate bridge. In higher eukaryotes this cap-0 structure is further expanded 
by methylations at the ribose moieties of the first and second translated bases (cap-1 and 
cap-2). Apart from protecting the mRNA from degradation, the 5’ cap structure is required for 
RNA quality control, nuclear export and translation initiation.  
At the 3’ end, transcripts are protected from degradation by a polyA tail that is added 
after transcription termination and that is required for export from the nucleus. In the 
cytoplasm, the polyA tail is tightly occupied by the polyA binding protein (PABP). It enhances 
mRNA stability and the interaction between cap binding proteins and polyA binding protein 
promotes translation efficiency. The length of the polyA tail varies considerably between 
species and between individual groups of mRNAs and is altered by deadenylation and 
readenylation during the lifetime of the mRNA. Generally, greater length is associated with 
increased stability, whereas reduction of the polyA tail to a critical threshold is the initial and 
often rate-limiting step of mRNA decay. From shortened oligoA tails, degradation can further 
progress in 3’-5’ direction by action of the cytoplasmic exosome complex or the oligoA tail is 
recognized by the LSm1-7-Pat1 complex that recruits the decapping machinery. Generally, 
mRNA degradation is initiated by deadenylation activity at the 3’ end of a transcript. 
Subsequent degradation can take place from both ends of the mRNA, from 5’ to 3’ and from 
3’ to 5’, however the determinants that assign a transcript to either of the pathways remain 
unclear. The decapping enzyme Dcp2 and the scavenger decapping protein DcpS eliminate 
the 5’ cap structure in the two pathways respectively to prevent inhibition of cap dependent 
processes such as nuclear export, translation or RNA processing by excessive 
concentrations of free cap structure. The products of these hydrolytic events are 7-methyl 
guanosine mono- or diphosphate. In human and Drosophila cells, these compounds are 
dephosphorylated to yield the methylated base m7G, however the details of its further 
degradation pathway remain unknown. [6] 
 
In the 5’-3’ pathway, the 5’ cap is hydrolyzed by the decapping enzyme Dcp2 between 
the Pα and Pβ yielding m7GDP and 5’ monophosphorylated RNA as products. Its activity is 
modulated by a variety of decapping factors, such as Dcp1, Edc3 or Dhh1. While the proteins 
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involved in mRNA decay are conserved throughout evolution, interestingly their interaction 
network is not. The decapping step is irreversible and leaves the mRNA body vulnerable for 
fast and processive degradation by the 5’-3’ exoribonuclease Xrn1. The components of the 
5’-3’ degradation pathway localize to cellular compartments termed P-bodies in which the 
mRNA degrading enzymes interact in a phase separating net. The cellular function of P-
bodies is still being debated.  
 
After initial deadenylation, the 3’-5’ degradation pathway proceeds with hydrolysis of 
the mRNA from the 3’ end by the decameric exosome complex. This complex degrades 
transcripts until they measure ~10nts in length. These short and capped mRNA molecules 
can compete efficiently for translation initiation machinery and are sequestered from the cell 
by the scavenger decapping enzyme DcpS that hydrolyses the triphosphate bridge in the cap 
between the Pβ and Pγ position yielding m7GMP and 5’-dephosphorylated RNA.  
 
Sm proteins were initially named after Stephanie Smith, a patient suffering from 
systemic lupus erythematosus. In this autoimmune condition, antibodies are targeted against 
a set of proteins that share between them the two conserved sequence motifs Sm1 and Sm2 
encompassing 32 and 14 amino acids respectively. The Sm proteins (B, D1, D2, D3, E, F, G) 
are assembled into heteroheptameric toroidal rings that associate with the five snRNAs at 
their Sm sites forming the snRNP core assemblies. These core snRNPs are part of the U1, 
U2, U4 and U5 snRNPs (reviewed in [7]). They are indispensible for formation of the 
spliceosome and thus for correct splicing of pre-mRNAs. 
Sm-like proteins (LSm) have been identified bioinformatically by their shared Sm1 and 
Sm2 motifs [8]. They assemble into two distinct complexes: LSm1-7 and LSm2-8 differ in 
function and localization but share all but one of their subunits. The order of proteins in the 
rings has been predicted according to their homology to the Sm components and has been 
confirmed by structural studies of LSm1-7 and LSm2-8 [9, 10]. More proteins containing Sm 
domains have been identified since in all trees of life [11]. Bacterial Hfq rings mediate 
interactions with small RNAs via surfaces on both sides and in the pore of the ring. Also 
archaea utilize homohexameric rings of Sm proteins to interact with small RNAs.  
In addition, divergent LSm domains have evolved to mediate interactions with short 
linear peptide sequences [12]. These moreover differ by their monomeric state and an 
interrupted β4 strand.   
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The LSm1-7 ring is involved in cytoplasmic mRNA degradation and is necessary to 
couple deadenylation and decapping in 5’-3’ decay via its interaction with Pat1p as in 
absence of the LSm proteins, oligoadenylated mRNAs accumulate while decapping is 
inhibited. [9,13-17]. Pat1p is a multifunctional multidomain protein that acts as a molecular 
platform by interacting with components of the 5’-3’ RNA degradation machinery such as the 
decapping enzyme Dcp1/2, the decapping activator Dhh1, the exoribonuclease XrnI, the 
deadenylation complex Ccr4/Not and polyU RNA. Pat interacts with LSm2 and LSm3 with its 
and C-domain in S. cerevisiae and H. sapiens and with its mid-domain in D. melanogaster[9, 
10, 18].  
It has been reported to locate preferentially to the 3’ end of oligoadenylated mRNAs in 
yeast, to the oligouridine tracts 5’ of oligoA tails and to oligouridine sequences close to the 3’ 
end of mRNAs in vivo. However, the precise sequence preference is unknown. Association 
of LSm1-7 can protect 20-30 nts of the message from trimming.  Both the LSm1-7 complex 
and Pat1p locate to P-bodies in vivo.  
 
LSm2-8 is localized in the nucleus. The snRNPs U1, U2, U4 and U5 are formed by 
their respective snRNA and an Sm ring. In contrast, the LSm2-8 ring provides together with 
Prp24 the protein moiety in the U6 snRNP. LSm2-8 complex binds specifically to the uridine-
rich 3’ end of the U6 snRNA [19] and remains bound throughout spliceosome assembly, 
catalysis, disassembly and subunit recycling. U6 confers both sequence specificity and 
catalytic activity to the spliceosome.  
The assembly pathways of the LSm1-7 and LSm2-8 ring appear independent of 
eukaryotic chaperones and an RNA template as they can be reconstituted during expression 
in E. coli. Some evidence indicates that assembly of LSm1-7 and LSm2-8 complexes is 
coupled, as overexpression of LSm1 reduces LSm2-8 levels[20]. The mechanism by which 
biogenesis of these complexes is linked is currently unknown but might involve competition 
for an assembly intermediate that comprises the common subunits LSm2-7.  
 
 
Structural data for a variety of LSm complexes is available [9, 10, 12, 21-25]. LSm 
domains adopt a short N-terminal helix followed by 5 antiparallel, highly bent beta strands. 
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Additional terminal sequences present in LSm1, LSm4 and LSm7 have been implied in 
functions as RNA binding (LSm1) or P-body association (LSm4). β-strands 2-4 are highly 
bent around a kinked residue in the middle of the strand. Strandβ5 crosses the open edge of 
the sheet leading to a roll topology. The hallmark Sm motifs encompassβ1-3 and β4+5 
respectively.  
Both Sm and LSm proteins assemble into toroid complexes. The most common 
assemblies are six or seven membered, but also eight-membered rings have been reported. 
Inter-subunit interaction occurs between β4 of one subunit and β5 of the adjacent subunit so 
that a continuous β-sheet extends throughout the ring. All N-terminal helices are located on 
one side of the ring termed the proximal side and pack against β2 and β4 of their own 
subunit and β2 of the adjacent subunits. Residues located in the loops 3 and 5 line the pore 
of the ring. These are highly conserved and mediate the interaction with RNA.  
Subunit order in the ring is thought to be specified by the subunit-specific interactions. 
In addition to non-specific hydrogen bonds between the strands, these are mainly 
electrostatic contacts between side chains in β4 and β5 and in the N-terminal helix. However, 
subunit interaction is in vitronot highly specific as demonstrated by the existence of non-
native interfaces in LSm protein heterooligomers [10, 26, 27]. Thus, subunit interaction is a 
compromise between affinity on one side and specificity and plasticity during assembly on 
the other side.  
 
 
In vivo, the formation of heptameric Sm rings requires the appropriate snRNA template 
and the ATP dependent action of assembly machinery. As the sequences upstream and 
downstream of the ring are base-paired, the Sm ring has to be assembled on its RNA 
template. In most species, snRNP assembly takes place in the cytoplasm, so that the snRNA 
is exported from the nucleus after transcription. Its Sm binding site is specifically recognized 
by GEMIN5 and bound to the SMN (survival of motor neurons) complex consisting of SMN 
and a group of proteins collectively termed gemins. The Sm proteins form building blocks 
consisting of SmD1/SmD2, SmB/SmD3 and SmE/SmF/SmG and are Arg-N methylated at 
their C-termini by action of PRMT5. These preformed Sm oligomers are assembled into the 
final heptameric complex around the snRNA target in the SMN complex. First, SmD1/SmD2 
and SmF/SmE/SmG are combined with pICln, a chaperone that occupies the position of 
SmD3/SmB in the ring shaped assembly intermediate. After insertion of the snRNA, the 
chaperone is expelled and the ring is completed by SmD3/SmB. After further processing as 
exonuceolytic trimming and hypermethylation of the cap structure, the snRNP is reimported 
into the nucleus.  
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Also in vitro, the Sm proteins multimerize into the stable subcomplexes SmD1/SmD2, 
SmB/SmD3 and SmE/SmF/SmG. These can assemble spontaneously into the native 
heptameric ring in presence of an appropriate snRNA [28, 29]. The action of the SMN 
complex in the cell is thought to provide specificity in RNA recognition and avoid the 
unproductive assembly of non-native intermediates[30-32].  
In contrast to the extensive assembly machinery used for Sm proteins, no accessory 
factors for LSm ring formation are known. LSm complexes assemble in contrast to Sm 
complexes without template RNA [19, 33] and chaperone action. Both the homology between 
Sm and LSm proteins and the presence of stable LSm subcomplexes however suggest that 
LSm proteins retrace the assembly mechanism of Sm proteins.  
 
 
Each of the two branches of mRNA degradation possesses a decapping activity to 
remove the 5’ cap from mRNA during degradation. DcpS was first described as activity that 
degrades the triphosphate cap in capped RNAs of < 10 nts and characterized in human cells 
[34, 35]. The protein was later termed scavenger decapping enzyme (DcpS). It performs the 
decapping reaction at the end of 3’-5’ decay, hydrolyzing the Pβ-Pγ phosphodiester. Human 
DcpShas been reported to interact with the exosome and suggested to coordinately decap 
mRNAs once degraded by the exosome[36].  
Scavenger decapping enzymes are conserved from fungi to higher eukaryotes, 
however no homologue is known in plants. As part the HIT family of pyrophosphatases, they 
have been identified as such by the typical histidine triad motif (H-Φ-H-Φ-H-Φ, where Φ 
denotes a hydrophobic amino acid). While the C-terminal domain of DcpS is homologous to 
HIT proteins and contains the histidine triad motif, it is, in contrast to other HIT proteins, 
inactive on its own accord and requires the N-terminal domain in cis or trans for activity [37]. 
Disruption of yeast DcpS induces cellular accumulation of m7GpppN [38].  
 
The catalytic mechanism of scavenger decapping enzymes is thought to proceed via a 
SN2 mechanism, which has been demonstrated for another member of the HIT family, the 
FHIT protein [39]. There, the deprotonated central histidine in the histidine triad carries out a 
nucleophilic attack on the nucleoside phosphate at the γ-position. The reaction proceeds 
through a bipyramidal transition state. Subsequently, pp-RNA is released while a covalent 
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nucleotidyl-phosphohistidine adduct is formed. Nucleophilic attack of a water molecule at the 
γ-position hydrolyzes the adduct and releases the other product m7GMP from the enzyme. 
 
The substrate range of scavenger decapping enzymes is mainly determined by three 
factors: Modifications of the capping base, length of the RNA body and the number of 
phosphates adjacent to the methylated 5’ base.  
Scavenger decapping enzymes are only active on N-7 methylated guanosine 
derivatives and thus exhibit intrinsic specificity for mRNA caps[34, 35]. Homologs from 
species that feature additional methylations in the capping base are able to hydrolyze these 
cap structures, however at different rates than the singly methylated bases [40].  
Concerning mRNA length, DcpS enzymes are most active on isolated cap structure 
(m7GpppN) without exhibiting specificity for the 5’ base[41]. Activity rapidly decreases when 
RNA body length exceeds 10 nucleotidesfor human DcpS [42]. This requirement is in 
agreement with scavenger decapping enzymes acting downstream of the 
exosome,whichproduces short, capped mRNA fragments. Thus, the cap structures of 
longmRNAs are preserved by DcpS proteins. A notable exception of this prerequisite is the 
enzyme from S. pombe that has been reported to act on longer transcripts[43].   
The presence of a base after the triphosphate bridge is not strictly required for 
scavenger decapping activity, as m7GTP has been shown to be hydrolysable by both the 
yeast and nematode enzymes. Rates of catalysis are in the range of the hydrolysis of 
m7GpppG[44].  
The requirement for three phosphates for catalysis is elucidated by the substrate 
m7GDP. Activity on m7GDP, the product of 5’-3’ degradation, has been reported, but 
issubject to controversy. While it has been reported active and implied in cross-regulation 
between the two branches of mRNA decay [45, 46], more recent studies did not detect 
significant activity on this compound[42, 44, 47]. As m7GDP can still bind to scavenger 
decapping enzymes, it acts as an inhibitor of DcpS activity. Thus, the minimal number of 
phosphate groups in the cap required for efficient catalysis is three.  
 
The localization of DcpS proteins varies among species. Its namesake function in 
mRNA turnover suggests a cytoplasmic localization, however a predominantly nuclear 
localization has been reported in mammals[37, 48] and S. pombe[43]. Accordingly, a 
canonical nuclear localization signal (NLS) and nuclear export signal (NES) have been 
identified in DcpS from H. sapiens. In agreement with these findings, human DcpS is a 
shuttling protein with its bulk located in the nucleus[37]. In contrast, DcpS enzymes in in 
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nematodes [47, 49] and S. cerevisiae[50] feature no distinct NLS or NES and localize mainly 
to the cytoplasm. This may reflect a different range of functions that DcpS proteins perform in 
different organisms.  
 
Many proteins involved in RNA metabolism moonlight in other cellular functions. While 
originally identified for their decapping activity, DcpS enzymes have been implied in a variety 
of cellular processes in different species, offering a rationale for their reported nuclear 
localization. The effects of DcpS function can be brought about either by a mechanism that is 
independent of its catalytic activity, by the effect of decapping activity on mRNAs or 
indirectly, by modulating the steady state levels of its substrate, inhibitor or product 
(m7GpppG, m7GDP and m7GMP). These small molecules in turn affect the cell by different 
mechanisms: if not cleared from the cell, they may compete with functional mRNAs for cap 
binding proteins [51] or become incorporated into DNA[46]. 
 
A first sector of action is modulation of miRNA and mRNA turnover independent of 
decapping activity. In C.elegans, DcpS has been reported to interact with XrnI, enhancing 
miRNA degradation independent of DcpS decapping activity [52]. In S.cerevisiae, Dcs1p has 
been found to activate 5’-3’ mRNA degradation by interacting with Xrn1 and increasing its 
affinity for RNA [38, 53]. This effect is observable in vitro and in vivo and is independent of 
the decapping activity of Dcs1p. In the absence of Dcs1p, the degradation defect of XrnI 
leads to decreased expression of the mitochondrial Por1 protein. As respiratory genes are 
required for yeast to metabolize non-fermentable carbon sources, this might explain the 
inability of Δdcs1 yeast strains to grow on glycerol as a carbon source[53]. It is notable that 
Dcs1p, a protein at the end of 3’-5’ degradation, co-regulates XrnI, an enzyme in 5’-3’ decay.  
 
Furthermore, DcpS has been involved in splicing regulation. First-intron splicing is 
reduced in DcpS knock-down cells, which has been attributed to sequestration of the nuclear 
cap binding protein CBP20 by excess cap structure resulting from reduced DcpS activity[51]. 
This function is affiliatedwith the nuclear fraction of DcpS that has been observed in human 
cells. By a similar mechanism, sequestration of the cytoplasmic cap binding protein eIF4E by 
excess cap structure due to absence or reduced activity of DcpS is thought to influence 
translation[51].   
Inhibition of scavenger decapping activity by C5-substituted quinazolines has been 
shown to increase SMN2 expression [54] and thus alleviate the symptoms of spinal muscular 
 - 12 - 
 
atrophy in a mouse model [55, 56]. The mechanism of expression activation is yet unknown. 
However, this finding stresses that DcpS is involved in humans to gene expression.  
 
Dcs1p has been described as a neutral trehalase inhibitor in yeast and has been 
reported to directly interact with it [57, 58]. Trehalose (α1-glucopyranosyl-α1-glucopyranosid) 
is accumulated under nutrient deprivation and stress conditions to protect the cell and 
organelles[59]. After alleviation of stress, it is hydrolyzed by the neutral trehalase Ntr1 
yielding glucose for quick resuming of growth. Ntr1 is already expressed under stress 
conditions and needs to be inhibited in order to prevent futile cycles of concomitant trehalase 
synthesis and degradation by Ntr1. DcpS is highly expressed jointly with Ntr1 at the onset of 
stress and to physically interact with Ntr1, reducing its interaction with Ntr1 activators. In a 
Dcs1p deletion strain, Ntr1 is constitutively active, pointing to a inhibitory function of Dcs1p in 
trehalose metabolism in response to stress[50, 60, 61].  
Furthermore, Dcs1p is regulated on a nutrient dependent basis. Dcs2p is a homologue 
of Dcs1p in S. cerevisiae that shares 65% sequence identity and 90% similarity with Dcs1p. 
Its expression is repressed in log growth phase but becomes induced both transcriptionally 
and translationally as soon as glucose becomes limited [46, 50]. Dcs2p localizes in stationary 
phase mostly to P-bodies with a fraction remaining distributed throughout the cytoplasm. 
Newly translated Dcs2p proteins can form inactive homodimers or heterodimers with Dcs1p 
[46], most likely adopting the same architecture as Dcs1p dimers. Dcs2p can be considered 
a nutrient-dependent modulator of Dcs1p activity as Dcs1/2p dimers exhibit reduced activity 
on m7GpppG compared to the Dcs1p dimers. Inhibition of Dcs1p by Dcs2p may feed into 
modulation of the 5’-3’ mRNA degradation but has also been implied in reducing life-span 
due to increased incorporation of methylated nucleotides into RNA [46]. 
 
Taken together, scavenger decapping enzymes are involved in mRNA and miRNA 
turnover, gene expression, stress response and metabolism. DcpS functions differ in cellular 
localization, in whether they are direct or nucleotide mediated and in whether Dcs1p acts as 
a homo- or heterodimer. If and how these functions are jointly coordinated is unknown at 
present, as are all molecular details of these additional activities.  
 
DcpS enzymes from human and mouse[62] have been studied extensively by x-ray 
crystallography. Structures of human DcpS in free, substrate (m7GpppG, m7GpppA), product 
(m7GMP) and inhibitor bound states (m7GDP, D153249, D156844, D157493) are available 
and picture intermediate states of its molecular mechanism of action [41, 54, 63]. 
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DcpS enzymes are homodimeric proteins with a distinct two-domain structurethat 
behave as rigid bodies in published structures. The N-terminal domain encompasses 
residues 1-134 in the human protein and is linked with the C-terminal domain (residues 148-
336) by a hinge region that consists of an α-helix and amino acids without secondary 
structure. Both domains are dimeric on their own accord. The N-terminal NTF2-like domain 
dimerizes by a domain swap where one protomer donates an α-helix and two anti-parallel β-
strands to complete the fold of the other protomer. In the C-terminal domain that is a 
homologous to the HIT protein family, the protomers interact via an extended shared surface 
that buries 1400Å2. In other HIT family pyrophosphatases, this domain is sufficient to carry 
out catalysis, however for DcpS the presence of the N-terminal domain is required for 
activity[37, 64].  
 
DcpS is a homodimer and adopts a symmetric conformation in the free form with a two-
fold symmetry axis. The domains do not interact with each other in this conformation but are 
separated by the hinge region [62, 63].  
In the substrate or inhibitor bound form, DcpS interacts with two molecules of m7GpppN 
but undergoes a conformational change that results in different binding sites for its two 
substrate molecules. In a flip-over motion, the N-terminal domain and the hinge fold down 
onto the C-terminal domain forming a binding pocket around a substrate molecule. The 
active site residues arelocated on the C-terminal domain and correspond to a canonical HIT 
protein catalytic site. Interestingly, the N-terminal residues involved in substrate binding are 
situated on the domain-swapped β-strands and thus contributed by the other protomer. This 
active site tightly encloses the substrate and is thus termed ‘closed’.  
The second binding site is occupied in crystal structures as well but compared to the 
apo structure, the domains have moved apart and binding residues from N- and C-terminal 
domain are remote from each other. The conformational change between free and bound 
states is mainly mediated by a series of changes in backbone torsion angles in residues in 
the hinge region, while the domains act as rigid bodies. This indicates that closure of one 
active site has to occur concomitantly with opening of the second site and that the productive 
arrangement of one active site is mutually exclusive with activity in the second. A 
hypothetical simultaneous closure of both sides would require a large distortion of either of 
the two domains, which is highly unlikely given their observed rigidity and stable domain 
interfaces. 
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The active site in the closed conformation compromises the C-terminal catalytic 
residues and is completed by parts of the N-terminal domain and the hinge region 
surrounding the substrate. A van-der-Waals cage that is mainly formed by aromatic residues 
encloses the methylated base;the phosphate groups are specifically recognized by 
electrostatic interactions. The binding pocket for the second base is promiscuous and can 
accommodate both purines and pyrimidines or remain void if m7GDP is bound. C5-
substituted 5-quinazoline inhibitors mimic key features of natural substrates and contact the 
same residues in the active site for interaction[54]. 
  Structural information is available for the open conformation in either the free form or 
occupied with either substrate m7GpppG, inhibitor D153249 or the product m7GMP. The C-
terminal domain recognizes substrate molecules with their methylated base moieties in a 
similar way as in the closed conformation. The conformation of the substrate differs in the 
phosphate bridge in Pα and Pβ and the non-methylated base: The dinucleotide adopts a 
more extended conformation and the second base is bound more loosely by stacking 
interactions with the hinge region compared to several electrostatic interactions in the closed 
conformation. Together with higher B-factors in the second base compared to the first one, 
this indicates that the bulk of binding energy is provided by interaction with the C-domain. 
The inhibitor D153249 is bound with lower occupancy to the open active site. In the open 
conformation, the methylated base of the substrate is bound in a similar manner as in the 
closed active site. Substrate conformation however differs in the orientation of the Pβ and the 
second base. The open binding site in complex with the product m7GMP bears more 
similarity with the free site than with the substrate bound one. The methylated base is 
recognized differently.  
The catalytic residues in HIT proteins are sufficient to perform catalysis. This implies 
that the C-terminal domain would also be sufficient to hydrolyze the cap structure. The 
arrangement of the C-terminal catalytic site residues is very similar between open and closed 
active site yet there is a large difference in substrate conformation. It is tempting to speculate 
that the activation in the pocket is brought about by activation of the leaving group in the 
substrate, enforced by the closed position of the N-terminal domain.  
 
Insight into the relationship between structure, function and dynamics in scavenger 
decapping enzymes is based on structural and kinetic investigations.  
The structures of free and ligand bound DcpS enzymes demonstrate that molecular 
motions are required for DcpS activity, as conformational change is required to release the 
product from the closed active site [41, 63]. Aconcertedmechanism for substrate binding and 
product release in the two active sites is suggested: Both the closed site A and open site B 
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are occupied with substrate. Product release after catalysis in A requires opening of the 
closed site. Opening of site A leads to simultaneous closure in B and thus to productive 
active site formation in the previously open site. This mechanism proposes an increase in 
catalytic efficiency as substrate binding and product release can take place simultaneously.  
DcpS mutants in whom the interaction between the domains in the closed conformation 
has been disrupted display increased activity, indicating that product release might be the 
rate-limiting step in the catalytic cycle[41]. However, the mutated residues are located in the 
hinge region and are interactwith the substrate in the open protomer. Thus, the mechanism 
by which the observed hyperactivity is realized remains to be investigated.  
Additional information was gained from kinetic analysis of homo- and heterodimers of 
human DcpS protein[65]. This study demonstrated that DcpS is a negatively cooperative 
protein, as implied previously. Additionally, pre-steady state kinetic experiments 
demonstrated that Dcs1p activity is not rate-limited by product release rates, raising the 
question of the rate limiting step. Interestingly Dcs1p is substrate-inhibited, i.e. activity is fast 
under single turnover conditions but slower under multiple turnover conditions. This effect 
was reduced in heterodimers that were unable to interact with substrate in one protomer, 
indicating that the second active site is involved in substrate inhibition. Comparing the events 
in single and multiple turnover reactions, it was concluded that the step differing between 
them, the conformational change between the symmetric and asymmetric state, had to be 
the rate limiting one.  
Structural and kinetic data demonstrate clearly that the active sites in Dcs1pinteract 
and that protein dynamics are required for Dcs1p function. These experiments have shed 
light on DcpS enzyme function. However, in order to understand the interplay between 
structure and conformational dynamics and how they give rise to its properties as allostery 
and substrate inhibition, experimental measurements of the rates of conformational 
exchange are still required.  
 
 
The term allostery describes the phenomenon that an interaction in one site of a 
biomolecule can influence activities such as binding or catalysis at a distant site. This 
phenomenon has long been known and recognized for its biological relevance. Allostery is 
relevant for cellular signaling, metabolism and disease; drugs acting at allosteric sites have 
successfully been designed. By integrating information from one site of a macromolecule 
with activity in another it is possible to tune activity according to physiological conditions. 
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Compared with a system, in which progression of a reaction is determined kinetically by the 
concentration of reactants or products, integration of information by allosteric mechanisms 
allows for additional levels of regulation between pathways for heterotropic systems or for 
other dynamic ranges of ligand for homotropic systems. 
Allostery can be divided in homotropic and heterotropic effects. In homotropic allostery, 
molecules of the same compound interact with the allosteric site and regulate activity in the 
orthosteric site. In heterotropic allostery, different compounds are bound to the different sites. 
Homooligomers are particularly prone to homotropic allosteric phenomena because multiple 
binding sites are present in the molecule already. Additionally, residues in the interfaces that 
permit signal transduction in between the protomers exert their effect in all copies and are 
thusmore efficient in propagating conformational or dynamic changes. Allosteric behavior has 
however been demonstrated for monomeric proteins as well.  
Classically, allostery in homooligomers has been described by the concerted (MWC) 
model or the sequential (KNF) model. The concerted modelassumes that all protomers in a 
complex adopt the same conformation, which can be either highand low affinity 
conformation. Ligand binding shifts the equilibrium between all-high and all-low affinity states 
and thus alters the affinity of subsequent binding events.In contrast, the sequential model is 
based on the principle of induced fit and states that single protomers undergo conformational 
change upon ligand binding. Thus, liganded protomers always occur in the binding 
competent conformation, and a change in affinity of subsequent binding sites is due to 
stabilization or destabilization of interfaces between protomers of different conformations. 
Both models have been successfully applied to describe protein allostery. 
These models are deterministic insofar as a binding event always leads to 
conformational change elsewhere in the protein, either in all protomers in the MWC model or 
in only the binding subunit in the KNF model. These rely on a strict mechanical coupling 
between intermediate stages of conformational exchange. In contrast, probabilistic allosteric 
models model mutually dependent conformational equilibria for all protomers and invoke 
ensembles of proteins that statistically explore conformational space. This is in 
correspondence with the notion that proteins in solution exhibit considerable conformational 
diversity. Binding events differentially stabilize populations and thus alter the composition of 
the ensemble, ligand binding is thus interpreted as a remodeling of the free energy 
landscape of the ensemble. Probabilistic models still cover the concerted and sequential 
model as extreme cases. 
These models describe allostery on a phenomenological level, however the underlying 
molecular mechanisms are understood for few examples. Underlying paradigms that apply 
include conformational change, change of protein dynamics and population shifts in protein 
ensembles. In studying a given allosteric system it is a challenge to determine which effects 
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govern allostery on the molecular level and which model reflects and describesthis 
mechanism appropriately. Recent workhas shown that the same protein can act according to 
different models for different ligands indicating the difficulties in predicting allosteric 
mechanisms[66].  
 
First insights on the molecular details of allostery were obtained by structural 
investigations that provided static structures of end-point states of conformational change. 
Early theoretical considerations demonstrated that measurable allosteric effects can be 
generated by shifts in frequency and amplitude of thermal fluctuations without perturbing the 
average structure of a protein [67]. Indeed, using solution techniques as NMR, examples are 
accumulating that demonstrate that allostery in proteins can be brought about by changes in 
protein dynamics that increase or decrease the ability of a protomer to interact with a ligand. 
The mechanisms found expand the repertoire of mechanisms frompurely enthalpic structural 
changes to dynamically driven allostery where entropic contributions manifest as motions in 
side-chains, the backbone or local or complete unfolding of the protein.Further information is 
accessible by computational methods as transition state analysis, anisotropic thermal 
diffusion, normal mode analysis or statistical coupling analysis. Thesecontribute information 
on possible allosteric mechanisms on a range of timescales between femtoseconds and 
microseconds. As dynamics have been established as important factor in allostery, the 
complete description of protein movements has become relevant in discerning allosteric 
mechanisms. Thus, detailed molecular information on populated states, the conformational 
width of their ensembles, their relative populations and the rates of interconversion are 
required to complete the static description.  
 
Michaelis-Menten kinetics postulate that catalytic rates increase with increasing 
substrate concentration until reaching saturation, where the turnover is limited by the 
catalytic rate inherent to the enzyme and not by the supply of substrate molecules. However, 
a significant amount of enzymes defies this model as, after a maximum in activity, turnover 
rates decline with increasing reactant concentrations either to a constant or to zero. As 
increasing substrate concentration reduces activity, this phenomenon is termed substrate 
inhibition and is common to many enzymes [68]. The biological significance of substrate 
inhibition is controversial. While it is fairly common occurring in an estimated 20% of 
enzymes [69], it has often been argued to result from non-physiological substrate 
concentrations in assays. Nevertheless, a number of enzymatic reactions in the cell take 
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place under inhibiting substrate concentrations so that a biological function substrate 
inhibition has to be suspected.  
 
For some substrate-inhibited enzymes, the cellular function of their inhibition has been 
elucidated. Generally, in context of a metabolic pathway, substrate inhibition alters steady 
state levels of metabolites or modulates the substrate concentration ranges in which the 
pathway will be active as demonstrated by several examples.One is phosphofructokinase, 
the third enzyme in glycolysis, which is inhibited by its substrate ATP[70]. This inhibition is 
physiologically worthwhile as ATP is also the end product of the metabolic activities of 
glycolysis, citric cycle and ATP synthase so that an end-point inhibition is here conveyed by 
substrate inhibition.  
Alternately, substrate inhibition can modulate the temporal response of a pathway to a 
given stimulus. For instance, substrate inhibition of acetylcholinesterase (AChE) provides for 
accelerating clearance of its substrate acetylcholine (ACh) from the synaptic cleft. Thus, the 
very fast build-up of acetylcholine after vesicle discharge leads to AChE inhibition and faithful 
signal transduction. The inhibited enzyme slowly degrades ACh until the threshold of 
inhibition is crossed and ACh is cleared quickly from the synaptic cleft. Thus, both robust 
signal transduction and fast ACh degradation are realized[71, 72].  
 
The kinetic model of substrate inhibition invokes a doubly substrate bound state of the 
enzyme with decreased turnover. With increasing substrate, the occupancy of the enzyme is 
shifted to this less active state and its overall activity decreases. However how the reduction 
in turnover is realized on the molecular level is yet to be elucidated for most substrate 
inhibited proteins. Nevertheless, substrate inhibition has to be considered an allosteric effect 
as interaction at a remote site regulates activity at the active site. 
Substrate inhibition can be realized by secondary, nonproductive binding sites that 
impede substrate access to the active site or reduce turnover [73-75], or hinder product 
release [72, 76]. Secondary binding sites can be close to the active site [77] or more distant 
and act via an allosteric mechanism[78]. Known mechanisms of substrate inhibition have 
been characterized by structural investigations and mostly rely on steric effects at the active 
site. The analogy with allostery in binding proteins however suggests that protein dynamics 
may have a role in mechanisms of substrate inhibition as well.  
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P-bodies are cellular structures resulting from phase transition in the cytoplasm that 
have been described in a variety of mammalian species. While the list of proteins localized 
there is expanding, their function is still being debated and the molecular mechanisms of 
their formation are not fully understood. Our aim was to address a variety of questions: 
 Can a minimal reconstituted system of purified proteins undergo phase 
transition in vitro using the known interations between the Edc3 protein and 
HLM motifs from Dcp2 from S. pombe? 
 Does disruption of an interaction in vitro mirror in vivo effects?  
 What other properties of P-bodies are emulated by this system, such as 
dynamic fusion or recruitment of other mRNA decay factors? 
 What is the influence of number and affinities of the protein components on the 
conditions where phase transition occurs? 
 Pdc1 is a multi-domain protein has been implied in P-body integrity. Which of its 
interactions recruit it to P-bodies and what are their structural details? 
In order to analyze the contribution of single interactions to the formation of an 
indefinitely extending network of interacting proteins that leads to phase transition, we set out 
to characterize affinities and interacting motifs in these proteins. In S. pombe, these include 
Edc3, the decapping complex Dcp1/Dcp2 and Pdc1. We use a combination of NMR, ITC and 
x-ray crystallography to study structural determinants of the relevant interactions and their 
affinities. Additionally, insights into the effect of these interactions on phase transition are 
gained by a bottom-up in vitroassay that uses fluorescence microscopy.  
 
 
Dcp2 contains helical leucine-rich motifs (HLMs) that interact with the LSm domain of 
Edc3 [79]. Here, seven interacting HLMs from Dcp2 have been confirmed by NMR. Their 
affinities range from the low μM to the mM order, as determined by ITC. When mixing the 
purified Dcp2 far C-terminal region containing four HLMs with purified with dimeric full-length 
Edc3, a clear phase transition can be observed under a bright field microscope. The resulting 
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droplets contain both proteins as Oregon green labeled Dcp2 (553-741) and Edc3 are 
significantly enriched in the droplets in individual assays.  
In order to investigate the requirements for phase transition, a series of assays was 
carried out under varying concentrations of both proteins and with two Dcp2 constructs 
containing either four or five HLM sequences. Overall, phase separation was found 
depending on a number of conditions: The overall concentration of both proteins has to be 
sufficiently high. Secondly, the molar ratio between the proteins had to be within certain 
limits, as too much of an excess of either protein abolished phase separation. Thirdly, the 
valence, i.e. the number of interacting modules within one protein, and their affinities 
influence the concentration range in which phase transition can be observed.  
Following these concepts, it was speculated that an increasing concentration of 
monomeric HLM peptide added to a phase transition assay should be able to interrupt phase 
transition. Monomeric HLMs should saturate the interactions sites of Edc3 without promoting 
the formation of an indefinitely branched continuous network. Indeed, addition of monomeric 
HLM-1 suppressed phase separation in vitro. When the same HLM peptide from Dcp2 is 
overexpressed in vivo, this interferes with the localization of Edc3 to P-bodies. Interestingly, 
P-bodies are still present in these cells underlining the redundancy of mechanisms for P-
body formation. This experiment demonstrates that findings from the in vitrosystem are in 
agreement with proceedings in a cellular environment.  
To additionally investigate how accurately our in vitro system could represent the 
properties of P-bodies, their dynamics and ability to incorporate interacting proteins were 
examined. Indeed, fusion events similar to those observed in the highly dynamic P-bodies 
[80-83] could be observed. Moreover, phase separation was also observed when mixing 
Dcp1/Dcp2 constructs (Dcp2 1-289 + 553-741 excluding the mid-domain) with full length 
Edc3. The droplets contained Dcp1 protein, demonstrating that as in the cellular foci, 
additional factors can be recruited into the droplets by additional interaction sites on the 
scaffolding proteins.  
 
Pdc1 has been implied in P-body formation in S. pombe [84] and is related to 
metazoan Edc4 [85]. It encompasses a WD40 domain, a coiled-coil multimerization domain 
and a C-terminal domain with similarity to D. melanogaster Ge-1c. Additionally, the N-terminal 
region of Pdc1 displays three HLM motifs. To assess the function of the HLM motifs in P-
body formation, the interaction between the motifs and the Edc3-LSm domain was validated 
and quantified by NMR and ITC. The affinities range from high μM to mM. Pdc1 that can 
multimerize via its coiled coil domain can theoretically promote phase transition by a high 
valence of HLMs per molecule. As no soluble Pdc1 could be obtained, an engineered version 
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in which the coiled-coil domain was replaced by glutathione S-transferase (GST) to permit for 
dimerization was expressed. Phase transition assays demonstrated that also Pdc1 
undergoes formation of an oil-like droplet phase in presence of Edc3 indicating the presence 
of an indefinite network of intermolecular interactions. Hence, Dcp2 and Pdc1 are redundant 
proteins in their ability to induce phase separation by interaction with Edc3. 
 
In addition to the HLM motifs and the coiled-coil multimerization domain which are 
required for induction of phase transitions, Pdc1 encompasses in the far C-terminus a 
sequence with similarity to Ge-1cdomains. We verified the fold of this domain by solving the 
x-ray crystal structure of Pdc1 932-1076 at a resolution of 1.35Å. The structure revealed 
close structural similarity to the C-terminal domain of D. melanogasterGe-1. It consists of a 
very closely packed helical bundle with eight α-helices. The N-terminal three and C-terminal 
five helices are oriented in a 90-degree angle from each other.  
The C-terminal 290 residues of Pdc1 interact with Dcp2 [84] and encompasses the Ge-
1C domain. To assess whether it is directly involved in this interaction, NMR titrations with 
labeled Pdc1 Ge-1C and unlabeled Dcp1/Dcp2 complex were performed. Upon addition of 
the decapping complex, resonances of residues located in the C-terminal helices were 
perturbed indicating interaction with Dcp1/Dcp2 in this site. This finding demonstrates that at 
least two types of interaction take place between Pdc1 and components of P-bodies: Firstly, 
HLM motifs in the N-terminus interact with dimeric Edc3 and secondly, the C-terminal Ge-1C 
domain directly contacts the decapping complex. Multimeric Pdc1 has for both interactions a 
valence of > 1 so that both interactions are expected to contribute to phase transition 
processes. These findings explain the described function of Pdc1 in P-body integrity and 
underline its importance as a scaffolding protein.  
 
 
Using a bottom-up approach to reconstitute a minimal system that can undergo phase 
transition from purified recombinant proteins, it was possible to characterize the determinants 
required for phase transitions in vitro. The droplet phase contained both recombinant 
proteins as demonstrated by the localization of Oregon Green dotted Dcp2 and Edc3. We 
investigated the influence of overall concentration of proteins, of relative excess of one 
protein over the other and of valence. 
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Overall concentrations to obtain phase separation were required to be in the high 
micromolar range and the modular concentrations needed to be similar to each other. A high 
excess of either of the components did not result in phase separation, as this component 
would saturate the binding sites of the other interaction partner and then does not allow for a 
branched network that can indefinitely expand within the protein phase. Also, addition of an 
excess of a monomeric HLM peptide resulted in disruption of the droplet phase as the 
interaction with the peptide would bind available Edc3 LSm sites without allowing for a 
branched network. In vivo, overexpression of the same peptide resulted in the loss of Edc3 
localization to P-bodies, demonstrating that Edc3 is recruited to P-bodies by the interaction 
with HLM motifs. Moreover this experiment underlines the redundancy of mechanisms for P-
body formation in the cell.  
As expected, the valence of interactions was relevant, i.e. the number of interacting 
motifs per molecule. In Dcp2, there are seven identified HLMs whereas the valence of Edc3 
is two, as the dimer encompasses two LSm domains. Increasing the valence of the Dcp2 
construct lowered the overall concentrations needed to obtain phase separation, consistent 
with the concept of avidity.  
The affinities of the interactions between Edc3 LSm and the various HLMs from Dcp2 
and Pdc1 vary between low μM and the mM range. Due to the high overall concentrations in 
P-bodies even interactions that are considered weak may result in appreciable saturation 
under these conditions. 
 
We here present a bottom-up approach to model the phase separation events 
occurring in P-bodies in vitro. Due to the redundancy of the process in vivo, efforts to study 
its mechanisms by genetic approaches are hampered [86]. Thus a reconstituted system of 
recombinant proteins allows building up a minimal essential system in which single events in 
phase transitions can be studied without redundancy.  
This model emulates diverse properties of cellular P-bodies, such as fluid dynamics or 
incorporation of interacting proteins into the droplet phase, e.g. Dcp1 via its interaction with 
Dcp2. Additionally, we have shown that overexpression of monomeric HLM peptide interferes 
with Edc3 localization in vivo and in vitro.  
Further work will explore how more components of mRNA decay can localize to the 
droplet phase. For example, the helicase Dhh1 has been shown to interact with the FDF 
repeat of Edc3 and could thus be recruited. mRNA can be bound by the catalytic domains of 
both the helicase and the decapping complex and in return provide a binding platform for 
other RNA interacting proteins.  
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Furthermore, this in vitro model can be used to investigate the mechanisms that 
underlie P-body formation upon stress. It has been speculated that protein concentration in 
the cellular environment are close to a phase transition in order to allow for rapid phase 
separation upon small changes in the system such as application of a posttranslational 
modification or small changes in protein concentration. Our model allows for the investigation 
of the effects that permit droplet formation, such as concentration, avidity and affinity of the 
interactors. It could also be used to study if and how phase separation influences the activity 
of the enzymes involved.  
 
As mentioned before, the mechanisms underlying P-body formation are highly 
redundant and variable among species [87]. Previous work has demonstrated that low 
complexity regions in the RNA binding protein FUS can induce the formation of amyloid-like 
fibrils and induce phase separation [88-90]. This mechanism is different from the interaction 
we observe between HLMs from Dcp2 and Pdc1 and the Edc3 LSm domain. However, also 
other proteins that localize to P-bodies display low complexity regions e.g. LSm4, Pat1p and 
XrnI. Both interactions are expected to occur concomitantly enhancing the phase separation 
process. Therefore, protein concentrations required for phase separation in the cell are 
expected to be much lower than in the simplified and less redundant in vitro system.   
We have characterized an additional interaction within the network of P-body proteins. 
We show that Pdc1 contains a Ge-1Cdomain and have solved its structure by x-ray 
crystallography. This part of the protein had been reported to interact with Dcp2 and we have 
shown by NMR that this domain indeed interacts with the decapping complex Dcp1/Dcp2 
using its C-terminal helices. Any additional interaction between P-body components is 
expected to influence the requirements of the phase transition process so that direct protein-
protein interactions have to be characterized and taken into account to predict conditions of 
phase transition.  
It remains to be noted that interactions in the network of P-body components may not 
only serve the purpose of localizing proteins to these foci, but also to modulate their catalytic 
or binding functions. Thus, further work will be aimed at dissecting how molecular 
interactions lead to P-body formation and function.  
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Structure and RNA sequence specificity have been well established for the Sm 
complex. For the closely related LSm proteins structural information was lacking at the time 
of the work. The sequence conservation between Sm and LSm proteins argues for similar 
ternary and quaternary structures for the LSm proteins.  Particularly, the pairwise sequence 
similarity suggests that each single LSm protein is most similar to a single Sm protein (SmB-
LSm1/LSm8; SmD1-LSm2; SmD2-LSm3; SmD3-LSm4; SmE-LSm5, SmF-LSm6 and SmG-
LSm7). This argues for conserved functions and a common assembly pathway shared by the 
LSm ring. On the other hand, the complexes differ however in their cellular function, their 
stability in the absence of RNA, their requirement for RNA and the action of chaperones 
during assembly. Thus, experimental data is required to characterize LSm rings and their 
assembly on a structural and functional level.  
 
 
We here present the structure of the LSm657 complex from S. pombe solved by x-ray 
crystallography at a resolution of 2.5 Å. 
Two copies of each LSm protein are arranged in a ring-shaped heterohexamer, which 
is together with heptamers a typical oligomerization state for Sm and LSm complexes [29, 
91, 92]. The order of the monomers in the ring is 657-657. Two hexameric rings are present 
in the asymmetric unit of the crystal. The dimensions of the torus are approximately 33 Å in 
height, 54 Å in outer diameter and 11 Å in pore size.  
The structure comprises residues 4-79 of LSm5, 3-73 of LSm6 and 26-99 of LSm7 
which cover the canonical components of the LSm fold for all proteins: an N-terminal α-helix 
followed by 5 highly bent β-strands. The strands form a continuous antiparallel β-sheet that 
extends across the subunits by the interactions between the second half of β-4 of one 
monomer with β-5 of the next one. These strands are contained in the hallmark Sm2 motif, 
while the Sm1 motif spans β-1, β-2 and β-3. The topology of the LSm domains is an SH3-like 
barrel that is closed by the crossover of the β-5 strand over the highly bent β-sheet. In 
addition to trans-β-strand contracts, intersubunit interactions are mediated by the N-terminal 
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helix that stacks onto the β-sheet of the neighboring subunit at the proximal side of the ring. 
Side chain contacts between subunits involve salt bridges and hydrophobic interactions.   
Interestingly, the number of contacts in the two native interaction surfaces is higher 
than in the non-native interface between LSm6 and LSm7. Analysis of the structure of 
LSm657 by the PISA server (Protein Interfaces, Surfaces and Assemblies) supports this 
finding as fever hydrogen bonds and electrostatic interactions are detected.  
The crystal structure includes eight Zn2+ ions that are bound to each hexameric 
complex in our structure. Four of these ions are located at the surface, one at the Lsm6-
LSm5 interface and three are cluster at the interface between LSm6 and LSm7. This 
interaction most likely results from high concentrations of zinc acetate in the crystallization 
condition, which was present at 100 mM.  
 
All copies of the LSm proteins adopt the canonical LSm fold. Cα RMSDs of the Sm 
motifs of identical LSm proteins are very small (0.20 Å, 0.58 Å, 0.13 Å respectively for LSm5, 
LSm6 and LSm7). The larger RMSD of the four copies of LSm6 results from a different 
conformation of loop 2. Also RMSD values between the mean structures of the individual 
LSm proteins are small ranging between 0.75 Å and 1.34 Å. 
The similarity between corresponding pairs of Sm and LSm proteins that is easily 
observed on the sequence level is not mirrored in structural similarity. The RMSDs between 
pairs of corresponding LSm and Sm proteins were not significantly lower than these of 
unrelated pairs. Previously, RMSDs between human Sm, archaeal Lsm and bacterial Hfq 
proteins had been reported to be below 1.5 Å for the conserved Sm1 and Sm2 motifs, 
indicating a stable, rigid and conserved fold. Interestingly, the RMSDs are low independent 
from the oligomeric state of the complexes in question. The features that give rise to 
assembly of the LSm proteins in their specific order and to RNA specificity are thus not 
coded in overall topology. Rather, the side chains of contributing positions located on the 
rigid LSm scaffold dictate specificity by forming the complementary interaction surfaces of 
the native ring.   
 
The pore of the LSm657 is composed of residues from loop 3 and loop 5. It   is 
positively charged suggesting a role in RNA binding. Previous structural studies on the 
archaeal homoheptameric Sm1 protein have revealed interaction with a uridine nucleotide in 
this region [92]. Similarly, in the complex between human Sm ring and RNA the RNA passes 
through the pore. All Sm proteins in this structure interact with consecutive bases in a slightly 
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different fashion. In addition to binding to 3’ ends, the LSm complexes have also been 
reported to interact more transiently with RNA than their Sm counterpart. This is reflected in 
varying conservation of positions in the nucleotide binding pocket in Sm and LSm proteins: 
these range from virtually complete conservation to substitution to chemically similar 
residues. These differences in conservation support alternative sequence specificities for the 
Sm and LSm rings but at the same time complicate sequence prediction for LSm interacting 
RNAs. 
 
NMR studies were carried out to confirm the quaternary structure of the LSm657 
complex in solution. These experiments were prompted several considerations: Firstly, 
previous work has demonstrated that LSm proteins can adopt different oligomeric states in 
crystals than in solution [23]. Furthermore, the ring shaped assembly requires interruption of 
two interfaces upon formation of the native heptameric LSm rings from the LSm657 
hexamer. Thus, the observed quaternary state might hamper assembly and should thus be 
confirmed independently. Finally, we asked whether the presence of zinc ions in the buffer 
influenced protein-protein interfaces and thus the composition of the complex.  
 
Following a divide and conquer strategy aimed to investigate LSm657 in solution, we 
first studied the LSm57 complex that does not assemble into a higher oligomeric state. 
LSm57 being dimeric demonstrates an inability of β-strand 5 of LSm7 to interact with the β-
strand 4 of LSm 5 and to form a non-native LSm75 interface.  A complete backbone 
assignment was obtained for this complex using a U-[13C, 15N,1H] labeled sample. Analyzing 
secondary chemical shifts demonstrated that secondary structure elements in the complex 
are present as predicted for the canonical LSm fold. Additionally, short amide-amide 
distances observed in NOESY spectra are in very good agreement with the substructure of 
LSm57 that was extracted from the LSm657 structure. Together, these data demonstrate 
that both the fold and the mode of dimerization of LSm57 are similar in solution as in the 
crystal. 
 
In order to study the LSm657 complex, sample preparation and pulse sequences had 
to be adapted to a 60kDa protein complex. Therefore, fully deuterated samples and 
transverse relaxation optimized spectroscopy (TROSY) experiments were used. A full 
assignment of the LSm657 complex was performed, as assignments from the LSm56 
complex could not be transferred due to a large number of chemical shifts between the 
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spectra.  Also for the LSm657 complex, the secondary chemical shifts indicate the presence 
of the canonical LSm secondary structure elements. 15N-edited NOESY and TROSY-15N (t1)-
NOESY-TROSY 15N (t2) – 1H(t3) spectra demonstrate that almost all short-range amide-
amide distances predicted from the crystal structure are observable, including intermolecular 
cross-strand contacts. These experiments confirm the formation of a stable, hexameric 
LSm657 complex in solution in absence of zinc acetate. Hence, no artificial intramolecular 
contacts are introduced by interaction with the zinc ions. Together, we demonstrate the 
agreement between the crystallized quaternary structure and the solution state for LSm657.  
 
The contacts that differ between the LSm57 dimer and the LSm657 hexamer are the 
interfaces between LSm7 and LSm6 and between LSm5 and LSm6. Thus, a change in the 
chemical environment and thus chemical shifts are expected for residues in these areas. 
Comparing the spectra of LSm57 and LSm657, significant chemical shift perturbations in 
these areas are detectable, yet also regions distant from these site display chemical shift 
changes. We argue that these small but significant effects result from an effect that globally 
affects protein structure. In a dimeric assembly, LSm proteins are predicted to adopt an 
angle of 51° as is the case for dimeric Sm intermediates [93]. This angle is optimal for their 
further assembly into a heptamer. Contrarily, in the hexameric LSm657 complex, the 
subunits are expected to interact in a 60° angle, which we confirm in our crystal structure. 
We argue, that the change in the spectra results from subunits interacting in different angles 
in both complexes. The strain induced by the hexameric assembly might be compensated for 
by formation of the two non-native LSm67 interfaces. This observed angular plasticity has 
also been reported for the A. fuldigusLSm2 protein, which can assemble in hexamers and 
heptamers depending of pH, ionic strength and the presence of RNA [91, 94].  
 
LSm7 contains long presumably unstructured N- and C-terminal extensions. These are 
readily cleaved during proteolytic treatment during sample preparation for crystallization. 
NMR experiments show that these sequences are most likely disordered in solution, as 
resonances corresponding to these residues are absent from NMR spectra. 
 
 
To probe whether LSm657 is a functional assembly intermediate, we examined 
whether a subsequent assembly step could be recapitulated in vitro. Pull-down experiments 
on His-tagged LSm657 incubated with untagged LSm23 were performed to assess the ability 
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of these LSm proteins to assemble into a stable subcomplex. Indeed, LSm23 could be 
copurified with LSm657 after incubation. This demonstrates that LSm23 strongly interacts 
with LSm657 and forms a complex containing all five LSm proteins. Interestingly, when using 
an excess of LSm23, the resulting complex contains an increased amount of LSm23 
indicating the formation of a heptameric LSm23-23-657 assembly. Contrary, LSm56 is not 
able to copurify LSm23 indicating that the LSm7 interface is required to mediate the 
interaction with LSm23. This is in agreement with the position of LSm23 adjacent to LSm7 in 
the native ring.  
To gain molecular detail on the assembly reaction we observed its procession by NMR. 
Spectra of U-[15N,1H] labeled LSm657 were recorded and the incorporation of unlabeled 
LSm23 monitored over time. We find that LSm23 interacts strongly with LSm657 as 
demonstrated by strong chemical shift changes in LSm657. These changes occur on a slow 
exchange regime over a period of hours indicating a process with high activation barrier. This 
argues for the fact that the observed interaction is indeed a remodeling of LSm proteins into 
a common ring and not mere binding of LSm23 on top of the hexameric LSm657 ring. 
 
  Again, upon incorporation of LSm23, large differences in the spectra of LSm657 
occur. These are, as observed previously for the LSm56 and LSm657 complexes, affecting 
more resonances than the interfaces involved. There, we attributed the extent of the shifting 
resonances to a changing angle between subunits upon change of oligomeric state. Also 
upon incorporation of LSm23, the number of LSm proteins in the ring changes. This might 
induce a change in LSm angle resulting in chemical shift changes from angular 
rearrangement in LSm657 in addition to those from direct interaction. However, since no 
assignment is available for the LSm23-23-657 complex, the location of the interacting 
surfaces with LSm23 cannot be mapped to LSm657 to validate the topology in LSm23-23-
657. Nevertheless the fewer contacts between LSm7 and LSm5 argue for a weaker interface 
that would more easily dissociate and accommodate LSm23 subunits. This is in agreement 
with the location of LSm23 next to LSm7 in the native complex.  
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We here report the structure of the hexameric LSm657 assembly intermediate. The 
structure displays the features of a canonical, ring-shaped LSm multimer in sequence, 
topology and tertiary and quaternary structure. The subunit order in the hexamer is 657-657. 
The Sm intermediate SmFEG that corresponds to the LSm657 complex also forms a 
hexamer in vivo and has been shown by biochemical experiments to adopt that subunit order 
(Plessel et al., 1997, Kambach et al., 1999). This complex has a physiological role in Sm ring 
formation. It is recognized by the SMN protein and by successive addition of other preformed 
assembly intermediates (SmBD3, SmD1D2), the functional Sm ring is assembled around the 
snRNA [7]. Our data demonstrate that the LSm657 complex is an intermediate in LSm 
assembly. 
 
The interfaces between LSm6 and LSm5 and between LSm5 and LSm7 in the LSm657 
complex are present in the final LSm1-7 and LSm2-8 rings. In contrast, the interface between 
LSm7 and LSm6 in LSm657 occurs only transiently during assembly. Other non-native LSm 
interfaces are present in stable complexes and have been reported. These include LSm6-
LSm7, Lsm3-LSm2, LSm2-LSm7 and LSm3-LSm3 interactions [10, 23, 27]. Other interfaces, 
however, do not stably associate. In this work, we have shown that LSm57 is a dimer in 
solution indicating that β-4 of LSm5 is not able to stably interact with β-5 from LSm7. The 
main interactions between LSm subunits are hydrogen bonds between the β-4 and β-5 of 
neighboring subunits and are thus sequence unspecific. Yet, a specific order of subunits is 
maintained in Sm and LSm rings. The information must thus be coded in other contacts in 
the interface, which constitute complementary protein interfaces.  
Unfortunately, comparing the native and non-native interaction surfaces between the 
LSm proteins in the LSm657 complex doesn’t reveal the residues that are required for 
specific assembly. Previous work has suggested, that different interactions occur between 
subunits in assembly intermediates compared to the native complex [29, 93]. Hence, direct 
comparison with the final LSm1-7 or LSm2-8 complex from S. pombe might elucidate the 
molecular details of specificity, however these structures are currently not available. Recent 
structural studies have characterized the S. cerevisiae LSm1-7 and LSm2-8 rings that differ 
from S. pombe.  
Additionally, direct measurement of interface stability would provide data on the 
correlation between stability and specificity in LSm assembly. Mutational analysis can point 
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out crucial residues that specify the sequence of assembly events and final subunit order in 
LSm and Sm complexes. 
 
Sm and LSm proteins have previously been shown to assemble into diverse multimeric 
complexes. The native LSm1-7 and LSm2-8 complexes are heptameric rings, but stable 
rings with different stoichiometries are known as well. The closely related bacterial Hfq, 
SmFEG and LSm657 are both hexameric while the structure of an octameric LSm3 complex 
has been solved [23, 26, 27, 95]. Angular plasticity is a common feature among Sm and LSm 
proteins of which the molecular basis is yet unknown. 
In this work we observe that the spectra of the subunits in the LSm57, LSm657 and 
LSm23-657 complexes differ substantially. Chemical shift changes occur not only at 
resonances corresponding to sites close to the interaction surface but also in more remote 
locations. We interpret these smaller but significant chemical shifts changes as changes in 
the angular rearrangement upon forming a ring of different size. As the angle in the dimeric 
LSm57 is not restrained, it is possible that it will adopt the same angle as the dimeric protein 
complexes SmBD2 and SmD1D2. These have been reported to adopt angles close to 51°, 
which is the angle in a native heptamer. The ring-shaped hexameric LSm657 adopts an 
angle of 60° between its subunits. Thus a change of oligomeric state between dimer and 
hexamer would be consistent with angular change and thus with the remote chemical shift 
perturbations between LSm57 and LSm657.  
The oligomeric state of the intermediate LSm23-657 can be either pentameric or 
heptameric depending on whether one or two units of LSm23 are incorporated. Both our 
biochemical data and the absence of pentameric LSm assemblies suggest the heptameric 
state. In both cases however, the intersubunit angle changes upon incorporation of LSm23, 
which is consistent to the additional chemical shift changes we observe in the spectra upon 
LSm23 incorporation.   
How do LSm proteins achieve this angular plasticity? The rearrangement could occur 
via changes in the arrangement of secondary structure elements or by repacking the side 
chains in the interfaces. Our NMR data suggests that changes upon incorporation of subunits 
are propagated to more distant locations in the protein. This would argue for a 
rearrangement throughout the secondary structure elements. However, if the oligomeric state 
was mainly coded in the secondary structure, the Cα RMSD values in heterooligomers should 
reflect mainly the oligomeric state of a complex. There, subunits in the same oligomeric 
state, e.g. in heptamers, should be similar and differ from protomers in a hexameric state. 
This is however not the case.    
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Interestingly, it has been shown that the interactions contributing to dimerization in Sm 
subcomplexes are different to those present in the final Sm ring [29, 93]. This finding argues 
for a side chain rearrangement in the interfaces although the angular change is small 
between these complexes. In LSm complexes, the angular change of 9° per interface upon 
transition from a hexameric to a heptameric complex results in a maximal change in distance 
of 4 Å between two subunits. Repacking side chains can span this distance. Furthermore, 
side chain rearrangement may occur additionally to a tighter packing of secondary structure 
elements.   
It remains to be seen how the transition from hexameric to heptameric intermediates 
influences the stability of the complex and whether the change in oligomeric state serves 
functional purposes during assembly.  
 
The assembly of the Sm ring has been well studied [7]. After the snRNA is transported 
into the cytoplasm, preformed subcomplexes (SmFEG, SmBD3, SmD1D2) of the seven Sm 
proteins are deposited successively on the snRNA by the SMN protein. The order of 
assembly in Sm proteins is SmFEG, followed by SmD1D2 and SmBD3. SmFEG has been 
shown to be a hexameric assembly intermediate [96]. This suggested that the homologous 
hexameric LSm657 complex performed a similar function during LSm assembly. Indeed, in 
our vitro experiments have shown that under physiological conditions, LSm657 can 
incorporate LSm23, the homologue of SmD1D2 in vitro and thus retrace the assembly 
pathway of the Sm ring. This finding is in agreement with the notion that proteins are under 
evolutionary pressure to retrace ordered assembly pathways [97].  
In vitro, the binding of LSm23 into LSm657 takes place on a timescale of hours. This 
indicates that the process has a relatively large activation barrier, arguing for an 
incorporation event rather than simple binding on a preexisting surface. Incorporation of 
LSm23 into hexameric LSm657 would require the opening of two LSm interfaces, which 
would be in agreement with a slow process. The remodeling of the ring that we describe is 
rather slow, but could in vivobe accelerated by the presence of RNA, chaperones and 
LSm1/LSm4/LSm8 that are incorporated into the LSm ring at a later stage.  
Considering the conservation between Sm and LSm proteins, other features of the 
complexes may be similar, too. Our structure of the LSm657 assembly intermediate shows 
that N- and C-terminal extensions that are predicted to be unstructured are indeed not visible 
in electron density. NMR experiments support the conclusion that these sequences are 
unstructured as no resonances corresponding to these amino acids were observed, in 
agreement with fast exchange of amide protons with the solvent in unstructured regions. In 
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the SmD1D2 and SmBD3 subcomplexes, regions outside the Sm fold also appear 
unstructured but fold and interact with RNA in the context of the complete Sm ring [93]. 
Hence, the extensions of LSm7 could serve a similar purpose in the LSm ring.   
 
In the LSm657 assembly intermediate, the pore of the ring is positively charged, 
suggesting a role in RNA interaction. While the smallest Sm assembly with reported RNA 
binding ability is SmD1D2-FEG [32] corresponding to LSm23-657, the putative RNA binding 
surface of LSm657 can be inspected and compared with the known mode of RNA interaction 
of Sm proteins.  
Sm and LSm rings bind different RNAs in the cell: The Sm ring is locked on the snRNA 
by virtue of double-stranded segments on both sides of the recognition sequence. The 
interaction of LSm rings with RNA is at the 3’ termini and is thought to be more transient. 
These mainly contain a cyclic phosphate in case of the Lsm2-8 ring [98] that interacts with 
U6 snRNA or a hydroxyl group for the LSm1-7 complex that recognizes the 3’ end of 
mRNAs. The rings thus differ widely in the details of their mode of interaction impairing the 
prediction of binding preference of the LSm657 segment. 
The crucial residues for RNA interaction in the LSm domain are located in loops 3 and 
5 on the inside of the pore. In the canonical nucleotide binding site, an RNA base is stacked 
between an aromatic residue (H37, numbering according to A. fuldigus LSm) and a highly 
conserved arginine residue (R63). The Watson-Crick edge of the base is read out by 
hydrogen bonds to a conserved asparagine (N39) conveying specificity for uracil bases. R63 
also contacts the phosphate moiety of the previous protomer whereas D65 sandwiches 
between the phosphate groups of the backbone. These hallmark residues are highly 
conserved in the ring-forming LSm proteins 1-8 with two exceptions: R63 in LSm5 is 
substituted for an asparagine. Additionally, the canonical aromatic residue that stacks with 
the base in LSm7 is substituted for a leucine.  
These observations suggest, that RNA interaction differs in LSm5 and LSm7 compared 
to the Sm binding mode. In the other LSm proteins the canonical sites are conserved, 
suggesting that their mode of interaction is more similar to that of the Sm ring, which features 
sequential interaction with internal bases. Overall, however, prediction of RNA interaction 
based on our structure remains elusive.  
Recently, the structure of the LSm2-8 ring from S. cerevisiae in complex with 5’-
GCUUUU-3’ and 5’-GCUUU-3’ has been determined [24]. These structures show that the 3’-
terminal uridine nucleotide is bound by LSm3 and the subsequent bases interact with LSm2, 
LSm8 and LSm4. This finding has been contested as the native RNA contains five terminal 
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uridine nucleotides and terminates often in a 2’-3’-cyclic phosphate [99]. It has been 
speculated that the additional uridine and the cyclic phosphate could be accommodated by 
LSm6. Both models however agree that the non-canonical LSm5 and LSm7 binding sites are 
not involved in sequential interaction with RNA.  
 
Future work on LSm ring assembly can be categorized in two parts: Theoretical 
considerations on the assembly mechanism and studies of assembly intermediates and 
assembly reactions in vitro and in vivo.  
 
The specificity of the order in the ring is coded in the complementarity of the interfaces 
and thus has to be predictable a priorifrom the sequence. Data on which interaction surfaces 
form in solution or in a crystal, and which do not, is available. However, there is no 
quantitative information on the energies of the interfaces that might be related to the specific 
formation of complexes. This hinders prediction of assembly intermediates. However, other 
information can be exploited to narrow down the residues that mediate specific interaction: 
LSm proteins and Sm proteins show pairwise similarity on the sequence level, but have not 
been reported to form mixed complexes. Thus, specificity has to be achieved with residues 
that differ between corresponding Sm and LSm proteins. Also, LSm1 and LSm8 act in 
different complexes but integrate at the same location in the ring. Thus, residues relevant for 
specificity have to be the same in these proteins ensuring their identical location. This work 
can make use of computational methods as well as assessment of the capacity of mutant 
proteins to assemble in the ring. This endeavor will profit from high-resolution structures of 
assembly intermediates and native rings from the same species to compare the contributions 
of single residues in the interfaces throughout assembly. 
 
Along these lines, it will be worth investigating, how the angular flexibility of LSm 
domains is mediated. The oligomeric state of Sm and LSm proteins ranges from bacterial 
Hfq that constitutively form hexamers to the archaeal Sm2 protein can form homohexamers 
and homoheptamers and eukaryotic Sm and LSm proteins that vary in oligomerization during 
assembly. It is unknown at present, what determines the oligomerization state of LSm and 
Sm rings and what its physiological function is. It is also unknown, whether the different 
oligomerization states of LSm subcomplexes is solely a result of interface promiscuity or 
whether it has a function in defining the energy of the intermediates along the pathway 
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towards the native ring. Again, high-resolution structures of different intermediates will help 
uncover the molecular details behind angular plasticity.  
 
Having established that LSm rings can undergo assembly in vitro, it will be interesting 
to investigate the further assembly pathway. We have shown that LSm657 can incorporate 
LSm23 subcomplexes. The molecular structure of LSm23-657 is currently unknown, 
although the known assemblies comprise hexamers and heptamers indicating that an 
LSm23-23-657 complex is more likely than a pentameric LSm23-657. Subsequent work will 
characterize the following assembly pathway leading to the native LSm1-7 and LSm2-8 
rings. Previous data demonstrates that the formation of these rings is correlated suggesting a 
coordinated assembly or a common precursor [20]. Future insight into the assembly 
mechanisms of both rings will indicate whether availability of LSm1-7 and LSm2-8 links RNA 
degradation with splicing.  
Our work also forms the basis of future structural analysis of LSm rings. While the 
molecular structure of the LSm2-8 ring in complex with RNAs and of the LSm1-7 ring in 
complex with Pat1p from S. cerevisiaehave been solved, the mode of 3’ end recognition for 
both rings are still unclear. For LSm2-8 the mode of 2’-3’ cyclic phosphate recognition is 
unknown as are the features defining a 3’ end of mRNA that are recognized by LSm1-7.  
LSm proteins are building blocks for a vast variety of rings. In addition to LSm1-7 and 
LSm2-8, also the hexameric LSm2-7 has been described that is involved in 
pseudouridination of rRNA [100]. Moreover, a variety of additional LSm proteins exist that 
have been reported to assemble into rings and are unrelated to RNA binding [101]. Studies 
addressing their assembly in rings will facilitate the investigation of their function and reveal 
principles of specific multimer assembly. 
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This thesis is concerned with understanding the molecular details underlying two steps 
in mRNA decay: The specific assembly of the LSm1-7 and LSm2-8 ring and the relevance of 
conformational dynamics for enzymatic function in the scavenger decapping enzyme Dcs1p. 
Addressing these questions will shed light on both mechanistic details of mRNA decay and 
on the principles governing specific protein complex assembly and enzyme dynamics in 
general.. 
 
At the beginning of this thesis, the structure and function of scavenger decapping 
enzymes had been characterized. These data and MD simulations implied a crucial role for 
conformational change in its catalytic cycle. Models for the DcpS catalytic cycle were 
however limited by a lack of experimental data of its protein dynamics: The structural 
characterization relied on interpolation between static states and the kinetic analysis on 
interpolation between known rates of binding and hydrolysis to describe the conformational 
change, yet no direct measurements of its rate or its trigger were available.  
The absence of quantitative data of enzyme dynamics is a common hindrance in 
understanding their molecular mechanism. Especially data on large proteins is scarce. NMR 
spectroscopy provides experimental means to investigate protein dynamics on various 
timescales and recent advances allow for application to large proteins. Thus, the goal of this 
part of my thesis was to measure and characterize the dynamics in the yeast scavenger 
decapping enzyme during catalysis. Thus, several questions are addressed: 
 What are the structural and kinetic details of Dcs1p conformational dynamics? 
 In which state (substrate-bound, product bound, singly or doubly occupied) do 
Dcs1p motions occur?  
 What are the molecular determinants in the protein and the ligand that give 
rise to Dcs1p motions? 
 What is the binding mode of the substrate m7GpppG to Dcs1p?  
 Do Dcs1p dynamics contribute to its enzymatic function, in particular to the 
phenomena of allostery, substrate inhibition and mutant hyperactivity? 
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To address these questions, a biophysical approach was used that combined NMR 
spectroscopy with x-ray crystallography, ITC and activity assays to obtain a comprehensive 
picture of Dcs1p function via dynamic, structural, functional and binding data.  
The significance of this work is twofold: Understanding the relevance of Dcs1p 
conformational dynamics will shed light on the mechanism of an important enzyme in mRNA 
degradation, how its substrate preferences and modes of inhibition are mediated. Also it will 
improve the understanding of its other cellular functions. Moreover, this work will improve the 
general notion of how protein dynamics can shape enzyme function. The concept of 
dynamically mediated allostery or substrate inhibition may be a general mechanism and thus 
expand our understanding of protein function.  
 
 
We solved the structure of inactive S. cerevisiae Dcs1p H268N in complex with the 
inhibitor m7GDP by x-ray crystallography to a resolution of 2.3 Å. Initial phases were obtained 
by molecular replacement using a search model based on the structure of human DcpS in 
complex with m7GpppG (1ST0).  Phases were improved by iterative rounds of model building 
and refinement. The model is in good agreement with experimental data and has good 
stereochemistry. 
The model of yeast Dcs1p in complex with m7GDP encompasses residues 7-343 of 
both chains. The overall structure is very similar to asymmetric structures of the human and 
mouse proteins. The dimeric C-terminal domain is adopts a HIT pyrophosphatase fold and 
dimerizes via a large shared surface. The N-terminal domain dimerizes via a strand swap 
where one protomer donates two β-strands to the β-sheet in the N-domain of the other 
protomer. The topology is identical to human and mouse proteins except for a 14 amino acid 
insertion in the N-terminal domain that is structured in the crystal but does not adopt a 
secondary structure. This stretch participates in crystal contacts and includes a disulfide 
bond. We conclude that without the stabilizing contacts and in the reducing environment of 
the cell, this loop is very likely unstructured.  
Yeast Dcs1p in complex with m7GDP adopts an asymmetric conformation that 
encloses the ligand tightly in a closed active site by interactions with the C-terminal domain, 
the hinge region and the N-terminal domain. Both domains behave as rigid bodies so that the 
residues involved in the ligand binding in the closed site are located at a distance in the open 
protomer. Interestingly, the second active site is empty.  
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For the human protein the C-terminal domain contributes most of the interaction 
surface with the ligand,as reported previously. Comparing the conformations of the 
interacting residues in the C-terminal domain for the open and closed active sites, the C-
domain of the closed active site resembles most to that of either the closed or open 
m7GpppN bound state. In contrast, the empty open site is most similar to the either empty 
open site in inhibitor bound structures or to the product bound open site. The differences 
between these conformations mainly affect Y264 the nearby residues S263 and W161. Y264 
is part of the triad that mediates recognition of the substrate methyl group and domain 
closure. Interestingly, the conformations of the catalytic residues are similar, raising the 
question why the open protomer is inactive. Additionally, the model of the open protomer 
lacks the loops 169-173 and 196-200 for which no interpretable electron density was 
obtained.  
The structure features three ordered sulfate ions. Due to the high concentration of 
ammonium sulfate, which is used as a precipitant during crystallization, lower affinity binding 
sites of sulfate are occupied in this condition. Two sulfate ions are located in the active sites 
respectively and make contacts with residues that in the substrate bound human DcpS 
enzyme interact with the triphosphate bridge. The third sulfate ion is located beyond the 
binding site of the second base of the substrate and might thus interact with a site that would 
coordinate the phosphate moiety of the RNA body in longer substrates. The residues 
interacting with the first two sulfates are conserved, while the residues that interact with the 
third sulfate are not.  
Overall the structure of yeast Dcs1p is very similar to these of human and mouse 
scavenger decapping enzymes. It is noteworthy that in this structure, only the closed active 
site is occupied with m7GDP.  
 
NMR experiments on larger proteins require specialized strategies to reduce signal 
loss due to relaxation and to reduce spectral complexity due to spectral overlap. Methyl-
TROSY pulse sequences select for less slowly decaying component of magnetization and 
thus improve signal intensity for larger proteins. The methyl TROSY experiments we exploit 
here were carried out on uniformly 1H13C Ile-δ and Met-ε labeled and otherwise deuterated 
samples. The benefit of using methyl groups as probes is threefold: Three equivalent protons 
provide triple signal to noise, and using methyl groups reduces spectral overlap while still 
providing well distributed probes throughout the protein. Moreover, the effective correlation 
time of the nuclei is reduced due to the high flexibility of the hydrophobic residues used for 
this labeling scheme, resulting in slower relaxation.  
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To relate information from recorded spectra to the molecular events on the protein 
level, each peak needs to be assigned to the residue that gives rise to it. In case of 
isoleucine and methionine residues, assignment was carried out by a mutational approach. 
Mutation of relevant residues to a similar amino acid, such as leucine, which does not get 
specifically labeled, results in disappearance of the respective peak, which is thus assigned.  
In case a peak of interest was to be assigned, prior knowledge was used to speculate 
on the identity of the corresponding amino acid: Comparing spectra from separate domains, 
the location of a residue in either the N- or C-terminal can be deduced. Additionally, chemical 
shift perturbation of a residue upon mutation of another one argues for proximity of the two. 
Finally, the x-ray crystal structure of yeast Dcs1p we solved previously was used for structure 
based chemical shift prediction with shiftx [102] in order to make an educated guess on 
residue identity. Subsequent validation by mutating the candidate residues allowed for 
unambiguous assignment.  
Using this strategy, a set of residues was assigned that covers 49% of isoleucine and 
33% of methionine methyl groups. The assigned residues are distributed over both domains, 
the hinge region and the active site and thus provide a comprehensive set of probes 
throughout the protein.  
 
The presence of only one molecule of m7GDP in our structure of yeast Dcs1p argues 
for non-identical mechanism of ligand binding to the two sites. Also, the structures of DcpS 
proteins in complex with two ligand molecules have revealed strikingly different modes of 
interaction for the two sites. The closed site is formed by N-terminal, C-terminal and hinge 
domain and encloses the substrate m7GpppN tightly. In contrast, the open site consists of the 
C-terminal domain interaction surface with few additional contacts between the flexible 
second base and the hinge domai. Differing both in number and character of contacts, the 
structures suggested different strength of interaction. Given the anti-cooperative nature and 
substrate inhibition of scavenger decapping enzymes, a more complex mode of interaction 
than independent binding to the two active sites had to be suspected.  
In order to elucidate the order of events in DcpS substrate binding, we conducted NMR 
and ITC experiments to obtain information on both affinities and the residues involved in 
binding.  
NMR titration experiments on inactive Dcs1p H268N protein and the substrate 
m7GpppG revealed that substrate binding occurs in two subsequent steps.  
In the free state, the number of peaks corresponds to the number of isoleucines and 
methionines in one Dcs1p chain. This demonstrates that Dcs1p is a symmetrical homodimer 
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in which a residue encounters the same chemical environment in both chains. Additionally, 
the free spectra correspond well to an overlay of the separate N- and C-terminal domains 
indicating no significant interaction between the domains in the free state. Both findings are 
in agreement with the published crystal structures of free human and mouse DcpS proteins.  
 During titration of Dcs1p with m7GpppG, at first large overall changes in the spectrum 
occur until reaching a molar ratio of 1:1 between Dcs1p dimer and ligand. The number of 
peaks increases significantly in a slowly exchanging process. The intensity of newly 
appearing peaks increases while a portion of previously present peaks decreases in 
intensity. These findings indicate a global conformational transition upon binding of one 
substrate molecule per Dcs1p dimer, consistent with the reported asymmetric state of ligand-
bound Dcs1p. The conformational change influences a larger part of the protein than that 
involved in ligand interaction. As the protein adopts an asymmetric conformation, the same 
residue in the binding and free protomer experiences a different chemical environment. 
Interestingly, some peaks split into two new positions, indicating that the symmetrical state 
differs from both the open and closed conformation in the asymmetric state. In contrast, 
some peaks split, with one peak displaying identical chemical shift as the symmetric peak. 
This indicates that, in many respects, one conformation is similar to the symmetric one. 
Referring to the structure, this is the case for the open protomer.  
When titrating to an excess of more than one substrate molecule per Dcs1p dimer, 
again, chemical shift perturbations occur. These affect few peaks and take place on a fast 
exchange regime, while the chemical shift changes occurring due to protein asymmetry are 
still present. The newly occurring chemical shift perturbations can be mapped to residues 
close to the open active site in the C-domain and to interacting residues in the hinge and in 
the N-terminal domain close to the hinge. In contrast, the resonances corresponding to 
closed active sites do not experience further chemical shift changes. These findings indicate 
a secondary substrate-binding event in which a second molecule of m7GpppG interacts with 
asymmetric Dcs1p and is bound to the open active site.   
The NMR titration experiments reveal a sequential binding mode for Dcs1p with a 
nanomolar first binding event that is concomitant with symmetric to asymmetric transition and 
a second binding event to the open active site that is estimated to be of micromolar affinity.  
In order to obtain thermodynamic parameters, isothermal titration calorimetry (ITC) was 
used to further characterize the sequential binding of m7GpppG to inactive Dcs1p H268N. 
This inactive but otherwise wt protein did not yield interpretable isotherms as an additional 
endothermic process hindered analysis. Rationalizing that the cause might be an 
aggregation event, mutants and conditions were screened for interpretable isotherms. 
Isothermal titration data of Dcs1p K126A H268N were free of the additional endothermic 
event and were interpreted using a sequential binding model. In this mutant, a lysine residue 
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contacting the β-phosphate group in the closed active site, is replaced by an alanine. It 
displays the same conformational change and secondary binding site as the wild-type. As the 
overall properties of the protein are the same, the thermodynamic parameters are a good 
estimate for the wild-type although they may differ and underestimate the true values. The 
fitted affinities for the first and second binding site are 240 ± 90 nM and 280 ± 30 μM 
respectively. 
The C-terminal domain contributes the main surface for the second binding. To 
investigate the relative contribution of N- and C-terminal domains to overall binding, we also 
characterized the interaction between separately expressed C-domain (residues 130-350) 
and m7GpppG by NMR spectroscopy and ITC. NMR demonstrated that the same residues 
mediate substrate binding to the C-domain in the separate domain as in the full-length 
context (residues I165 and I210). Some additional shifts in the full length Dcs1p protein are 
present in the N-terminal domain (I42 and I116). These are located in the hinge and adjacent 
side chains. The ligand in the open site cannot make direct contact with all of these residues 
in the N-terminal domain. The hinge region interacts directly with the substrate but structural 
changes expand into the N-terminal domain (see later paragraphs).  
Taken together, our x-ray structure of Dcs1p in complex with one molecule of m7GDP 
suggests the presence of a singly occupied state. Subsequent titration experiments via NMR 
agree with published structures of free, singly and doubly occupied DcpS proteins. We show 
here that Dcs1p follows a sequential binding mechanism with affinities in the nano- and 
micromolar range.  
 
The previously determined structures of human DcpS in complex with substrates are all 
captured in the closed asymmetric conformation. The proximity of catalytic residues and of 
residues with influence on activity suggest that the formation of this state is required for 
catalytic activity, The network mediating the interaction between the domains encompasses 
a set of hydrogen bonds around tyrosine 94 that recognizes the methylation on the RNA cap 
structure. In order to assess the relevance of this interaction for the formation of the closed 
conformation we recorded spectra of the Y94A mutant in presence and absence of m7GpppG 
and of wt Dcs1p in presence and absence of the unmethylated cap analog GpppG. In both 
instances, we observed an interaction of the ligand with the enzyme in the C-domain part of 
the active site as demonstrated by shifting resonances of reporter peaks (I165, I210). 
However, we found no indication of an asymmetric state upon disruption of the interaction 
between Y94 and the methyl group. We then determined the activity of wt Dcs1p on GpppG 
and of Dcs1p Y94A on m7GpppG and found them to be inactive. Thus we demonstrate that 
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both establishment of a closed conformation and activity depend on the interaction between 
the methyl group of the cap substrate and Y94. 
 
Asymmetric crystal structures contain either substrates (m7GpppG, m7GpppA) or 
inhibitors (m7GDP, 5-quinazolines) in the closed active site. To test whether completed 
catalysis is sufficient to open the closed active site and release the product, we performed 
NMR titration experiments with the product m7GMP on Dcs1p H268N. The hallmark peaks 
that report on domain rearrangement display similar shifts in presence of m7GMP indicating 
that Dcs1p undergoes symmetric to asymmetric transition upon binding of m7GMP. Not all 
shifts are identical to the m7GpppG titration experiment, which is expected for a chemically 
different interaction partner. Thus, m7GMP can sustain the asymmetrical conformation of 
Dcs1p indicating that hydrolysis of the substrate is not sufficient to induce conformational 
change back to the symmetric state and thus product release from the closed active site.  
To address whether interaction with m7GpppG in the second catalytic site can induce 
product release from Dcs1p, we introduced a reporter isoleucine residue (L279I) in the active 
site of Dcs1p that probes the presence of m7GMP or m7GpppG in the active site. We then 
conducted experiments in which Dcs1p is converted to the asymmetric product bound form 
by addition of m7GMP. Then, the titration is continued with m7GpppG and the reporter peak 
clearly indicates that the product is displaced from the closed binding site and that then 
substrate is bound in a closed active site.  
These results demonstrate that m7GpppG can displace m7GMP from the closed active 
site. This can occur via a mechanism where m7GMP leaves the closed active site according 
to its off-rate via a symmetric state and is replaced by the more tightly binding m7GpppG. 
Alternatively, m7GpppG could induce a flip-over motion of the N-terminal domain upon 
interaction with the open protomer. This result is consistent with a model in which product 
release from a recently active catalytic site is coordinated with substrate binding in the open 
active site.  
 
Scavenger decapping proteins in complex with substrates or inhibitors enclose their 
ligand in a secluded closed active site. It is evident from their crystal structures that they 
have to undergo conformational change after turnover to release products and bind substrate 
molecules for the next round of catalysis. Quantitative data on Dcs1p motions are required to 
understand the catalytic cycle and to evaluate molecular models for its cooperativity and 
substrate inhibition.  
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Amongst other methods, protein dynamics on the millisecond time-scale can be 
observed by longitudinal exchange NMR experiments. In this experiment, peaks originating 
from different conformations of a single NMR active residue that interconvert on the 
millisecond time-scale display cross peaks. When a residue changes conformation from 
open to closed during a delay time between detection of chemical shifts in the direct and 
indirect dimension in the NMR experiment, its gives rise to a cross peak. This peak displays 
the chemical shift of the closed conformation in the dimension that is measured first (here 
13C) and of the open conformation in the other dimension (1H). Observation of the cross 
peaks unambiguously correlates peaks arising from the same residue in different 
conformations. Additionally, the frequency of interconversion and the relative populations of 
interconverting states can be extracted by examining cross peak intensity in dependence of 
delay time. Together, this method allows for detection of protein dynamics, identification of 
the residues involved and quantitation of protein motions. 
To examine the motions in Dcs1p occurring during the catalytic cycle, we conducted 
longitudinal exchange experiments on the inactive mutant Dcs1p H268N under varying 
concentrations of the substrate m7GpppG. The inactive mutant was used to prevent 
substrate turnover during data acquisition, which is required to obtain meaningful data on 
kinetic parameters. Experiments were carried out at 298 K, which is the optimal growth 
temperature of yeast, to ensure physiological conditions.  
Indeed, cross peaks could be observed for all well separated and exchanging 
residues,indicating molecular motions under conditions of substrate excess. Peaks exhibiting 
cross peaks, and thus a conformational change, are located both in the N- and C-terminal 
domain. These protein movements are energy independent, as no source of chemical energy 
was present in the experimental conditions.  
 
Close examination of the longitudinal exchange data provides information on the nature 
of the observed molecular motions in Dcs1p.  
Peaks corresponding to the open and closed protomer in the asymmetric state display 
cross peaks in between each other. Hence, the protein is undergoing a conformational 
change in which a closed active site is opened while the other one is closed. This constitutes 
a flipping motion of the N-domain. Several other lines of argumentation consolidate this 
interpretation: Firstly, all exchange rates fitted to well separated sets of auto and cross peaks 
are similar. Thus, the molecular motions constitute one global process in which all residues 
exchange conformation at the same rate, consistent with N-domain flipping.  
Secondly, the populations of interconverting states robustly fit to pA = pB = 0.5. By 
definition, in a process in which the two protomers in a homodimer exchange conformations, 
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the two states each have a relative prevalence of 0.5. This argues against an additional state 
with which the two asymmetric conformations might interchange. 
Moreover, the position of cross peaks argues against an exchange between 
asymmetric and symmetric states. In peaks that display different chemical shifts for both 
asymmetric states and the symmetric state, exchange peaks appear between the positions 
of the asymmetric closed and asymmetric open peak and not between these two and the 
position of the symmetric protein.  
Taken together, position of the observed cross peaks and fitted exchange parameters 
clearly demonstrate that Dcs1p undergoes flipping motions of its N-terminal domain under 
conditions of substrate excess. The movements correspond to an alternating opening and 
closing of the both active sites. Interestingly, the motions observed occur in presence of 
excess substrate and thus do not correspond to the release of product with concomitant 
substrate binding. Contrarily, these motions occur in absence of product and thus reflect 
events during substrate binding. 
Dcs1p is a homodimer, so the end-point states of this motion are structurally identical 
and only differ in which of the identical protomers is closed. Structurally, this end-point state 
is likely very similar to the asymmetric conformation that has been trapped in crystals of 
human DcpS in complex with m7GpppN and yeast Dcs1p in complex with m7GDP.   
Moreover, this finding has implications for the interpretation of previous titration 
experiments. The observed motions are present under excess substrate conditions including 
NMR titration experiments. Hence, the chemical shifts that were observed in the N-terminal 
domain upon interaction with the second site result from the dynamic domain rearrangement 
and not from direct interaction.   
 
We performed longitudinal exchange experiments at various substrate excesses to 
investigate the influence of substrate concentration on protein dynamics, particularly in the 
light of Dcs1p substrate inhibition. Experiments were carried out at Dcs1p dimer to m7GpppG 
ratios of between 1:1 and 1:20. Millisecond timescale flip-over motions occurred at all 
concentrations. Quantitation of these motions revealed that with increasing ligand, also 
protein dynamics increased up to a level of saturation. Measured frequencies of flipping 
range from below 5Hz to 35 Hz.  
Flipping motions occur in asymmetric Dcs1p and their frequency increases with 
substrate concentration. Previous titration experiments have shown that Dcs1p interacts 
sequentially with two molecules of substrate. Interaction with the first interaction site does not 
result in Dcs1p motions. At the substrate concentration where flipping-motions were 
observed, titration experiments demonstrated that the substrate binds to the second binding 
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pocket of Dcs1p. Thus we conclude that interaction with the second binding site allosterically 
induces conformational change in Dcs1p.   
 
The human scavenger decapping enzyme DcpS has been shown to be inhibited under 
conditions of excess substrate. It is noteworthy that inhibition coincided with conditions of 
increased flip-over motions. To investigate this relationship, we determined catalytic rates of 
Dcs1p under multiple turnover conditions were determined using 31P NMR experiments.  
The progress of m7GpppG hydrolysis can be monitored by following substrate and 
product concentrations over time. In the phosphorous 1D spectrum, Pα and Pγ of m7GpppG 
exhibit identical chemical shifts, but are well resolved from the peaks resulting from Pβ and 
the phosphates in the products m7GMP and GDP. Thus, substrate turnover can be monitored 
by following the decrease in substrate peak intensity and the increase in product peak 
intensity over time. Turnover rates were obtained by fitting the progress curve with an 
integrated Michaelis-Menten equation.  
The resulting vmax value for wt Dcs1p is 0.12/s, which is in good agreement with 
previously published values for human DcpS. Under single-turnover conditions, where 
flipping motions are absent, human DcpS can perform catalysis an order of magnitude faster, 
with rates of >1.2 s-1. We thus asked whether frequent conformational change could 
decrease catalytic activity. 
Comparing rates of dynamics and catalysis, the flipping of Dcs1p is 300 times faster 
than catalysis under comparable experimental conditions. Structurally, the N-domain flipping 
motion opens an occupied closed active site to the open conformation, while concomitantly a 
liganded open site is closed. As the closed conformation is required for catalysis, its 
temporary disruption could be inhibiting protein activity. Under maximally inhibited conditions, 
the mean time that Dcs1p remains in one asymmetric conformation is 30 ms. If a following 
step in catalysis is slower and requires substantially more time than 30 ms for completion, it 
will likely be interrupted by domain rearrangement. In the Michaelis-Menten model of enzyme 
catalysis, ligand binding is followed by the chemical step. Catalysis itself however is 
commonly a fast process. Thus, we speculate that excess protein motions hamper an 
additional slow step that takes place after binding. This rate limiting process might be the 
active site rearrangement in which ligand and the closed active site form a productive 
complex.  
 
Previously, we established that in wild-type Dcs1p, frequent conformational change 
induced by substrate excess is correlated with reduced catalytic activity. If an excess of 
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protein motions is detrimental for Dcs1p activity, a mutant with reduced dynamics should 
exhibit increased activity. Thus, we investigated the correlation between dynamics and 
function further by examining the dynamics in a designed hyperactive variant of Dcs1p.  
For DcpS, a number of hyperactive mutants have been reported before. Here, we 
additionally describe the hyperactive Dcs1p K126A mutant. In this variant, a lysine residue in 
the hinge region is exchanged to an alanine residue. In the closed protomer, the ε-amino 
group makes an electrostatic interaction with the β-phosphate group; in the open protomer, it 
is close to the second base of the substrate and exposed to the solvent. We established the 
hyperactivity of Dcs1p K126A in a 31P NMR degradation experiment and determined a 
maximal turnover rate of 0.48 s-1, which is four times as active as the wild type.  
NMR spectra of the inactive variant Dcs1p K126A H268N recorded in the presence of 
m7GpppG show that the mutant undergoes symmetric to asymmetric transition and interacts 
with two substrate molecules. Additionally, ITC experiments have demonstrated a sequential 
binding mechanism for Dcs1p K126A H268N. Regarding its substrate binding mode, the 
K126A mutant thus behaves as the WT protein. To obtain information on protein dynamics, 
we performed longitudinal exchange experiments at excess substrate concentrations 
equivalent to the wt experiments. Even at the highest ligand concentration, no measurable 
cross peaks between the two asymmetric conformations could be detected. Their absence 
indicates that the exchange rate lies below the detection limit of the experiment and thus is 
less than 0.5 Hz.  
This result confirms the inverse relationship between flipping motions and activity under 
substrate excess in Dcs1p. While asymmetry and flipping motions are required for substrate 
binding and product release, their excess abundance reduces activity. This mechanism of 
substrate inhibition can however be alleviated by reduction of protein motions as shown in 
the mutant Dcs1p K126A.   
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In this work, we characterize and quantify the dynamics occurring during the Dcs1p 
catalytic cycle. From structural information, a conformational change during substrate binding 
and product release had been postulated. The trigger of this conformational change as well 
as its timescale and its function in the catalytic cycle however remained unknown and subject 
to debate.  
Using near-residue resolution solution NMR, we are able to address several 
mechanistic questions of Dcs1p function on the molecular level. Firstly, we investigated the 
mode of substrate interaction and its connection to Dcs1p cooperativity. In the course thereof 
we demonstrate that Dcs1p conformational change is a rigid body domain movement. The 
main focus of this work however is on the quantitation of protein motions and their function in 
catalysis and substrate inhibition. 
 
Previous structural studies suggested that both domains in DcpS proteins act as rigid 
bodies when undergoing conformational change. This notion was expanded by molecular 
modeling simulations in absence of substrate or product [103]. In the free form, DcpS 
displays fluctuating domain motions on the nanosecond timescale by distortion of its flexible 
hinge. The simulations demonstrate that DcpS domains move towards an asymmetric and 
more closed arrangement but do not close the active site as in the substrate bound state. 
Additionally, the rigid body model postulates negative cooperativity in DcpS as activity in one 
site is mutually exclusive with the second, which was verified by kinetic studies [65].  
Here, we present experimental evidence for the assumed N-terminal domain rigidity 
upon substrate interaction throughout the catalytic cycle. Our data demonstrate that upon 
substrate or product binding, Dcs1p transitions to an asymmetric state. NMR spectra confirm 
that the asymmetric conformation is present in solution in complex with m7GMP, m7GDP and 
m7GpppG. In contrast, the product GDP does not induce asymmetry or any measurable 
interaction in NMR. This finding stresses the requirement for the N-7 methylated base for 
conformational change and the major contribution of the methylated base to affinity.   
 
Numerous studies have reported affinities of scavenger decapping enzymes for its 
substrate, substrate analogues, inhibitors and products [44, 54, 65, 104-107]. Affinities for 
substrates and substrate analogues are in the very low nanomolar range, for the inhibitor 
m7GDP in the low nanomolar range and for the product m7GMP in the high nanomolar range. 
The structure of inactive human DcpS in complex with its substrates displays strikingly 
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different binding modes for the two active sites and thus indicates different affinities for the 
first and second binding site. Nevertheless, occupancies of both sites were equal in the 
crystal structures. Thus it remained an open question, how tightly Dcs1p interacts with 
substrate molecules in the closed and open site. In the light of Dcs1p substrate inhibition, it is 
important to obtain quantitative data on individual substrate binding to both active sites. This 
information is relevant to obtain a complete mechanistic description of the Dcs1p catalytic 
cycle.  
Here, we applied NMR and ITC to this question. Using NMR, we found that m7GpppG, 
m7GDP are indeed bound with different affinities in the two active sites in inactive Dcs1p 
H268N and follow a sequential binding mechanism. Affinities in the first site are in the 
nanomolar range for substrate and inhibitor and in the high micromolar range in the second 
site. The interaction sites are in agreement with crystal structures of doubly liganded DcpS 
proteins except for some peaks in the N-terminal domain that shift upon ligation of the 
second active site that are distant to the binding site. This effect is discussed further in the 
following section.  
To obtain quantitative information, we conducted ITC experiments. Isotherms of 
inactive Dcs1p H268N titrated with m7GpppG displayed three enthalpic events, including an 
additional endothermic process that prevented data analysis. We speculated that this 
process corresponds to an aggregation event during titration. The Dcs1p K126A H268N 
mutant did not display aggregation or the endothermic process and. yielded interpretable 
isotherms. To assess the comparability of this mutant, we demonstrated by NMR that overall 
topology, conformational change and the sequential binding mechanism are identical to wt 
protein, however this mutant displays increased activity. Fitting of ITC data yielded a Kd of 
240 ± 90 nM for the closed site and 280 ± 30 μM for the second site of Dcs1p H268N K126A 
using a sequential model for fitting. Interestingly, the sequential binding model is a special 
case of binding based on anti-cooperativity as only upon ligation of a first site the second site 
becomes available. 
In comparison to previous affinity measurements, our value for first-site affinity for 
inactive Dcs1p K126A towards m7GpppG is in the high nanomolar range compared to the 
low nanomolar values reported for wt human DcpS towards non-hydrolysable cap analogs. 
The reported affinities were determined in experiments on active DcpS protein and non-
hydrolysable cap analogs. Thus, these affinities are expected to diverge from ours due to the 
different chemical nature of ligand and active site. Indeed, the affinities of wt and inactive 
DcpS H277N have been reported to differ [65]. More importantly however, our ITC 
experiment was set up to quantify a nanomolar and a micromolar affinity in parallel. In ITC, 
the experimental protein concentration needs to be matched to the strength of the 
interaction. Here, the concentration was chosen to match both interactions acceptably and 
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thus is not ideal for obtaining data of the high affinity first site, which is reflected in the 
standard deviation of the Kd of the closed site.  
Regardless, the experiments clearly demonstrate the sequential binding mode in yeast 
Dcs1p and yield a quantification of the second site interaction. Our findings are in 
accordance with structures that feature equally occupied open and closed active sites. The 
high protein and ligand concentrations present in protein crystals allow for interaction at even 
lower affinity sites such as the open active site of scavenger decapping proteins. Our 
structure of Dcs1p was obtained with preformed complex from which less tightly bound 
ligand was removed in a gel-filtration step, resulting in occupancy at the closed site only. 
We thus confirm previous results with our binding data on closed binding sites, and 
further demonstrate that affinities for open active sites of scavenger decapping enzymes are 
in the high micromolar range following a sequential binding mode.  
 
We have shown by NMR that interaction with m7GMP induces the asymmetric 
conformation in Dcs1p, but no interaction with the open site could be detected. This is further 
corroborated by ITC experiments that detected interaction between product and Dcs1p only 
in one site with a Kd of 1 ± 0.64 μM. The Kd of the product to the open active site is 
undetectable and thus above the detection limit of both NMR and ITC. Thus, the product 
m7GMP is readily released from an open active site. This is in agreement with a mechanism 
in which conformational change simultaneously allows for substrate binding in a closed site 
and for product release from an open one. Interaction of m7GMP with an open site has been 
found in the crystal structure of human DcpS in complex with m7GDP. Again, high 
concentrations of protein and ligand in crystals can account for the saturation of very weak 
binding sites.  
Additionally, these data demonstrate that the presence of the Pβ conveys drastically 
increased affinity of a ligand to both closed and open binding site, with nanomolar vs. 
micromolar affinities in the closed site and micromolar vs. undetectable affinities in the open 
site. The residues interacting with the Pβ mediate the discrimination between the product 
m7GMP and the inhibitor m7GDP. In the closed site, these residues comprise K126, K196, 
S263, K287 and H259 which are highly conserved. This is indeed expected for resdues 
defining the substrate range of an enzyme. 
Having demonstrated that m7GMP can induce the asymmetrical conformation in Dcs1p, 
we went on to establish that the substrate m7GpppG could release the product. In a mutant 
that contains a reporter peak to distinguish between substrate- and product-bound proteins, 
we showed that product-bound Dcs1p is converted to substrate-bound Dcs1p upon addition 
of m7GpppG. Two mechanisms of exchange are conceivable:, Firstly, product release can 
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occur due to conformational change induced by interaction with m7GpppG in the open active 
site, so that this open site is closed and m7GMP can exit the then open site. Alternatively, in 
a mechanism of competition, m7GMP can be  released according to its off-rate and the free 
protein binds m7GpppG preferentially due to its higher affinity. While our data are consistent 
with both models, NMR experiments on substrate bound Dcs1p have shown that interaction 
of m7GpppG with the open site can induce conformational change. Thus it is likely, that the 
substrate can also induce conformational change when m7GMP, a weaker ligand is bound to 
the first site.  
Taken together, these results demonstrate that Dcs1p has to undergo conformational 
change in presence of its substrate and products during the catalytical cycle, and suggest 
that this conformational change might be induced by interaction of the substrate with the 
open active site. 
 
Dcs1p displays substrate inhibition [65], a phenomenon that is common among 
enzymes [69]. The mechanism by which substrate inhibition is conferred is known for only a 
small number of enzymes and mostly associated with steric interference of a secondary, 
either orthosteric or allosteric binding site with catalysis or product release. These insights 
are usually obtained by structural investigations. Here, we explore the contribution of protein 
dynamics to Dcs1p substrate inhibition. 
Our work provides qualitative and quantitative data on Dcs1p domain movements 
during the catalytic cycle. We demonstrate that interaction of substrate with the second 
binding site induces flip-over motions of the N-terminal domain in a concentration dependent 
manner. The frequency with which the conformational change occurs increases with 
substrate concentration. Conceptually, these motions are required for substrate binding and 
product release after catalytic turnover. However, the motions are likely mutually exclusive 
with ongoing catalysis as the productive active site is dismantled during each flip-over 
movement.  
We determined the frequencies of flip-over motions in inactive Dcs1p H268N protein 
and find that they occur under substrate excess at magnitudes higher than catalysis under 
comparable conditions, 35 Hz kex vs. 0.12 Hz kcat. This finding suggests that overly frequent 
conformational change as it occurs under substrate excess reduces catalytic efficiency 
compared to the single turnover condition. This finding provides a rationale for the 
mechanism of substrate inhibition in Dcs1p. By induction of N-domain flipping at an 
unproductive frequency, interaction of m7GpppG with the open active site reduces catalytic 
efficiency. This interpretation is supported by previous experiments that demonstrated that a 
heterodimeric DcpS protein that is unable to interact with substrate in one protomer displays 
 - 52 - 
 
reduced substrate inhibition [65]. The closed active site of this protein has to be constituted 
by the binding-competent protomer while the open site is the binding incompetent one. 
Hence, due to strongly reduced interaction with the substrate in the active site, also flipping 
would be reduced in this protein variant, leading to increased activity under multiple turn-over 
conditions. 
We support our argumentation by analysis of the hyperactive mutant Dcs1p K126A. 
This mutant exhibits strongly reduced flipping motions compared to the wild-type protein 
(<0.5 Hz vs. 35 Hz) under the same conditions. This finding confirms the inverse correlation 
between fast flipping motions in Dcs1p and the catalytic activity under multiple turnover 
conditions. Additional supporting data for this correlation stems from a previous study that 
has examined how rigidifying the hinge region by mutation to proline affects activity [41]. 
Three amino acids in the hinge region (human DcpS: aa 145-147) mediate the 
conformational change between open and closed state by changes to their φ and ψ angles. 
Clearly, reducing their flexibility to an extent that Dcs1p cannot adopt the asymmetric 
conformation will result in loss of activity. However, attenuating flip-over motions to a smaller 
extent would abolish futile motions and increase DcpS activity according to our model. 
Indeed, DcpS R145P and DcpS Q146P exhibit 113% and 142% activity compared to the wild 
type, respectively. Thus, reduced flexibility in the hinge region is not associated with 
decreased, but with increased activity. These data support our model, however the actual 
rates of conformational change remain to be determined. Also, the DcpS R145A mutant 
yields an even higher activation than R145P, for an additional function of this residue. This 
aspect is further discussed in section 4.1.6. 
Together, these data argue that movements that are essential to catalysis can impede 
enzyme function in scavenger decapping enzymes when occurring in excess.  
 
In substrate-inhibited enzymes, the rate-limiting step varies between low-substrate and 
high-substrate conditions. In the classical model of substrate inhibition, the doubly substrate-
bound enzyme ES2 complex exhibits a different kcat than the ES complex and thus features 
different activity. It has been shown that the rate-limiting step in Dcs1p differs between single 
and multiple turnover conditions. Identifying the respective rate limiting steps and elucidating 
how the presence of substrate excess can induce a switch between them is necessary to 
understand substrate inhibition in Dcs1p on the molecular level.  
The rate-limiting step under single-turnover conditions is the initial binding step [65]. 
Interestingly, under multiple-turnover conditions this shifts to a later event in the catalytic 
cycle. In presence of excess substrate, the observed rate constant was reduced by a factor 
of 7.7 compared to single turnover conditions. 
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Our data supports the finding from pre-steady state kinetics that product release is not 
the rate-limiting step in Dcs1p [65]. If product release were the slowest step, enhancing 
protein flipping motions would activate DcpS and limiting dynamics would further inactivate 
DcpS. In contrast, a mutant with reduced N-domain mobility (Dcs1p K126A) and thus a 
reduced capacity to release product, is more active than the wild-type protein.  
By means of elimination, a step between substrate binding and product release had 
been proposed as the limiting step. The conformational change before catalysis in the doubly 
liganded protein had been considered a candidate and assumed to be either slow or 
unfavorable [65]. This hypothesis was supported by the reduced substrate inhibition in 
heterodimeric DcpS that contained one binding-compromised protomer arguing that this 
protein could not undergo the conformational change and thus increase activity by using only 
one active site. This experiment supported that inhibition takes place via a state with 
occupied second active site.  
We complement and expand the kinetic work by structural and dynamic data on the 
domain movement of doubly liganded protein in solution. Our data indicates that the 
asymmetric to asymmetric transition (35 Hz) is faster by two orders of magnitude than the 
observed rate constant (0.12 Hz). Hence, conformational rearrangement can be excluded as 
slowest step. Additionally, NMR spectra indicate that inactive Dcs1p protein adopts an 
asymmetric conformation in presence of excess substrate. Thus, conformational change 
cannot be unfavorable, as then the symmetric conformation would be significantly populated 
and observable in the spectra. Using NMR spectroscopy we can exclude that a symmetrical 
conformation is populated significantly in solution. Thus, the conformational change is not 
slow or unfavorable.  
We therefore propose an additional rate-limiting step in the Dcs1p catalytic cycle that 
occurs after substrate binding, yet before product release. The catalytic step cannot be 
excluded, yet chemical steps are often faster than protein rearrangements. The time required 
for completion of the rate-limiting step has to be significantly larger than the mean time that 
Dcs1p samples the asymmetric state so that substrate inhibition can occur.   
The side-chain conformation of the active sites is notably different between the closed 
and open substrate bound form on one side and the empty or product bound state on the 
other side. Also the substrate adopts an extended conformation in the open site as opposed 
to a kinked conformation of the triphosphate bridge in the closed site. Thus it is tempting to 
speculate that the arrangement of a productive active site might be the slowest step. These 
structural differences between empty open and closed site are evident from the crystal 
structures of DcpS in complex with various ligands, however the time they require for 
completion is unknown. We speculate that the rate of the reverse flipping reaction 
disassembling the closed active site (17.5 Hz) might be faster than the subsequent side-
 - 54 - 
 
chain rearrangement so that the protein would not remain in the closed conformation for a 
sufficient period to proceed to the productive active side state.  
These rearrangements are equally necessary for catalysis under single turnover 
conditions. However under single turnover conditions no disassembly of the active site is 
induced so that then the substrate-binding step could remain limiting.With the NMR labeling 
scheme that we used in the current studies, we have not been able to observe this rate-
limiting step experimentally. 
All longitudinal exchange experiments were conducted using inactive Dcs1p H268N 
protein in which the catalytic histidine is replaced with an asparagine residue. Thus, 
progression through the catalytic cycle is not possible, as the catalytic step cannot take 
place. Hence, this set-up allows observation of all steps prior to catalysis. Catalysis itself 
however cannot be ruled out as slowest step so that our speculations remain to be tested 
experimentally. 
In summary, our work has introduced a new step to the catalytic scheme of Dcs1p: 
futile flipping that follows double substrate binding and precedes successful catalysis. Thus 
we expand the previous notion that assuming the asymmetric conformation before catalysis 
is the rate-limiting step in Dcs1p under multiple turnover conditions. We suggest that this 
conformational change is not direct and that futile motions prevent Dcs1p from stably 
adopting the productive asymmetric conformation.   
 
Binding of one molecule of substrate leads to a conformational change and locks 
Dcs1p rigidly in the asymmetric state. Interaction with a second substrate molecule triggers 
conformational exchange between the two asymmetric states and increases flexibility in 
Dcs1p. These effects have opposed impacts on catalysis, as noted previously. How does the 
interaction of m7GpppG with the open active site induce motion of the N-terminal domain? In 
classical models of allostery, conformational change can be transduced by a series of 
structural changes that stabilize the other state. This information could be gained from 
structural data capturing intermediate states or from molecular modeling. Unfortunately, no 
data is available on this matter for Dcs1p yet. However, existing structural and mutational 
data can be examined to hypothesize on the molecular mechanism of allostery in Dcs1p.  
Examination of the interactions between m7GpppG and the open and closed active site 
in the crystal structure of human DcpS and of residues that experience chemical shift 
perturbations upon substrate interaction in NMR experiments and might thus contribute to 
the allosteric path reveals two main sites: the C-terminal domain and the hinge region. 
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The methylated base and the β- and γ-phosphate groups interact with multiple residues 
in the C-terminal domain. Compared with the closed binding site, the interactions of the first 
base and the triphosphate bridge are very similar in both sites differing only in the side-chain 
positions of L206 and K207.  
If flipping motions were triggered and transduced through the C-terminal domain only, 
different the C-terminal domain should also display different binding properties for its two 
binding sites as interaction with the two binding sites would yield different effects on the 
protein. Titration of C-terminal domain with m7GpppG however shows independent and 
identical binding to the two sites in the protomers in isothermal titration calorimety. Also NMR 
titration experiments with C-domain and m7GpppG display only one set of shifting peaks, 
indicating independent and identical interaction for both active sites.  
These data argue against an allosteric pathway whose molecular determinants are 
located solely in the C-domain.  
 
The second base of m7GpppG is stacked between two arginine side chains in the C-
domain and the hinge region while the ribose moiety makes few contacts at all. Mutating 
residues in the hinge area leads to increased activity in yeast Dcs1p, as shown in this work. 
As hyperactivity can be achieved by relieving substrate inhibition, this could indicate 
involvement of the hinge region in mediating allostery in Dcs1p. However, it is unclear if the 
effect of these mutations is mediated by action in the closed or open protomer. This question 
is, generally, difficult to answer as most residues in substrate interaction in Dcs1p have 
different functions in both conformations. Considering the Dcs1p K126A mutant we studied, 
the residue contacts the β-phosphate group in the closed protomer. In the open side, it is 
solvent exposed but located in proximity of the location of the second base interaction site in 
the human protein. The second base in the open site manifests a higher level of flexibility 
compared to the methylated base moiety of the same cap structure as demonstrated by 
decreased occupancy and higher B-factors of this part in structures of human DcpS in 
complex with m7GpppN [41]. Flexibility in the second base of the substrate can allow the 
second base to interact with additional residues in the hinge region, including K126A. For this 
mutant we have shown that catalytic activation occurs via decreased dynamics. To discern 
the effects of K126A in the open and closed site, we argue that the effects in the two sites 
are opposite: Disruption of the interaction between lysine 126 and the substrate in the closed 
site would likely not result in decreased motion, but rather in weakening of the closed 
conformation. In contrast, disrupting the putative interaction between the second base and 
K126 in the open protomer could reduce stabilization of the flipping motion. Thus, we 
hypothesize that in this mutant, the reduction of the dynamics is mediated by the mutation in 
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the open active site. A positively charged surface extends in Dcs1p from the hinge region 
into the N-terminal domain to K112 that contacts the carbonyl group of the second base in 
the closed conformation. It is conceivable that this stretch provides a continuous interaction 
surface along which the second base of the substrate can move. This succession of 
interactions could gradually stabilize the protein during conformational change as enthalpy is 
lost from the opening other active site. Flipping is the interconversion between two identical 
states that are thus of equal potential energy. As by definition, one state cannot be stabilized 
in respect to the other, enhancement of flipping has to occur by lowering the energy of the 
transition states. It is thus tempting to speculate that the activation energy of the 
interconversion is lowered by interaction with K126 and other charged residues. Its disruption 
would penalize the conformational change between the opposite asymmetric states and thus 
reduce flipping and ultimately alleviate substrate inhibition.  
This hypothesis is supported by the finding thatin the human DcpS protein, mutations 
of several positively charged residues in the hinge region result in hyperactive proteins [41]. 
These residues however also have functions in the closed active site so that their action in 
the allosteric path needs to be verified.  
 
The Dcs1p C-terminal domain is similar to proteins of the HIT family of 
pyrophosphatases. Other HIT and HINT proteins are nucleoside phosphoramidate 
hydrolases, dinucleotide hydrolases or nucleotidylyl transferases. The turnover rates of HIT 
proteins are rather low compared with other enzymes. The kcat of the most closely related 
FHIT protein 73 s-1for its substrate ApppA [108], however other hydrolases of this family 
exhibit lower activities that are in the range of Dcs1p activity [39]. It has to be noted that HIT 
proteins are active on their own accord while the Dcs1p C-domain is inactive on its own even 
though it comprises the catalytic triad. Only in context with the N-domain in cis or trans can 
Dcs1p perform catalysis [37].  
The N-terminal domain of Dcs1p is structurally related to NTF2-like proteins. While 
these proteins form heterodimers via their exposed β-strand, the homodimerization of the 
Dcs1p N-domain via a β-strand swap at that site is unique. The function of the N-terminal 
domain is twofold: Firstly, its interaction with the C-terminal domain requires the N7-
methylation on the substrate to stably form the asymmetric state. The N-terminal domain 
thus provides specificity for methylated di-nucleotides and nucleotide polyphosphates. We 
have shown that Dcs1p enzymes in which the interaction between the N7-methyl group and 
the recognizing tyrosine residue has been impaired do not form stably closed conformations. 
This was achieved by either using unmethylated cap analog or the Dcs1p Y94A mutant. An 
interaction between enzyme and ligand can be observed, but is limited to mostly the C-
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terminal domain and occurs in a fast exchange regime. The asymmetric state is either 
scarcely or not populated. Additionally, we demonstrated that combinations of enzyme and 
substrate with disrupted methyl recognition are inactive consistent with data on human DcpS 
[41]. These findings underline the connection between the prolonged formation of the closed 
conformation and catalysis. According to our model, substrate inhibition exploits the same 
mechanism as the Y113A mutant, by preventing the formation of a closed conformation for a 
sufficient period of time. In contrast, this is not achieved by prohibiting interdomain 
interactions, but by stabilizing the opposite asymmetric conformation. Interestingly, the triad 
of residues that recognizes the N7-methyl group and mediates closure is highly conserved, 
with the exception of C. elegans. In this species, Y113 and Y273 are exchanged to 
phenylalanine residues and H139 to leucine and are thus unable to establish the conserved 
hydrogen bonds. The C.elegans Dcs1 protein can accommodate larger functional groups in 
the N7 position [107]. Thus it has to specifically recognize its substrates and lock the 
domains onto each other by virtue of a different mechanism.  
Secondly, the substrate has to adopt a different conformation in the closed site 
compared to in the open site due to steric constraints. It has been speculated that catalytic 
turnover is achieved by activation of the leaving group by distortion of the substrate. Thus, 
the N-terminal domain could mediate and couple closure and activity and limit both to 
methylated substrates.  
Evolutionary acquisition of the N-terminal domain provided for a mechanism to ensure 
specificity and activity for methylated substrates. Here we demonstrate an additional function 
of the N-terminal domain, which is the allosteric mediation of substrate inhibition by 
undergoing futile motions in the yeast Dcs1p protein.  
 
We show that a tightly coordinated balance between necessary and unproductive 
motions governs Dcs1p activity. Interestingly, scavenger decapping enzymes have not 
evolved for optimal turnover rates as demonstrated by the presence of hyperactive variants 
both in human and yeast. This suboptimal turnover is realized by substrate inhibition in 
Dcs1p. The residues in Dcs1p that maintain dynamic substrate inhibition are conserved; also 
human DcpS is readily inhibited by substrate excess. Conservation of the residues involved 
in N-domain flipping suggests that this behavior is common to scavenger decapping 
enzymes. Hence, a cellular function of substrate inhibition can to be suspected. Interestingly, 
substrate inhibition by excessive dynamics would allow for reduced activity as well as for 
increasing activity when quenching these motions.   
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The significance of substrate inhibition in the cell is still subject to speculation. In order 
to establish a cellular function of Dcs1p substrate inhibition in the cell, it will be necessary to 
obtain data on Dcs1p dynamics in presence of short, capped mRNAs and on the abundance 
of the different species of substrate in the cell. While the concentration of Dcs1p in yeast 
under normal growth conditions is ~0.3 µM [109], the concentration of short capped RNAs 
and cap structure in the cell can only be estimated hampering a prediction of cellular 
function. As Dcs1p substrate inhibition is likely conserved between yeast and human, a 
cellular function can be suspected. Assuming substrate inhibition of Dcs1p in the cell, 
conditions where high amounts of Dcs1p substrates are generated by the exosome complex 
will reduce Dcs1p activity and maintain high levels of cap structure. Catalytic turnover would 
accelerate only once substrate concentrations lessen. Thus, both temporally and spatially, 
larger differences in cap structure concentrations would result from substrate inhibition. This 
mechanism could provide switches in cross talk to other cap dependent processes such as 
translation initiation or splicing.  
In addition to prompting experiments to explore Dcs1p cellular functions, our findings 
have practical implications for future structural analyses of scavenger decapping proteins. 
The fact that substrate excess can induce unproductive motions in Dcs1p provides a 
rationale for crystallization strategies. Molecular motions and conformational heterogeneity 
are expected to be detrimental for crystallization. Thus, using an equimolar ratio of substrate 
has likely improved our crystallization results and we expect it to facilitate future 
crystallization of scavenger decapping enzymes from other species.  
 
With our work we describe a unique molecular mechanism of substrate inhibition by 
inducing motions that are crucial for catalysis at a frequencies that reduce overall activity. 
This result challenges the idea that protein dynamics, and conformational change in 
particular, are necessarily coordinated for optimal catalytic turnover. We rather find that also 
the dynamic properties of a protein, i.e. the frequency with which it transits between stable 
states, can be utilized to regulate its activity. Moreover, not only by decreasing, but also by 
increasing protein motions, activity can be modulated.  
Our work underlines the necessity to expand our understanding of proteins and 
particularly enzymes on the molecular level, as conformational change is common during 
protein action. In addition to describing series of static states, measuring and taking into 
account the flexibility around these states and the rates and triggers of transition between 
them will be required.  
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Our work prompts future experimentation in three areas: the details of 
substrate inhibition in Dcs1p, the relevance thereof in the interplay between Dcs1p 
and its other interaction partners and most generally the contribution of dynamics in 
other substrate inhibited proteins. 
 
Our results demonstrate that unter multiple turnover conditions, conformational 
change is two orders of magnitudes faster than the overall catalytic rate in Dcs1p and 
thus not rate-limiting. Considering previous investigations ruling out substrate binding 
and product release, we hypothesize that the rearrangement of the closed active site 
into a productive state or the catalytic step could be rate limiting. Future work would 
need to probe these hypotheses in order to gain complete understanding of the 
catalytic cycle. Complete description ideally would also provide rate constants for the 
transitions between all observable states and allow a statistical description of the 
catalytic cycle.  
To further confirm the dynamic mechanism of substrate inhibition, longitudinal 
exchange experiments on other hyperactive mutants could further establish that the 
general potential for hyperactivity of Dcs1p is due to futile motions in excess 
substrate states. Thus, the timeframes in which Dcs1p motions are beneficial or 
detrimental could be determined. Additionally, single-turnover activity assays on 
hyperactive mutants are required to confirm that their hyperactivity is founded in 
alleviation of substrate inhibition and not in generally enhanced catalytic turnover.  
Considering the molecular basis of the interplay between structure, dynamics 
and function in Dcs1p, we have proposed a model in which conformational change is 
induced by electrostatic interaction between a the second base of a substrate 
molecule in the secondary active site and the charged residues in the hinge region. 
Mutations in this region have been shown others and us to increase Dcs1p activity. 
However, activity of these mutations has been measured in homodimeric protein so 
that despite rational argumentation, the effect of the mutation cannot be pinpointed to 
either the active or the allosteric site. Thus, future experimentation on heterodimeric 
Dcs1p samples will provide protomer-specific data on functional residues. 
Furthermore, determining the flipping rates in presence of more Dcs1p substrates, 
such as m7GTP or m7GpppA will reveal molecular details of the trigger for 
unproductive dynamics on the substrate side.   
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To study the events underlying allostery in Dcs1p, molecular dynamics 
simulations of the rearrangements in the second binding site upon interaction with 
the substrate will be very instructive. Results thereof can subsequently be tested and 
validated for both activity and dynamic properties in established experiments.  
 
Scavenger decapping proteins interact in the cell with their substrates and a 
number of inhibitors, such as m7GDP and 5’-quinazolines. Moreover, they contribute 
to other cellular processes including sugar metabolism, splicing and miRNA 
degradation. Future work will have to address whether the dynamic mode of 
substrate inhibition we describe here influences other Dcs1p functions than mRNA 
decapping.  
 
Recent work has shown that DcpS is inhibited effectively by 5’-quinazolines 
that mimic the RNA cap structure and that its inhibition influences SMN splicing [54-
56]. Combined with our mechanistic results on substrate inhibition, this poses the 
question, whether these inhibitors also exert their function via futile protein motions.   
In the cell, Dcs1p acts on short, capped mRNA fragments whose mRNA 
moieties are shorter than 10bp. The next step in understanding the dynamic nature 
of Dcs1p action would be to determine how Dcs1p structure and dynamics are 
affected by its larger substrates. A previous model states that the presence of an 
increasing number of bases poses an entropic penalty on active site closure. 
Evidently, crystallographic analysis of a state of enhanced dynamics is difficult, 
however the system may be amenable to NMR. As methyl group assignments are 
available, both the interaction surface of the additional bases as well as the effect on 
protein dynamics could be investigated. The positively charged surface in the hinge 
region of the open protomer is located in the proximity of the negatively charged RNA 
and would be a plausible interaction surface.  
 
In yeast, Dcs2p is a closely related homolog of Dcs1p that is expressed under 
stress conditions. Even though the relevant catalytic residues are conserved in 
Dcs2p, it is inactive and inhibits Dcs1p by heterodimerization. Interestingly, two of 
these residues are mutated in Dcs2p a conserved homologue of Dcs1p that has 
been shown to inhibit Dcs1p function by dimerization.  
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The most obvious differences between Dcs1p and Dcs2p are the mutations 
K126G and K287M. Both residues interact with the β-phosphate group of the 
substrate. We expect that Dcs2p differs in its binding preferences for substrate and 
product from Dcs1p and may thus exhibit different kinetic properties and thus 
modulate these of the inhibited heterodimer Dcs1/2p. However, mutation of K126 
residue to alanine in Dcs1p results in decreased motions and increased instead of 
activity. The effect of this mutation differently affects the two protein variants and is, 
based on our results, likely to modulate protein dynamics. 
Dcs1p moonlights in other cellular functions. It has been reported to contribute 
to modulation of RNA degradation by Xrn1 activation, sugar metabolism and 
regulation of splicing events. In the light of the mobility of scavenger decapping 
enzymes and its relevance for enzymatic turnover, it would be interesting to further 
investigate how its protein dynamics influence these other functions. In vitro 
experiments can evaluate the requirement of asymmetric, mobile or static Dcs1p for 
these reported interactins.   
In this work we have demonstrated advances in understanding the molecular 
basis of substrate inhibition of scavenger decapping enzymes. Its function in the cell, 
however, is unclear. It has been suggested previously, that action of Dcs1p reduces 
the concentration of methylated nucleotides that can be incorporated in nucleic acids 
and thus reduce the lifespan of yeast. By expanding the repertoire of mutants that 
lack inhibition under multiple turnover conditions, mutant yeast can be generated and 
analyzed for methylated bases in nucleic acids, accumulation of cap structure and 
activity of cap dependent process. Thus, the physiological significance of Dcs1p 
substrate inhibition can be elucidated.  
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The nuclear LSm2–8 (like Sm) complex and the cytoplasmic LSm1–7
complex play a central role in mRNA splicing and degradation,
respectively. The LSm proteins are related to the spliceosomal Sm proteins
that form a heteroheptameric ring around small nuclear RNA. The assembly
process of the heptameric Sm complex is well established and involves
several smaller Sm assembly intermediates. The assembly of the LSm
complex, however, is less well studied. Here, we solved the 2.5 Å-resolution
structure of the LSm assembly intermediate that contains LSm5, LSm6, and
LSm7. The three monomers display the canonical Sm fold and arrange into a
hexameric LSm657–657 ring. We show that the order of the LSm proteins
within the ring is consistent with the order of the related SmE, SmF, and
SmG proteins in the heptameric Sm ring. Nonetheless, differences in RNA
binding pockets prevent the prediction of the nucleotide binding
preferences of the LSm complexes. Using high-resolution NMR spectros-
copy, we confirm that LSm5, LSm6, and LSm7 also assemble into a 60-kDa
hexameric ring in solution. With a combination of pull-down and NMR
experiments, we show that the LSm657 complex can incorporate LSm23 in
order to assemble further towards native LSm rings. Interestingly, we find
that the NMR spectra of the LSm57, LSm657–657, and LSm23–657
complexes differ significantly, suggesting that the angles between the
LSm building blocks change depending on the ring size of the complex. In
summary, our results identify LSm657 as a plastic and functional building
block on the assembly route towards the LSm1–7 and LSm2–8 complexes.
© 2011 Elsevier Ltd. All rights reserved.
Introduction
Sm proteins were initially identified as the target of
autoantibodies from patients with systemic lupus
erythematosus.1 These antibodies recognize an epi-
tope that is present in seven different Sm proteins
common to the U1, U2, U4, and U5 small nuclear
ribonucleoproteins (snRNPs) that perform the splic-
ing reaction (reviewed by, e.g., Wahl et al.2). In
snRNPs, the Sm proteins arrange into a seven-
membered ring around the uridine-rich sequence in
the small nuclear RNA (snRNA).3–6 The Sm proteins
*Corresponding author. E-mail address:
remco.sprangers@tuebingen.mpg.de.
† M.M. and A.N. contributed equally to this work.
Abbreviations used: snRNP, small nuclear
ribonucleoprotein; snRNA, small nuclear RNA; NOESY,
nuclear Overhauser enhancement spectroscopy; TROSY,
transverse relaxation optimized spectroscopy;
LSm, Like Sm.
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Fig. 1. LSm and Sm proteins. (a) Sequence alignment (calculated with T-Coffee10) of the human (hs), S. pombe (sp), and A. fulgidus (af) (L)Sm proteins. The residues are
colored according to residue type; sequences endingwith an asterisk are longer in the full-length protein and truncated in the figure for clarity. Related SmandLSmproteins
are grouped together.11 Residues that are important for the interactionwith RNA in the Sm and archaeal LSm complexes are indicatedwith red dots.4,12,13 The open red dot
indicates an interactionwith a nucleotide that ismainly coordinated by aneighboring (L)Smprotein.4 (b) Structure of the humanSmring (PDB ID: 2Y9A4). TheU4RNAthat
passes through the hole in the middle of the Sm complex is removed for clarity. Broken lines indicate the Sm assembly intermediates. Figures displaying molecular
structures were prepared with PyMOL (http://pymol.org/). (c) Predicted topology of the LSm2–8 (or LSm1–7) complex based on sequence conservation.
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are characterized by the highly conserved Sm1 and
Sm2 motifs that are 32 and 14 residues in length,
respectively. Based on these signature sequences,
additional proteins that contain an Sm fold have been
identified and were termed LSm (like Sm) proteins7–9
(Fig. 1a). Two different heptameric LSm complexes
have been identified: a cytoplasmic LSm1–7 complex
that is involved in mRNA degradation and a nuclear
LSm2–8 complex that is involved in splicing.
The LSm2–8 complex contains a single copy of each
of the seven LSm2–8 proteins and is based on electron
microscopy data structurally similar to the Sm
complex.11,14,15 LSm2–8 is part of the U6 snRNP,
where it specifically interacts with the 3′ polyU tract in
the U6 snRNA.7,9,14,16 The related LSm1 protein does
not associate with LSm8 or any of the snRNPs16 but is
involved in the degradation of mRNA.5 In that case,
LSm1 associates specifically with LSm2–7 and multi-
ple components of themRNAdegradationpathway.17
The RNA recognition sequence for the LSm1–7 ring
has not been established yet. It has, however, been
proposed that the cytoplasmic LSm complex interacts
with the oligoadenylated 3′ end of mRNA species.18
Interestingly, overexpression of the LSm1 protein in
yeast reduces the level of the LSm2–8 complex,19
suggesting a competition between the assembly
pathways of the two different LSm complexes.
Initial structural insights into the Sm and LSm
protein complexes came from the high-resolution
structures of two dimeric Sm complexes (SmD3B and
SmD1D2).20 The individual Sm proteins fold into a
highly bent β-sheet preceded by a short α-helix. Sm
proteins assemble into higher-molecular-mass com-
plexes through the interaction of β-strand 4 of one
monomer with β-strand 5 of the next monomer,
resulting in the formation of an intermolecular anti-
parallel β-sheet.20 This mode of interaction is
reiterated multiple times to form hexameric,21 hepta-
meric (Fig. 1b),4,12,21 or octameric22 (L)Sm rings.
The heptameric Sm complex is unstable in the
absence of RNA and requires the help of chaperones
to form a stable ring. In that process, the SMN
(survival of motor neurons) complex23 recognizes
three preformed Sm assembly intermediates
(SmEFG, SmBD3, and SmD1D2) that are then
positioned around the snRNA. In contrast, the
LSm1–7 and LSm2–8 rings (Fig. 1c) are stable
without RNA and are fully preformed before
Table 1. X-ray structure of the LSm657 complex
Data collection statistics
Unit cell axes a, b, c (Å) 79.53, 63.10,
92.76
Unit cell angles α, β, γ (°) 90.00, 90.01,
90.00
Space group P21
Wavelength (Å) 1.00
Resolution (Å) (highest-resolution bin) 46–2.5 (2.54–2.50)
Total reflections 146,718 (9867)
Unique reflections 60,656 (4062)
Redundancy 2.4 (2.4)
Completeness 96.9 (87.9)
I/σI 18.9 (2.0)
Rmerge (%) 4.0 (57.7)
Wilson B-factor (Å2) 60.7
Refinement statistics
Rwork (%) 21.8 (35.5)
Rfree (%) 26.9 (45.6)
RMSD bond length (Å) 0.006
RMSD bond angle (°) 1.03
Number of protein atoms 6750
Average B-factor (Å2) 62.0
Number of solvent atoms 38
Average B-factor (Å2) 62.8
Ramachandran plot
Residues in the most favorable region (%) 86.4
Residues in theadditionally allowedregion (%) 13.6
Notes to Table 1
The LSm657 complex was purified using Ni-affinity chromatography,
where the His-tag was present at the N-terminus of LSm7. The
eluted protein complex was digested with tobacco etch virus
protease to remove the affinity tag and was further purified by
binding the complex to an ion-exchange matrix under low-salt
conditions. Elution with a NaCl gradient separated the LSm657
complex from an LSm57 complex that was present due to the
lower expression level of LSm6 compared to LSm5 and LSm7.
Size-exclusion chromatography was performed as the final
purification step in 50 mM sodium phosphate buffer (pH 7.5),
150 mM NaCl, and 1 mM DTT. Based on the size-exclusion data,
the LSm657 complexes multimerize into hexamers, whereas the
LSm57 complex does not assemble further.
For crystallization, the purified LSm657 complex was treated with
trypsin to remove flexible regions. Based on the final structure,
this resulted in the removal of the first 21 unstructured residues of
LSm7. The trypsin was removed from the LSm complex using
ion-exchange chromatography and size-exclusion chromatogra-
phy, and the final protein concentration was adjusted to 10 mg/
ml in 5 mM Tris (pH 7.5) and 150 mM NaCl. Crystals grew in
100 mM zinc acetate and 5% glycerol after 2 weeks upon sitting-
drop vapor diffusion. X-ray diffraction data were collected at
beamline X10SA of the Swiss Light Source (Villigen, Switzerland).
Diffraction data were indexed, integrated, and scaled using
XDS.24 In the data set, there was a significant anomalous signal
that extended to 3.1 Å due to bound Zn2+ from the crystallization
solution. The structure was solved with the molecular replace-
ment–single-wavelength anomalous dispersion protocol of Pha-
ser in CCP4,25 starting with a polyalanine search model derived
from the homohexameric AF-SM2 ring, an archaeal LSm protein
(PDB ID: 1LJO).21 Two hexameric rings and 16 Zn2+ were located
in the asymmetric unit. An electron density map at 2.5 Å
resolution was generated from the molecular replacement–single-
wavelength anomalous dispersion phases by density modifica-
tion in Resolve26 using phase extension, the 2-fold noncrystallo-
graphic symmetry between the two hexameric rings, and a prime-
and-switch algorithm for eliminating model bias. The map
revealed that the hexameric rings consist of dimers of LSm657
and was used for initial model building in Coot.27 After rigid-
body and simulated-annealing refinement with Phenix, the
structure was rebuilt and refined iteratively with Refmac5 and
Phenix.28,29 The noncrystallographic symmetry relating the two
copies of the ring was restricted to the secondary structure
elements and was used as a constraint during refinement.
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interacting with RNA.15 Therefore, the RNA inter-
action and recognition properties of the heptameric
LSm rings are thought to differ from those of the Sm
ring. On the other hand, the high degree of similarity
between the individual LSm and Sm proteins (Fig.
1a) suggests that the structure of the LSm ring is
similar to the structure of the Sm ring (Fig. 1c). This
also implies that there are assembly intermediates
for the LSm ring similar to those that have been
identified for the Sm proteins. Indeed, for the human
LSm proteins, stable and soluble complexes of
LSm23 (corresponding to SmD1D2), LSm48 (corre-
sponding to SmD3B), and LSm657 (corresponding
to SmEFG) have been purified.15
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The LSm657 complex forms a hexameric ring
Here, we present the 2.5 Å crystal structure of the
Schizosaccharomyces pombe LSm complex containing
the LSm5, LSm6, and LSm7 proteins (Table 1). The
asymmetric unit of the crystal contains two hex-
americ LSm657–657 rings (Fig. 2a). In the complex,
LSm5 is in-between LSm7 and LSm6, in agreement
with the order of the Sm proteins in the Sm ring,
where SmE is located in-between SmF and SmG
(Figs. 1b and 2a). This finding confirms the predicted
topology of the native LSm2–8 and LSm1–7 rings
that was derived from sequence conservation
(Fig. 1c) and underlines the conservation between
the Sm complex and the LSm complex. This
conservation is further reflected by the fact that
electron microscopy studies have shown that the
SmEFG complex (the equivalent of the LSm657
complex) assembles into hexameric rings in vivo.31
The individual LSmproteins in the LSm657 complex
multimerize into a hexameric ring in a canonical
manner. β-Strand 4 of one monomer interacts with β-
strand 5 of a neighboring monomer, thereby forming
one continuous β-sheet through the ring. The LSm–
LSm interfaces are stabilized by theN-terminal α-helix
and through additional intermolecular contacts, in-
cluding hydrophobic interactions and salt bridges, as
previously observed for the Sm proteins.4,12,20
The LSm5, LSm6, and LSm7 proteins each adopt a
canonical Sm fold that contains a short N-terminal
α-helix, followed by five β-strands that assemble
into a highly bent anti-parallel β-sheet (Fig. 2b). The
Sm1motif forms the core of the Sm fold and contains
most of β-strands 1–3. The Sm2 motif folds around
the Sm1motif andmostly consists of β-strands 4 and
5, which engage in intermolecular contacts. Differ-
ences between the four copies of each LSm protein in
the asymmetric unit are very small, and their Sm1
and Sm2 motifs superimpose with a low root-mean-
square deviation (RMSD; 0.20 Å, 0.58 Å, and 0.13 Å,
respectively; see Table 2, bold diagonal entries).
Small displacements of the residues in loop 2 of
Table 2. Structural differences between LSm and Sm proteins
RMSD of Sm1 and Sm2 (Cα atoms)
LSm5 LSm6 LSm7 LSm3
SmE
(LSm5)
SmF
(LSm6)
SmG
(LSm7)
SmB
(LSm8 LSm1)
SmD1
(LSm2)
SmD2
(LSm3)
SmD3
(LSm4)
LSm5 0.20 1.13 0.75 0.99 0.64 0.78 0.83 0.82 0.81 0.81 0.78
LSm6 0.58 1.34 1.45 1.11 1.45 1.29 1.36 1.23 1.38 1.32
LSm7 0.13 0.97 0.69 0.76 0.86 0.61 0.91 0.71 0.86
LSm3 0.06 0.92 0.84 0.99 0.85 0.91 0.87 1.00
SmE 0.33 0.73 0.69 0.79 0.77 0.68 0.85
SmF 0.33 0.81 0.71 0.73 0.77 0.84
SmG 0.33 0.87 0.72 0.70 0.81
SmB 0.32 0.88 0.75 0.79
SmD1 0.37 0.84 0.67
SmD2 0.32 0.79
SmD3 0.26
Numbers indicate the RMSD (Å) of the Cα atoms in the Sm1 and Sm2 motifs. Coordinates were extracted from the 4 structures in the
asymmetric unit of the LSm657 complex (LSm5, LSm6, and LSm7), from the 2 structures in the asymmetric unit of the Saccharomyces
cerevisiae LSm3 octameric ring (LSm3, sc; PDB ID: 3BW1),22 and from the 12 structures in the asymmetric unit of the human Sm complex
(SmE–SmD3; PDB IDs: 2Y9A–2Y9D).4 The diagonal italicized numbers indicate differences within the ensembles of the same protein; off-
diagonal numbers indicate differences between the average structures of the different proteins. RMSDs and average structures were
calculated using MOLMOL.32 Numbers in boldface indicate the LSm structures solved in this study. Underlined entries indicate the Sm
protein with the lowest RMSD to the LSm proteins. Note that the structural differences are small and do not show the relationship
between the Sm and LSm proteins present at the sequence level (Fig. 1).
Fig. 2. Crystal structure of the LSm657 complex. (a) Crystal structure of the LSm657 ring viewed from the proximal
side. The LSm proteins form a continuous β-sheet that includes intermolecular interactions between β-strand 4 of one
monomer and β-strand 5 of a neighboring subunit. The interface between LSm6 and LSm7 (see the text below) is indicated
by a continuous line. The other interfaces are indicated with broken lines. (b) Superposition of the four copies of LSm5
(yellow), LSm6 (brown), and LSm7 (green) present in the asymmetric unit of the crystal structure. All LSm proteins show
a typical Sm fold: an N-terminal α-helix followed by a highly bent five-stranded β-sheet. The RMSD between multiple
copies of the LSm proteins is low, as are the differences between LSm5, LSm6, and LSm7 (see Table 2, bold entries). Loops
and secondary structure elements are indicated. (c) Electrostatic surface potential of the LSm657 ring. The orientation of
the structure on the left is identical with the orientation shown in (a); the right panel displays the distal face of the ring. The
potential was calculated with APBS.30 Note the positive charge in the central pore of the ring. The approximate borders of
the individual LSm proteins are indicated with lines. Note that the surface potential is not exactly symmetric due to small
differences between two copies of the same LSm protein in the ring. (d) View into the putative RNA binding pockets of the
LSm5, LSm6, and LSm7 proteins in the LSm657 complex. The 2Fo−Fc electron density map is shown at 1σ. Left and
middle: View as in (a). For clarity, residues in loop 3 (left) and loop 5 (middle) are displayed separately. Right: View as in
(b), displaying the inside of the pore of the ring.
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LSm6 result in a larger RMSD between the four
LSm6 copies. Differences between the LSm5, LSm6,
and LSm7 proteins are also small, as reflected in the
RMSDs well below 1.5 Å for the differences between
the average LSm5, LSm6, and LSm7 structures
(Table 2, bold off-diagonal entries). Similar RMSDs
between the different Sm proteins within the
heptameric Sm complex had been observed previ-
ously (Table 2).4
Differences in (L)Sm sequences are not reflected
in the domain fold
Based on the sequence conservation between the
individual Sm and LSm proteins (Fig. 1), we
expected the LSm5, LSm6, and LSm7 proteins to
possess the highest structural similarity with the
SmE, SmF, and SmG proteins, respectively. The
RMSDs between related Sm and LSm proteins were,
however, not significantly lower than the RMSDs
between more distant Sm and LSm proteins (Table 2
and Fig. 1). RMSDs between human Sm proteins,
archaeal LSm proteins, and bacterial Hfq proteins
were also observed to be below 1.5 Å.33 These
observations imply that the relationship between the
Sm protein and the LSm protein that is present at
the sequence level is not reflected in the three-
dimensional structure of the core of the proteins.
This suggests that the differences in protein
sequence determine the specific assembly into
high-molecular-mass complexes without disturbing
the fold of the isolated domains. In that case, the
amino acids that are unique to each of the seven
classes of the Sm and LSm proteins (Fig. 1a) provide
the complementary surfaces that determine the order
of the proteins in the native rings (Fig. 1b and c).
Comparison of the available interfaces within the
LSm complex solved here, however, did not allow us
to identify what residues determine this high speci-
ficity. A structure of the native LSm complexes might
provide the additional data necessary to identify how
the order of the LSm proteins in the native complex is
established. In that regard, it is interesting to note that
intermolecular hydrogen bonds and salt bridges
present in the dimeric SmD1D2 and SmBD3
complexes20 are not identical with those found
between these subunits in the fully assembled Sm
ring.4 It is thus tempting to speculate that the Sm and
LSm assembly intermediates are held together by a
slightly different network of interactions than the
proteins in the fully assembled complexes are.
Implications of the LSm657 structure for
RNA binding
The central region of the LSm657 complex is
positively charged, suggesting an important role for
the pore in the interaction with RNA substrates (Fig.
2c). Indeed, the structure of the homoheptameric
Archaeoglobus fulgidus Sm ring in complex with
polyU RNA identified a nucleotide (uridine) bind-
ing pocket in this region.13 In this structure, each of
the Sm proteins interacts with a single base through
conserved residues in loops 3 and 5 (Fig. 1a, red
dots). The structures of the heptameric Sm ring (Fig.
1b) in complex with RNA3,4,12,34 show that the RNA
substrate is passed through the central Sm pore,
where all Sm proteins interact with the consecutive
bases in a slightly different manner.4,12 The residues
in the Sm complex that contact the RNA are largely
conserved in the LSm proteins (Fig. 1a). This
suggests that the LSm1–7 and LSm2–8 complexes
use the same nucleotide binding pockets as the Sm
complex. Nevertheless, several key amino acids in
loops 3 and 5 are different in the structure of the
LSm657 complex. Firstly, the LSm5 protein contains
a conserved asparagine in loop 5 instead of a
canonical arginine or lysine that hydrogen bonds
to the base in the Sm ring. Secondly, the LSm7
protein contains a conserved leucine residue in loop
3 instead of a canonical aromatic residue that
provides a stacking interaction with the base in
Sm–RNA complexes. These differences prevent the
prediction of the base preference for the LSm
nucleotide binding pockets based on the known
Sm–RNA structures. Extrapolation of RNA binding
preferences from the Sm complexes to the LSm
complexes is further complicated by the fact that the
Sm proteins assemble around the snRNA to form a
stable snRNP, whereas the LSm1–7 and LSm2–
8 complexes are thought to interact more transiently
with the free 3′ end of RNA.35 Future studies that
address the RNA recognition properties of the LSm
complexes will be able to address these differences
at a structural level.
Both LSm657 rings in the asymmetric unit of the
crystal interact with eight Zn2+ in a very similar
fashion (Supplementary Fig. 1). Four Zn2+ are
bound on the surface of the hexameric ring and
are localized through interaction with one or two
protein side chains. In addition, one Zn2+ is tightly
bound at every LSm5–LSm6 interface, and a cluster
of three Zn2+ localizes to one of the two LSm6–LSm7
interfaces in each ring. Zinc binding to the LSm657
complex is most likely a direct consequence of the
very high concentration of zinc acetate (100 mM)
from the crystallization solution (Table 1).
NMR analysis of the LSm657 complex confirms
the crystal structure
We have shown by X-ray crystallography that the
LSm5, LSm6, and LSm7 proteins arrange into a
hexameric LSm657–657 ring structure. To indepen-
dently confirm this quaternary arrangement in
solution, we decided to use high-resolution NMR
spectroscopy. These studies were motivated by
several considerations. Firstly, for the formation of
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the native LSm1–7 or LSm2–8 complexes, two of the
six intermolecular interfaces in the LSm657–657
complex need to dissociate to allow for the
incorporation of the four additional LSm proteins.
The circular structure could thus be disadvanta-
geous for the assembly process of the native LSm
complexes. Secondly, we wanted to assess if the
presence of Zn2+ at the interfaces between the LSm
proteins in the crystal structure (Fig. 2d) interfered
with the quaternary structure of the complex. Our
solution studies will address the multimerization
state of the LSm657 complex in the absence of zinc.
Finally, differences between the crystal structure
and the solution state were previously observed for
the LSm3 protein. In that case, the crystal structure
suggested the assembly of the LSm3 rings into
complexes of very high molecular mass, a feature
that was not observed in solution.22
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Fig. 3. NMR analysis of the LSm57 and LSm657 complexes. (a) Two-dimensional 1H–15N spectrum of LSm57; exemplary
assignments are indicated. U-[13C,15N,2H]-labeledNMR samples were prepared by overexpression of the LSm complex in a
D2O-basedminimal medium containing 2H13C-labeled glucose and 15N-labeled ammonium chloride as the sole carbon and
nitrogen sources, respectively. The overexpressed proteins were purified as described in the legend to Table 1. The NMR
samples contained the full-length proteins andwere not subjected to digestionwith trypsin. The final protein concentration in
the samples was between 0.8mM and 1.5mM in size-exclusion buffer supplemented with 5%D2O and 0.03% sodium azide.
Nozinc acetatewas added to theNMRsamples.NMRexperimentswere recorded at 303K/308K (LSm57) or 308K (LSm657)
on Bruker AVIII-600 and AVIII-800 NMR spectrometers equipped with a room temperature probehead. The backbone
resonances of the LSm57 complex were assigned using TROSY36 versions of standard triple-resonance experiments
(HNCACB/HNCOCACB). (b) Secondary chemical shifts of LSm57 (calculated as ΔΔCα−ΔΔCβ). Positive values
correspond to helical regions, and negative values correspond to extended conformations. Note that the positive secondary
chemical shift in themiddle of some of theβ-strands corresponds to the locationwhere theβ-strands aremost highly bent. In
general, the solution data (bars) correspond very well to the crystal structure (gray areas that represent the secondary
structure elements). Residues 100–113 in LSm7 that are invisible in the NMR spectra are not displayed in the plot. (c) Two-
dimensional 1H–15N spectrumof the 60-kDaLSm657 complex. Backbone resonanceswere assigned using TROSY36 versions
of HNCA/HNCOCA, HNCB/HNCOCB, HNCACO/HNCO, and 15N-edited NOESY spectra (Supplementary Fig. 3). In
addition, a diagonal free N–N-edited TROSY–NOESY–TROSY experiment was recorded to resolve spectral overlap37
(Supplementary Fig. 3). (d) Secondary chemical shifts of the LSm657 complex (see (b)) agree very well with the secondary
structure elements in the crystal structure. (e) Superposition of the LSm57 (a) and LSm657 (c) spectra indicating the large
number of residues that experience chemical shift changes upon the interaction of LSm57 with LSm6. (f) Chemical shift
differences between LSm57 dimer and LSm57 in the LSm657 hexamer. The largest differences (e.g., G90 in LSm7; a and c) are
located at the outerβ-strands of LSm5 and LSm7. These strands engage in interactionswith LSm6 to form the hexameric ring
observed in the crystal structure. Most other residues change their chemical shifts, likely as a result of a different
intermolecular angle between LSm5 and LSm7 in the different complexes (see text).
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From a technical point of view, it is not straight-
forward to study the hexameric LSm657 ring with a
molecular mass of 60 kDa using high-resolution
NMR spectroscopy. We thus decided to first dissect
the complex into smaller building blocks that are
easier to tackle spectroscopically. To that end, we
made use of the fact that the 20-kDa dimeric LSm57
complex does not assemble into a higher oligomeric
state (Fig. 1). This implies that β-strand 4 of LSm5 is
unable to form a stable intermolecular β-sheet with
β-strand 5 of LSm7 (see also the text above).Our
1H–15N NMR spectra of LSm57 are of high quality,
and we could obtain a complete backbone assign-
ment using a U-[13C,15N,2H]- labeled sample
(Fig. 3a). Two lines of evidence confirm that the
dimeric LSm57 complex is folded similarly in
solution as within the hexameric LSm657 complex
in the crystal. Firstly, the secondary chemical shifts
derived from the NMR data agree well with the
secondary structure elements of the LSm57 complex
(Fig. 3b). Secondly, almost all short amide–amide
distances derived from the crystal structure are
maintained in solution, as observed in 15N-edited
nuclear Overhauser enhancement spectroscopy
(NOESY) spectra (Supplementary Fig. 2). The
dimerization of LSm57 in solution is also similar
to that observed in the crystal structure, as we
observed the corresponding intermolecular contacts
in our solution studies.
We next studied the 60-kDa hexameric LSm657
complex in solution using full protein deuteration
and transverse relaxation optimized spectroscopy
(TROSY) techniques (Fig. 3c). Comparison of the
1H–15N spectra of LSm57 and LSm657 shows that a
transfer of assignments is not possible due to the
large number of chemical shift changes (Fig. 3e and
the text below). We therefore performed a com-
plete resonance assignment of the LSm657 complex
(Fig. 3c). As for the LSm57 dimer, the secondary
chemical shifts of the LSm657 complex are in good
agreement with the crystal structure of the LSm657
complex (Fig. 3d). In addition, 15N-edited NOESY
spectra recorded on the LSm657 sample confirmed
short-range amide–amide distances derived from
the crystal structure, including intermolecular
cross-strand contacts (Supplementary Fig. 3). In
cases of amide resonance overlap, we made use of
the recently developed diagonal free TROSY 15N
(t1)–NOESY–TROSY15N (t2) 1H(t3) experiment,37
which also unambiguously confirmed the presence
of intermolecular contacts in solution. In summary,
we conclude that the LSm657 complex forms a
hexameric ring in solution that is structurally very
similar to the crystal structure that we solved. This
also confirms that the Zn2+ in the crystal does not
induce an artificial formation of intermolecular
interfaces.
In addition to the Sm fold, LSm7 contains a 25-
residue-long N-terminal extension and a 15-residue-
longC-terminal extension. In solution, these residues
are likely disordered, as judged from the absence of
corresponding resonances in the NMR spectra. This
results from the elevated pH (7.5) and temperature
(35 °C) during the measurements that lead to a rapid
loss of the NMR signal from unprotected amide
protons due to a fast exchange with bulk water.
Further evidence for the unstructured nature of these
residues comes from the observation that the N-
terminal residues of LSm7 were readily cleaved
during the trypsin treatment of the protein complex
used for crystallization and from the lack of electron
density for the C-terminal LSm7 residues. Interest-
ingly, regions in the Sm proteins that lie outside the
Sm fold also seem disordered in the assembly
intermediates SmBD1 and SmD1D2.20 However, in
the context of the RNA-bound Sm complex, these
regions adopt a folded state that then directly
interacts with the RNA.4
The angle between LSm proteins is adaptable in
different LSm complexes
Upon incorporation of the dimeric LSm57 into the
hexameric LSm657 complex, two new intermolecu-
lar interfaces are formed: the free β-strand 4 in LSm5
engages in interactions with β-strand 5 of LSm6, and
the free β-strand 5 in LSm7 engages in interactions
with β-strand 4 of LSm6. As such, we expected
chemical shift differences between the NMR spectra
of the LSm57 complex and the NMR spectra of the
LSm657 complex that were limited to these residues
(Fig. 3e). Indeed, resonances corresponding to these
residues change their chemical shift significantly
(Fig. 3f). However, we also observed smaller but
significant chemical shift changes for many other
resonances remote from the newly formed interface
(Fig. 3e and f). We interpret these additional shifts as
resulting from the adjustment of the angles between
the individual LSm proteins. In the free LSm57
dimer, the LSm–LSm angle is predicted to be close to
51°, which is optimal for the formation of a
heptameric ring.4,20 In the crystal structure of the
hexameric LSm657 ring, we observe, however, that
the angle is restrained to 60°. Interestingly, a similar
change in the angle between (L)Sm proteins has been
observed for the A. fulgidus Sm2 protein. This
archaeal Sm complex can arrange into a hexameric
ring in the free state; 21 however, it forms a
heptameric ring in the presence of RNA,38 which
shows the plasticity of the (L)Sm proteins that allows
for assembly into differently sized complexes.
LSm657 is a functional assembly intermediate
At least two intermolecular interfaces within the
hexameric LSm657–657 complex need to open to
allow for the formation of the heptameric LSm1–7 or
LSm2–8 complex (see the text above). Previous
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attempts to reconstitute the LSm657 particles into
LSm1–7 or LSm2–8 rings were performed in the
presence of high levels of urea, a condition that is
very remote from that found in a cellular
environment.15 To test if additional LSm proteins
can be incorporated into the LSm657 complex under
physiological conditions, we performed pull-down
experiments with purified His-tagged LSm657 and
untagged LSm23 complexes (Fig. 4a, left). While
untagged LSm23 alone (Fig. 4a, lane 1) showed no
affinity for the Ni resin (Fig. 4a, lane 2), His-tagged
LSm657 (Fig. 4a, lane 3) interacted with the affinity
resin (Fig. 4a, lane 4). Whenwe applied an incubated
mixture of untagged LSm23 andHis-tagged LSm657
(Fig. 4, lane 5) to the affinity resin, LSm23 was
copurified with LSm657 (Fig. 4, lane 6). This clearly
shows that LSm23 interacts strongly with LSm657
and that a stable complex containing five different
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Fig. 4. LSm657 can further assemble into LSm23–657. (a, left) Pull-down experiments of LSm657 and LSm23. Untagged
LSm23 (lane 1) does not interact with the affinity resin (lane 2). His-tagged LSm657 (lane 3) does bind to the affinity resin
(lane 4). Mixing untagged LSm23 with His-tagged LSm657 in a 1:1 ratio (lane 5), followed by incubation at 37 °C for 1 h,
results in the selective purification of LSm23 with LSm657 due to the (partial) formation of an LSm23–657 complex (lane
6). Interestingly, incubation of LSm657 with a 5-fold molar excess of LSm23 resulted in the formation of an LSm23–657
complex that was about 2-fold enriched in LSm23. This suggests that the LSm23–657 complex contains two copies of
LSm23 and is thus heptameric. The purification of LSm23 was analogous to the purification of LSm657. LSm7 that binds
to the affinity matrix is underlined. Proteins were analyzed by SDS-PAGE and visualized with Coomassie blue. Molecular
mass is indicated on the left. Lanes marked “I” refer to the input, and lanes marked “B” refer to the complexes eluted from
the affinity resin with imidazole. (a, right) Pull-down experiments of LSm57 and LSm23. His-tagged LSm57 (lane 1)
interacts with the affinity resin (lane 2). Mixing untagged LSm23 with His-tagged LSm57 in a 1:1 ratio (lane 3), followed
by incubation at 37 °C for 1 h, did not result in the formation of an LSm23–57 complex (lane 4). This indicates that LSm57 is
not an efficient assembly intermediate of the LSm1–7 or LSm2–8 complexes. (b) 1H–15N TROSY spectrum of 2H–15N-
labeled LSm657 before (red) and 7 h after (blue) the addition of an excess of unlabeled LSm23. Chemical shift changes are
due to the formation of the LSm23–657 complex. (c) The formation of the LSm23–657 complex is slow, corresponding to a
process with a high-energy barrier, as expected of the reorganization of the LSm ring. Shown are the spectra of LSm657
(red contours) recorded before the addition of LSm23 (top left) and 30 min, 2 h, and 7 h after LSm23 was added. The
LSm657 resonances are shown as single contours in the three latter spectra. Thirty minutes after the addition of LSm23 to
LSm657 (green contours), the LSm23–657 resonances appear. Some of the LSm657 resonances are still visible after 2 h
(cyan contours). After 7 h (blue contours), LSm657 has been completely converted into LSm23–657. The region displayed
corresponds to the boxed region in (b).
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LSmproteins is formed. Interestingly, the addition of
an excess of LSm23 compared to LSm657 resulted in
the formation of an LSm23–657 complex that was
enriched in LSm23 (Fig. 4, lane 7). This suggests
that the LSm657 complex can incorporate two copies
of LSm23 to form a heptameric LSm(23)2–657
complex. This is in agreement with known assembly
states of (L)Smproteins that have been reported to be
either hexameric, heptameric, or octameric. It is
interesting to note that the LSm23–657 complex
corresponds to the SmD1D2–EFG complex,39 which
is the smallest Sm assembly intermediate for the Sm
complex that has been shown to interact with RNA.
In a control experiment, we show that LSm57 (Fig.
4a, right, lane 4) is not able to efficiently form a
stable complex with LSm23. This indicates that
LSm57, as opposed to LSm657, is not a functional
building block of the native LSm ring; this correlates
well with the prediction that LSm3 interacts with
LSm6 in the native LSm ring (Fig. 1c).
To observe the assembly reaction of LSm657 and
LSm23 at atomic resolution, we added NMR-
inactive LSm23 to U-[15N,2H]-labeled LSm657 (Fig.
4b). As in the pull-down experiments, we clearly
observe that LSm23 interacts with LSm657, since we
found significant chemical shift changes in most of
the resonances of LSm657. Interestingly, the changes
in the NMR spectrum did not occur instantaneously
but were induced over a time period of several
hours (Fig. 4c). This indicates that the interaction
between LSm23 and LSm657 is not a simple binding
event between the two complexes. The slow change
in the spectra rather reports on an event with a high
energetic barrier, as is expected of the remodeling of
the LSm657 complex into an LSm23–657 complex.
Although the process we observe here in the NMR
tube is relatively slow, it is reasonable to believe that
the assembly is significantly faster in a cellular
environment due to the presence of assisting protein
complexes and/or LSm14, LSm48, or RNA.
The differences between the NMR spectra of
LSm657 and the NMR spectra of LSm23–657 are
reminiscent of the changes that we observed in the
NMR spectra of LSm57 upon assembly into the
hexameric LSm657 rings (Figs. 3e and 4b). There,
the spectra of LSm57 changed due to the direct
interaction with LSm6 and due to changes in the
intermolecular orientation of the LSm5 and LSm7
proteins (see the text above). The differences between
the NMR spectra of LSm657 and the NMR spectra of
the LSm23–657 complex could be explained similarly
as resulting directly from the interaction with LSm23
and indirectly from a change in the intermolecular
angle between LSm5, LSm6, and LSm7, which are no
longer assembled in a hexameric ring but in a
heptameric LSm(23)2–657 ring.
In order to identify residues that experience the
largest chemical shift changes and are thus at the
newly formed LSm657–LSm23 interface, we would
require chemical shift assignments of the LSm23–
657 complex. Unfortunately, this information cannot
be obtained based on the assignments of the LSm657
complex (Fig. 3c), as complex formation is slow on
the chemical shift timescale (see the text above; Fig.
4c), preventing the transfer of assignments from
LSm657 to LSm23–567. However, based on the
order of the LSm proteins in the native LSm
complexes (Fig. 1c), it is tempting to speculate that
the LSm6–LSm7 interface dissociates to accommo-
date LSm23. This notion is supported by the analysis
of our LSm657 structure using the PISA (Protein
Interfaces, Surfaces, and Assemblies) server (Euro-
pean Bioinformatics Institute‡), which indicates
that the LSm67 interface contains fewer hydrogen
bonds and salt bridges than the LSm56 and LSm57
interfaces.
In summary, our data provide the first insights
into the structure of heteromeric LSm complexes.
We solved the high-resolution crystal structure of
the LSm657 complex and show that it forms a
hexameric ring, where the order of the proteins is in
agreement with the order of the Sm proteins in the
Sm complex. Using high-resolution NMR spectros-
copy, we show that the structure and assembly state
of the complex in solution are very similar to the
crystal structure that we solved. In addition, we
used pull-down experiments and NMR spectrosco-
py to show that the hexameric LSm657 ring can act
as an assembly intermediate towards the native LSm
complexes by incorporating LSm23. Interestingly, it
was shown previously that SmEFG, which corre-
sponds to LSm657, is a functional assembly building
block of the spliceosomal Sm complex. Our data
thus indicate that not only the structure but also the
assembly process of the LSm and the Sm rings are
conserved. Finally, our results form the basis of
further studies addressing the assembly, structure,
and RNA recognition properties of the cytoplasmic
LSm1–7 complex and the nuclear LSm2–8 complex.
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been deposited in the ProteinData Bank (PDB) under
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accession codes 17781 and 17782, respectively.
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  Figure	  1:	  The	  LSm657	  complex	  coordinates	  zinc	  in	  the	  
crystal	  structure	  View	  of	  the	  LSm657	  ring	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  the	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  as	  in	  Figure	  2A.	  The	  location	  of	  the	  Zn2+	  ions	  in	  the	  crystal	  structure	  (left)	  is	  indicated.	  One	  Zn2+	  ion	  is	  tightly	  bound	  between	  LSm5	  and	  LSm7	  (middle).	  A	  cluster	  of	  Zn2+	  ions	  is	  located	  at	  the	  LSm6:LSm7	  interface	  (right).	  The	  occupancy	  of	  some	  zinc	  sites	  is	  lower	  than	  1	  and	  therefore	  not	  all	  of	  the	  LSm6:LSm7	  interfaces	  necessarily	  contain	  3	  Zn2+	  ions.	  Side	  chains	  that	  coordinate	  the	  Zn2+	  ions	  are	  labeled	  and	  shown	  as	  red	  sticks.	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Supplementary	  Figure	  2:	  The	  LSm57	  structure	  in	  solution	  Top:	  Schematic	  representation	  of	  the	  topology	  of	  the	  LSm57	  complex,	  as	  derived	  from	  the	  crystal	  structure	  of	  the	  LSm657	  complex.	  The	  N-­‐terminal	  α-­‐helix	  is	  not	  shown	  for	  clarity.	  Residue	  numbers	  at	  the	  beginning	  and	  end	  of	  the	  strands	  are	  indicated.	  The	  red	  dotted	  lines	  correspond	  to	  short	  amide-­‐amide	  distances	  in	  the	  crystal	  structure.	  Bottom:	  Strips	  derived	  from	  a	  1H(t1)-­‐NOE-­‐TROSY	  15N(t2)	  1H	  (t3)	  experiment	  that	  display	  cross	  strand	  NOEs	  (intra-­‐	  or	  intermolecular)	  that	  confirm	  the	  presence	  of	  the	  contacts	  indicated	  with	  the	  red	  dotted	  lines	  (top)	  in	  solution.	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Supplementary	  Figure	  3:	  The	  LSm657	  structure	  in	  solution	  Top:	  Schematic	  representation	  of	  the	  topology	  of	  the	  LSm657	  complex,	  as	  derived	  from	  the	  crystal	  structure.	  The	  red	  dotted	  lines	  correspond	  to	  short	  amide-­‐amide	  distances	  in	  the	  structure.	  (see	  also	  legend	  of	  Supplementary	  Figure	  2)	  Middle:	  Strips	  derived	  from	  an	  1H(t1)-­‐NOE-­‐TROSY	  15N(t2)	  1H	  (t3)	  experiment	  that	  display	  cross	  strand	  NOEs	  (intra-­‐	  or	  intermolecular)	  that	  confirm	  the	  presence	  of	  the	  contacts	  indicated	  with	  the	  red	  dotted	  lines	  (top)	  in	  solution.	  	  Bottom:	  Strips	  derived	  from	  a	  diagonal	  free	  TROSY	  15N	  (t1)-­‐NOESY-­‐	  TROSY	  15N	  (t2)	  1H(t3)	  experiment	  1,	  displaying	  the	  “circular	  walk”	  through	  the	  LSm657	  hexameric	  ring.	  The	  crosses	  at	  the	  end/	  beginning	  of	  the	  red	  dotted	  lines	  indicate	  the	  location	  of	  the	  diagonal.	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In Vitro Reconstitution of a Cellular Phase-Transition Process that
Involves the mRNA Decapping Machinery**
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Abstract: In eukaryotic cells, components of the 5’ to 3’mRNA
degradation machinery can undergo a rapid phase transition.
The resulting cytoplasmic foci are referred to as processing
bodies (P-bodies). The molecular details of the self-aggrega-
tion process are, however, largely undetermined. Herein, we
use a bottom-up approach that combines NMR spectroscopy,
isothermal titration calorimetry, X-ray crystallography, and
fluorescence microscopy to probe if mRNA degradation
factors can undergo phase transitions in vitro. We show that
the Schizosaccharomyces pombe Dcp2 mRNA decapping
enzyme, its prime activator Dcp1, and the scaffolding proteins
Edc3 and Pdc1 are sufficient to reconstitute a phase-separation
process. Intermolecular interactions between the Edc3 LSm
domain and at least 10 helical leucine-rich motifs in Dcp2 and
Pdc1 build the core of the interaction network. We show that
blocking of these interactions interferes with the clustering
behavior, both in vitro and in vivo.
Processing bodies (P-bodies) are cytoplasmic micrometer-
scale ribonucleoprotein (RNP) foci that were initially iden-
tified in mammalian cells[1] and that have now been observed
in distant branches of eukaryotes. The list of proteins that are
found in these mRNP granules has grown significantly[2] and
comprises general mRNA decay factors including the Dcp2
decapping enzyme and the enhancers of decapping Dcp1,
Edc3, Pat1, and LSm1–7.[1c,3] The proposed roles of the
clustering of the decapping enzyme within a confined cellular
space includes enhanced substrate binding,[4] buffering of the
concentration of translating mRNAs,[5] regulation of the
concentrations of free cytoplasmic proteins,[6] and a means to
respond to cellular stress.[7]
The details of the interactions that underlie the self-
assembly process of proteins and RNA into P-bodies are
largely undetermined. Genetic studies have addressed the
importance of individual proteins[8] and revealed two major
characteristics. 1) the details of the intermolecular interac-
tions vary among species. For example, Edc3 and the Q/N rich
C-terminal region of LSm4 can act as a scaffold for P-body
assembly in S. cerevisiae,[3c,9] whereas the Pdc1 protein has
been shown to be important in S. pombe.[10] 2) the P-body
assembly process is highly redundant and deletion of a single
protein does not abolish the aggregation process completely.[8]
This redundancy complicates genetic approaches that aim to
identify the interactions that regulate the self-assembly
process.
Recently, it was shown that the purified Nck and N-WASP
proteins can undergo a phase transition in vitro.[11] These
experiments are in line with the idea that the formation of
cellular granules relies on a network of multivalent weak
interactions between different components.[6,12] Herein, we
ask whether it is possible to reconstitute a phase-transition
process with proteins that have been shown to localize to P-
bodies. To that end, we focus on the purified S. pombe Dcp2
mRNA decapping enzyme, its prime activator Dcp1 and the
scaffolding proteins Edc3 and Pdc1 and show that these
proteins can spontaneously self-assemble into oil-like drop-
lets.
The proteins Edc3 and Dcp2 (Figure 1A) have been
shown to interact through contacts between the Edc3 LSm
domain and short helical leucine-rich motifs (HLMs) in
Dcp2.[13] Herein, we use NMR spectroscopy titration experi-
ments and show that Dcp2 contains at least seven different
HLMs that are recognized specifically by the Edc3 LSm
domain (Figure 1B). Interestingly, the extent of the observed
chemical shift changes varies, indicating that the HLM
affinities vary considerably. To quantify these, we used
isothermal titration calorimetric (ITC) assays (Figure 1C,D)
and find that the Edc3:HLM affinities range from (2.5
0.3) mm to the mm range.
A prerequisite for protein phase separation is the
capability to associate into indefinite soluble assemblies. In
general, this condition is fulfilled for multivalent proteins with
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independent binding sites. Theoretically, Edc3 and Dcp2 can
form such an indefinite and highly branched network of
interactions because Edc3 is a dimer (and thus contains two
LSm domains) and Dcp2 contains seven Edc3 docking sites
(Figure S1A in the Supporting Information). In addition, the
binding affinities in the Edc3:Dcp2 system range from low mm
to mm which has been suggested to be beneficial for the
generation of phase transitions.[6] To address if the Edc3:Dcp2
network is suitable to induce a phase separation in vitro, we
mixed the recombinantly expressed and purified far C-
terminal region of Dcp2 that contains four HLMs (Dcp2
residues 553–741; Table S1A) with full-length Edc3. Interest-
ingly, a clear phase separation can be observed using a bright-
field microscope (Figure 2A, left). Both Edc3 and Dcp2 are
significantly enriched within the droplet-like structures as
judged from the fluorescent signal that resulted from the
Oregon green labeled proteins (Figure 2A, and Figures S1B,
S1C). Our data thus shows that the network of interactions
between Edc3 and Dcp2 is suffi-
cient to induce phase separations.
To obtain insights into the
conditions that result in phase
separation we varied the concen-
trations of Edc3 and the part of
Dcp2 that contains 4 HLMs (Fig-
ure 2B, left). We observed that
phase separation occurs when
a number of conditions are met.
First, the absolute concentration
of the individual proteins needs to
be sufficiently high. In case a cer-
tain threshold concentration is
not exceeded, phase separation
does not take place and the
proteins remain homogeneously
distributed in solution. Second,
the molar ratio of the two pro-
teins needs to be within specific
limits. In case the excess of either
of the two proteins is too large,
phase separation is abolished.
This occurrence can be explained
by the fact that a large excess of
Edc3 would result in a situation
where all HLMs are bound to
a dimeric Edc3 protein, which
would result in a loss of intertwin-
ing between different Dcp2
chains. A large excess of Dcp2
would, on the other hand, result
in a situation where there are
insufficient dimeric Edc3 proteins
available to link the Dcp2 chains.
In a second set of experi-
ments, we determined if the
number of intermolecular inter-
actions between components
influences the phase-separation
process. As full length Dcp2 that
comprises seven HLMs was not expressed stably in our hands,
we designed a version of Dcp2 that contains the complete
unfolded C-terminal region but that lacks a part of the
proline-rich region. This Dcp2 C-term DMid protein (Dcp2
residues 242–289+ 553–741; Supporting Information
TableS1A) contains five HLMs and undergoes phase tran-
sitions at concentrations that are significantly lower than
those required for the Dcp2 construct that contains four
HLMs. As an example: in the presence of 150 mm Edc3 phase
separation takes place when the Dcp2 C-term DMid (five
HLMs) concentration is 25 mm (125 mm modular HLM con-
centration), whereas double the concentration of the Dcp2-
fragment that contains four HLMs (50 mm ; 200 mm modular
HLM concentration) is required. In agreement with previous
observations,[11] we can thus conclude that the valency and
affinities of the interacting partners determines whether
phase separation occurs at specific concentrations. Impor-
tantly, as controls we performed experiments using either
Figure 1. The seven HLMs in Dcp2 bind to the Edc3 LSm domain with a wide range of affinities.
A) Schematic representation of S. pombe Dcp1 (EVH1 domain, yellow), Dcp2 (regulatory light green,
catalytic dark green, HLMs red, proline-rich mid domain white, C-terminus gray) and Edc3 (LSm dark
blue, FDF motif orange, YjeF N light blue). All used protein constructs are listed in Supporting
Information Table S1A. B) 1H–15N correlation spectra of the binding between the monomeric Edc3 LSm
domain and the seven isolated Dcp2 HLMs. Black: free 15N labeled Edc3 LSm domain, Red: the Edc3
LSm domain in the presence of a fivefold excess of the individual Dcp2 HLMs. The boxed region in the
top left panel is shown in all other spectra. Residues R38 and L58 are highlighted with ovals to indicate
that the HLMs induce chemical shift perturbations to a different extent. C) ITC graphs for the binding
of the Edc3 LSm domain to the Dcp2 HLM-1, HLM-C1 and HLM-C2 sequences. The best fit is drawn
with a red line and the extracted Kd values including the error (standard deviation) are indicated.
Deviations from n=1.0, where n refers to the stoichiometry, result from small inaccuracies in the
protein-concentration determination. D) Overview of the determined Kd values (error in parenthesis) for
the Dcp2 HLM:Edc3 interactions (n.d.: not determinable with ITC).
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a monomeric version of Edc3 or a Dcp2 sequence that only
contains a single HLM (Figure S1D,E). In none of these
control experiments we observed phase separation (Fig-
ure S1D,E), as the valency of one of the components is
reduced to one.
Cellular foci, including P-bodies, have been shown to be
highly dynamic.[14] To determine if the in vitro Edc3:Dcp2
phase separations that we prepared from purified compo-
nents display a similar behavior we monitored the droplets
over a longer time. We observed a number of fusion events
that confirm the liquid-like behavior of the in vitro droplets
(Figure 2C). This underscores that the in vitro system is
similar to the in vivo situation regarding this aspect.
In vivo, the foci that contain Dcp2 and Edc3 also comprise
numerous additional proteins. To test if it is possible to recruit
additional proteins within the reconstituted in vitro droplets,
we extended the Dcp2 C-term DMid construct such that it
also includes the Dcp2 catalytic and the regulatory domain
(Dcp2 DMid, residues 1–289+ 553–741; Table S1A) that has
been shown to interact with Dcp1.[15] We then mixed purified
Dcp1:Dcp2 complexes that harbored five HLM sequences
with Edc3 and observed a clear phase separation, indicating
that the Edc3:Dcp2 droplets can recruit additional factors
(Figure 2D). It should be noted that Dcp1 contains the
binding site for Xrn1,[16] thereby providing a mechanism to
recruit the exonuclease to the Dcp1:Dcp2:Edc3 assemblies. In
addition, the Edc3 protein contains an FDF repeat, providing
a means to recruit the helicase DDX6/Dhh1.[17] The catalytic
domain of Dcp2[18] and the helicase can then provide binding
sites for mRNA substrates.
The Edc3:HLM interactions form the core of the in vitro
droplets we assemble. Interference with this interaction is
thus expected to result in the loss of
phase separation. To test this hypoth-
esis, we supplemented the Dcp2:Edc3
droplet conditions with the HLM-
1 sequence (Figure 1D). With
increasing amounts of the HLM-
1 Dcp2 peptide, we observe a disap-
pearance of the phase separation
in vitro (Figure 2E). To assess the
consequences of the specific interfer-
ence with the Edc3:HLM interaction
for P-body formation in vivo, we
overexpressed the HLM-1 peptide
in S. pombe. To observe the recruit-
ment of Edc3 to P-bodies we replaced
the edc3+ gene at its endogenous
locus by the edc3+-mCherry fusion
construct. To simultaneously assess
P-body integrity we additionally
fused Dcp2 or Lsm7 to GFP at their
endogenous loci. In cells that did not
express the peptide that interferes
with the Edc3:HLM interaction we
observed P-bodies that contain Edc3-
mCherry and Dcp2-GFP or Lsm7-
GFP, respectively (Figure 3A,B, top
rows). On the other hand, in cells that
overexpress the HLM peptide the Edc3-mCherry protein is
no longer recruited into P-bodies (Figure 3A,B, bottom
Figure 2. In vitro phase transitions of purified Edc3 and Dcp2. A) Phase transition of 50 mm Dcp2
553-741 and 150 mm Edc3 (doped 1:100 with Edc3-OregonGreen). Left: bright field (BF) channel;
middle: Oregon Green (OG) channel; right: merge. B) Phase diagrams of phase transition of Edc3
together with Dcp2 553–741 (that contains 4 HLM sequences; left) or Dcp2 242–741DMID (that
contains 5 HLM sequences). Given concentrations are modular concentrations, for example, 50 mm
of Dcp2 553–741 is 200 mm HLMs, because 4 HLMs are in the Dcp2 553–741 construct. Modular
LSm concentration is identical with total Edc3 concentration as an Edc3 monomer has one LSm
domain. Occurrence of phase transition at a given condition is color coded; blue=no phase
transition; light blue=beginning phase transition; green= clear phase transition. Green lines
indicate progression of the phase boundaries. The red encircled condition is shown in (A) and (C).
C) The in vitro droplets are highly dynamic and fuse over time. The time-scale is indicated below
the OG channel pictures. D) Droplets formed by 25 mm Dcp1:Dcp2DMID and 100 mm Edc3 (doped
1:100 with Edc3-OG). Left: BF channel, Right: OG channel. E) Droplets formed by 25 mm Dcp2
242–741DMID and 100 mm Edc3 disappear by addition of increasing amounts of Dcp2 242–291
(containing HLM-1) (5 mm, 10 mm, 25 mm, 50 mm). Scale bars: 50 mm.
Figure 3. Effect of HLM-1 expression on Edc3 localization in vivo. A,B)
Fluorescent micrographs of S. pombe expressing mCherry and GFP
tagged versions of Edc3 and Dcp2 (A) or Lsm7 (B), respectively.
Without HLM-1 overexpression Edc3 and Dcp2 are enriched into P-
bodies (top row). Upon overexpression (adh1 promoter) of HLM-
1 Edc3 no longer localizes to P-bodies but is diffusely spread in the
cell (bottom row). Dcp2-GFP (A) and Lsm7 (B) still localize to P-
bodies upon overexpression of HLM-1, indicating that interference
with the Edc3:HLM interactions does not generally disturb P-body
formation. Scale bar: 5 mm.
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rows). This lack of recruitment is most likely a consequence of
the Edc3 LSm domains that are now saturated with the
overexpressed mono-valent peptide. These in vivo observa-
tions are in agreement with our in vitro phase separation.
Importantly, the overexpression of the HLM competition
peptide does not result in the general loss of P-bodies as both
Dcp2-GFP and Lsm7-GFP are still found in distinct cellular
foci (Figure 3A,B, middle panels, bottom rows). These
observations stress the fact that in vivo P-body formation is
a highly redundant process, where the loss of one P-body
component does not result in a general loss of these foci.
To obtain insights into the redundancy of P-body forma-
tion, we turned to the Pdc1 protein that was recently
implicated in P-body integrity in S. pombe.[10] Pdc1 is related
to metazoan Edc4 (Ge-1, Hedls)[19] and both proteins contain
an N-terminal WD-40 domain and a central coiled-coil region
(Figure 4A). Close inspection of the protein sequence at the
N-terminal region of the S. pombe Pdc1 protein indicates the
presence of several HLMs (Figure 4A). Using NMR titration
experiments (Figure 4B) we confirmed that the N-terminal
region of Pdc1 contains at least three HLM sequences that
can interact with the Edc3 LSm domain. The extent of the
induced chemical shift perturbations in the Edc3 LSm domain
varied between the Pdc1 HLMs, as was the case for the seven
Dcp2 HLMs (Figure 1B, 4B). Using ITC experiments, we
quantified the associated affinities and found that the three
Pdc1 HLM sequences interact with the Edc3 LSm domain
between 150 mm and lower mM range (Figure 4C,D). Inter-
estingly, the Pdc1 protein contains a central coiled-coil region,
through which the protein can oligomerize, resulting in an
increased number of HLMs in the biological unit of the
protein. Above, we have shown that a large number of HLMs
is favorable for the phase separation process (Figure 2B). To
test whether Edc3 and Pdc1 are able to induce phase
transitions in vitro we initially tried to purify the Pdc1 protein
from E. coli. Unfortunately, full-length Pdc1 was, in our
hands, not stable enough to allow for in vitro phase separation
experiments. Consequently, we engineered a Pdc1 protein
where the coiled-coil region was replaced with glutathione S-
transferase (GST). GST is a dimer in solution and thus mimics
the oligomerization effect of the Pdc1 coiled-coil region. We
then used this designed dimeric Pdc1 protein (that has an
HLM valency of six) and the dimeric Edc3 protein (that has
an LSm valency of two) to test whether Pdc1 and Edc3 can
undergo phase transitions in vitro. Interestingly, we observe
that Pdc1 and Edc3 are able to engage in an indefinite
network of intermolecular interaction that results in the
formation of an oil-like droplet phase (Figure 4E), as we
observed for Dcp2 and Edc3 (Figure 2A). We can thus
conclude from our in vitro experiments that Pdc1 and Dcp2
are redundant proteins with regard to the potential of
inducing phase separation when mixed together with Edc3.
Sequence alignments of the C-terminal region of the
S. pombe Pdc1 protein with the C-terminal regions of the
human, D. melanogaster and A. thaliana Edc4 proteins sug-
gest the presence of a Ge-1C domain
[20] in the Pdc1 protein,
although the sequence identity (17%) is very low (Fig-
ure S2A). To confirm the presence of a Ge-1C domain in
Pdc1, we solved the crystal structure of residues 932 to 1076 to
a resolution of 1.35  (PDB code: 4Q2S; Table S2). The
structure displays a closely packed helical bundle, where the
three N-terminal helices make an approximate 90-degree
angle with the five C-terminal helices (Figure 5A). The
structure of the domain is very similar to the known structure
of the Ge-1C region of the D. melanogaster Ge-1 protein
(Figure S2B).
Previously, it was shown that the C-terminal 290 residues
of Pdc1 interact with Dcp2.[10] To probe if this interaction is
direct, we performed NMR chemical shift titration experi-
ments with the 15N labeled Pdc1 Ge-1C domain and an
unlabeled Dcp1:Dcp2 decapping complex (Dcp2 residues 1–
95). We observe that resonance signals from residues that are
located in the C-terminal helices of the Pdc1 Ge-1C domain
are significantly perturbed (Figure 5B). This result indicates
that Pdc1 exploits a surface at the far C-terminus of the
protein to directly contact the Dcp1:Dcp2 decapping complex
(Figure 5A). Pdc1 can thus interact with Edc3 through
a number of HLMs at its far N-terminal region and with the
decapping complex through the Ge-1c domain at its far C-
terminal region. These results underscore the scaffolding
Figure 4. Pdc1 contains three HLMs at the N-terminus that bind to
Edc3 with different affinities. A) Domain organization of the Pdc1
protein (N-terminal HLMs cyan, WD40 repeats purple, coiled-coil or-
ange, Ge-1C-like domain (see below) pink). B)
1H–15N correlation
spectra of the monomeric 15N labeled Edc3 LSm domain in the
absence (black) and presence (cyan) of the individual Pdc1 HLMs. The
boxed region in the top left panel of Figure 1B is shown, ovals
highlight two specific residues (see above). C) ITC graph of the Edc3
LSm domain binding to HLM-N2 from Pdc1. The best fit is drawn
with a cyan line and the extracted Kd value is indicated. D) Overview of
all Kd values (error in parentheses) determined for binding of Pdc1
HLMs to Edc3 LSm (n.d., not determinable with ITC). E) In vitro
phase separation of designed dimeric Pdc1 construct that mimics full
length Pdc1 (50 mm) together with Edc3 (150 mm ; doped 1:100 with
Edc3-OregonGreen). Scale bar, 50 mm.
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function of Pdc1 and explain its importance for processing
body formation. Addition of Pdc1 to Edc3 and Dcp2 (Fig-
ure 2B) is thus expected to increase the strength of the
interaction network, which is advantageous for the phase
transitions process.
We have shown that it is possible to reproduce the in vivo
phase separation behavior of the mRNA degradation machi-
nery in a well-defined in vitro setting. Importantly, this
bottom-up approach provides insights into the clustering
behavior that could not have been obtained using genetic
approaches owing to the highly redundant nature of the
clustering process (Figure 5C,D).
Additional mechanisms that promote the self-aggregation
process of the mRNA degradation machinery will be
exploited in the cell. These additional interactions will be
able to lower the critical concentration required for phase
separation to biologically relevant levels. In that regard, it is
worth mentioning that it was recently shown that low
complexity (LC) regions in the RNA binding protein FUS
are able to induce phase transitions.[6,12,21] Mechanistically, the
LC regions aggregate through a mechanism that involves the
formation of amyloid-like fibers, a feature that we did not
detect in our current studies. This suggests that both processes
that lead to phase separation are of a fundamentally different
nature. Interestingly, short LC regions are also present in
Dcp2 and Pdc1 and in other S. pombe processing body
proteins, including LSm4, Pat1p, Sum2 (Scd6), Ste13 (Dhh1),
and Exo2 (Xrn1).[22] Future experiments will be able to shed
light on how these LC regions, the HLM:Edc3 interactions
and other specific intermolecular
contacts (Figure 5C) modulate the
phase-transition process that
underlies P-body formation (Fig-
ure 5D). It has been suggested
that biological systems might
have evolved such that specific
proteins are close to the phase
separation conditions.[6] Minor
modifications in the valency and
the affinity of the interacting part-
ners by post-translational modifi-
cations or small changes in protein
levels can then result in the sudden
appearance or disappearance of
cellular phase separation.[23] Inter-
estingly, the HLM rich region of
Pdc1 contains a large number of
phosphorylation sites[24] that could
potentially interfere with Edc3
binding and reduce the tightness
of the intermolecular interaction
network.
Our results form a starting
point for future in vitro studies
that address how the activity of
the cellular enzymes can be influ-
enced by local cellular molecular
crowding. In addition, we antici-
pate that in vitro approaches sim-
ilar to the one described herein can be exploited to address
how other cellular granules are formed and how specific
proteins are targeted to a specific class of granules.
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Experimental section 
 
Molecular Cloning and Protein Purification.  
All plasmids used for protein overexpression in E. coli strain BL21 (DE3) Codon Plus RIL (Stratagene) were 
generated using standard cloning techniques (Supplementary Table S1A). Transformed cells were grown at 
37 °C to an OD595 of 0.6-0.8 in LB and protein production was induced with 1 mM IPTG at 20 °C. Cells 
containing protein for NMR, ITC and X-ray experiments were lysed in buffer A (50 mM sodium phosphate, pH 
7.5, 150 mM NaCl, 10 mM imidazole, 1 mM DTT) supplemented with 0.1 % Triton X-100, 0.5 mg/ml 
Lysozyme and 0.2 U/ml DNase I. The soluble fraction of the lysate was applied to Ni2+-NTA resin equilibrated 
in buffer A. The retained protein fraction was eluted with buffer A containing 300 mM imidazole. After removal 
of the affinity tag with TEV protease, the protein was purified to homogeneity using size exclusion 
chromatography in SEC buffer (25 mM HEPES, pH 7.3, 125 mM NaCl, 1 mM DTT). HLM sequences were 
produced as MBP fusion constructs and were not digested with TEV protease.  
 
NMR spectroscopy  
Isotopically labeled proteins were grown in (H2O or 70% D2O based) M9 minimal medium containing 15NH4Cl 
as the sole nitrogen source and/ or 1H 13C glucose as the sole carbon source. NMR spectra were recorded at 
30 °C on Bruker AVIII-600 or AVIII-800 spectrometers. Titration experiments were carried out with 0.1 mM 
15N labeled protein (Edc3 LSm or Pdc1 Ge-1C) and 0.5 mM unlabeled protein (MBP-HLMs or 
Dcp1:Dcp2regulatory; containing full length Dcp1 and residues 1-95 of Dcp2). The backbone resonances of the 
Pdc1 Ge-1C domain were determined using HNCACB and HN(CO)CACB pulse-sequences. Spectra were 
processed with the NMRPipe/NMRDraw software suite [1], figures showing NMR spectra were prepared using 
NMRView (onemoonscientific.com) and figures showing molecular structures were made using Pymol 
(pymol.org).  
 
ITC 
ITC data were recorded at 30 °C with a TA Instruments NanoITC Low Volume calorimeter, where the cell 
contained the individual HLM sequences into which the Edc3 LSm domain was titrated. ITC data were fitted 
using in house written scripts using an independent binding model. 
 
 
X-ray crystallography 
Residues 923 to 1076 of the Pdc1 protein crystallized in 0.2 M ammonium acetate, 0.1 M HEPES pH 7.5, 25% 
(w/v) PEG 3350. Data collection at 100K was performed at beamlines X10SA and X06DA at the Swiss Light 
Source, Villigen, Switzerland. Three data sets were recorded to determine the structure of the Ge-1C domain of 
the Pdc1 protein. A high-resolution data set resulted from data acquisition at 1.0 Å wavelength diffracting to 
1.35 Å resolution. Two additional crystals of Pdc1 served for data recording at 1.7 Å and 2.07 Å wavelength to 
establish phases using the anomalous signal of proteinaceous sulfur. All data sets were reduced using the 
XDS/XSCALE package [2], are of spacegroup P21212 and contain one protein chain in the asymmetric unit. Due 
to non-isomorphism initial structure determination was performed using both long-wavelength data sets. The 
sulfur sites were determined by SHELXD [3] using the data set recorded at 2.07 Å. Phase refinement as 
implemented in SHARP/AUTOSHARP [4] was performed including the data sets recorded at 1.7 Å and 2.07 Å. 
The electron density map resulting from density modification was interpretable and allowed manual model 
building using COOT [5]. A crude model consisting of 75 residues was transferred to the high-resolution dataset 
using PHASER [6]. After initial simulated annealing, refinement proceeded in alternating rounds of manual 
model rebuilding in COOT and restrained coordinate and anisotropic B-factor refinement in REFMAC [7]. 
Solvent molecules were added with COOT:find_waters. The structure was validated using Molecular Graphics 
System, Version 1.5.0.4 Schrödinger, LLC. Ramachandran statistics are as follows: 96.9% in favored regions 
and 3.1% in additional allowed regions. 
 
Phase separation and fluorescent microscopy.  
Proteins for phase separation microscopy experiments were purified in a buffer that contained 25 mM phosphate, 
pH7.3, 200 mM NaCl and 1 mM DTT. Proteins were fluorescently labeled with Oregon Green in the same 
buffer, however, in the absence of DTT. To optimize the labeling efficiency Oregon Green maleimide 
(dissolved in dimethylformamide) was added in 5-10 fold excess. The coupling reaction was incubated for 2 h at 
room temperature and contained less than 1 % DMF v/v. The reaction was stopped by addition of DTT to a final 
concentration of 4 mM. Uncoupled dye was removed from the protein fraction using a desalting PD-10 column 
and the coupling efficiency was determined via UV/Vis spectroscopy. A C-terminal cysteine was added to 
proteins that contained no accessible natural cysteine. Phase separation experiments were carried out in special 
96-well microscopy plates (MatTek Corp.). The final sample volume per well was 50-80 µl. Images were 
recorded at room temperature on a Zeiss Axio Observer.Z1 coupled to an AxioCam MRM camera after mixing 
of the different components. All images were processed with ImageJ (NIH, USA). 
 
S. pombe strains and imaging. 
S. pombe strains used in this study are listed in Supplementary Table S1B. PCR-based gene targeting was used 
to replace genes by gene fusions at their endogenous loci[8]. For overexpression of the HLM-1 the coding 
sequence of amino acids 242 to 291 of the dcp2+ gene fused to the 13myc epitope[9] were cloned into a pDual 
vector[10] under the control of the constitutive adh1 promoter[11] and integrated into the leu1 locus. Cell growth 
and imaging conditions for the visualization of P-bodies have been described previously[12]. 
 
SUPPORTING FIGURES 
 
 Figure S1 Phase separation of the Dcp2 and Edc3 proteins. (A): The Dcp2 protein has seven docking sites 
(HLM sequences) for the LSm domain of Edc3. The dimeric Edc3 protein has two LSm domains that can 
interact with HLM sequences. (B, C): Both the Edc3 and the Dcp2 protein are enriched in the droplet phase. In 
(B), the Edc3 protein is fluorescently labeled with Oregon green, in (C) the Dcp2 protein is fluorescently labeled 
with Oregon green. (D): A monomeric version of the Edc3 protein is not able to undergo phase transitions with 
Dcp2. (E) A Dcp2 protein that contains a single HLM is not able to undergo phase transitions with the dimeric 
Edc3 protein. The proteins that are fluorescently labeled are indicated. The scale bars correspond to 50 µm.  
  
 Figure S2 (A): Sequence alignment of the S. pombe, D. melanogaster, H. sapiens and A. thaliana Edc4 
homologs. The residue numbers are indicated and the alignment is colored according to residue type, where the 
color intensity correlates with sequence conservation. (B): Overlay of the structures of the Pdc1 Ge-1C domain 
and the D. melanogaster Ge-1C domain of the Ge-1 protein [13].  The view is identical to the view in Figure 5 of 
the main paper. 
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Protein/Protein 
complex 
Residues Purification/Solubility-
Tag 
Used in Figure Internal 
reference  
Edc3 1-94 N-His6-TEV 1B, 1C, 1D, 4B, 
4C, 4D, S1D 
194 
Dcp2 242-291 (HLM-1) N-His6-MBP-TEV 1B, 1C, 1D, 2E 226 
Dcp2 292-318 (HLM-M1) N-His6-MBP-TEV 1B, 1D 882 
Dcp2 482-504 (HLM-M2) N-His6-MBP-TEV 1B, 1D 895 
Dcp2 553-576 (HLM-C1) N-His6-MBP-TEV 1B, 1C, 1D 302 
Dcp2 577-604 (HLM-C2) N-His6-MBP-TEV 1B, 1C, 1D 880 
Dcp2 605-640 (HLM-C2') N-His6-MBP-TEV 1B, 1D 881 
Dcp2 709-741 (HLM-C5) N-His6-MBP-TEV 1B, 1D 329 
Edc3 1-454 N-His6-TEV 2A-E, 4E, S1B, 
S1C, S1E 
180 
Dcp2 553-741 N-His6-TEV 2A-C 68 
Dcp2 
Dcp2 C-term ΔMid 
242-741Δ290-552 N-His6-TEV 2B, 2E, S1B, 
S1D 
752 
Dcp2 C742 
Dcp2 C-term ΔMid 
242-741Δ290-552 (cysteine at C-
terminus)  
N-His6-TEV S1C 764 
Dcp1:Dcp2 C742 
Dcp1:Dcp2 ΔMid 
1-127 (Dcp1), 1-741Δ290-552 
(cysteine at C-terminus) 
N-His6-TEV 2D 769 
Control MBP N-His6-MBP-TEV 1B, 4B 189 
Pdc1 1-1076 N-His6-TEV text 829 
Pdc1-GST-Pdc1 1-105 (Pdc1)-GST-880-1076 
(Pdc1) 
N-His6-TEV 4E 928 
Pdc1 932-1076 N-His6-TEV 5A, 5B, 5C 892 
Dcp1:Dcp2 1-127 (Dcp1), 1-95 (Dcp2) N-His6-TEV (Dcp1), 
none (Dcp2) 
5B, 5C 50 
Dcp2 C292 96-291 (cysteine at C-terminus) N-His6-TEV S1E 767 
Pdc1 1-25 (HLM-N1) N-His6-MBP-TEV 4B, 4D 884 
Pdc1 49-73 (HLM-N2) N-His6-MBP-TEV 4B, 4C, 4D 885 
Pdc1 80-104 (HLM-N3) N-His6-MBP-TEV 4B, 4D 886 
 
Table S1A: List of proteins used in this study, including construct boundaries and affinity/ solubility tags. 
 
  
Figure 3A   
  RS001 h+ leu1 ade6-M216 dcp2+-GFP<<kanR edc3+-mCherry<<natR 
  RS035 h+ leu1 ade6-M216 dcp2+-GFP<<kanR edc3+-mCherry<<natR  
leu1+<<Padh1-dcp2-242-292-13myc 
   
Figure 3B   
  RS037 h+ leu1 ade6-M210 lsm7+-GFP<<kanR edc3+-mCherry<<natR 
  RS039 h+ leu1 ade6-M210 lsm7+-GFP<<kanR edc3+-mCherry<<natR  
leu1+<<Padh1-dcp2-242-292-13myc 
 
Table S1B: List of S. pombe strains used in this study. 
  
 Pdc1 Ge-1C domain 
Data collection  
Space group P 21 21 2 
Cell dimensions    
    a, b, c (Å) 47.33  77.84  36.51 
    a, b, g  (°)  90  90  90 
Resolution (Å) 40-1.35 
Rmeas  
Rmerge 
5.9(102.5) 
5.4(94.2) 
I / sI 17.19(2.03) 
Completeness (%) 99.7(100.0) 
Redundancy 6.3(6.4) 
  
Refinement  
Resolution (Å) 1.35 
No. reflections 30287 
Rwork / Rfree 18.5/21.2 
No. atoms  
    Protein 1092 
    Water 70 
B-factors  
    Protein 20.1 
    Water 29.9 
R.m.s. deviations  
    Bond lengths (Å) 0.01 
    Bond angles (°) 1.43 
Values in parentheses are for highest-resolution shell. 
 
Table S2:  X-ray data collection and refinement statistics. 
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Enzyme catalysis involves a finely tuned balance between pro-tein structure and dynamics1–3. Over the past several decades our knowledge regarding protein structure has grown signifi-
cantly4. At the same time, our understanding of how fluctuations 
in protein structure modulate function has lagged far behind5–8. 
Although indirect information about structural changes during 
catalysis can be gained from crystal structures of enzymes at differ-
ent states along the reaction pathway, these static structures do not 
provide information about the rates with which an enzyme samples 
these different states. These rates have important implications for 
catalytic activity; however, only in very few cases has it been pos-
sible to directly link protein dynamics with function9–14. Addressing 
this relationship experimentally is pivotal to advancing our under-
standing of enzyme function. Notably, conformational fluctuations 
also have implications for enzyme design15 and for the development 
of pharmaceutical compounds that modulate catalytic activity.
In eukaryotes, mRNA is protected against degradation by the 
presence of a 3′ poly(A) tail and a 5′ cap structure (Supplementary 
Results, Supplementary Fig. 1a). The scavenger decapping enzyme 
(DcpS in humans; Dcs1p in yeast) catalyzes cap hydrolysis of short 
(<10 nucleotides) mRNA fragments that are produced by 3′-to-5′ 
exosome-mediated mRNA degradation16,17. The products of the 
reaction are m7G monophosphate (m7GMP) and an RNA body that 
carries a 5′ diphosphate (Supplementary Fig. 1a). The activity of 
the DcpS enzyme must be regulated to prevent premature decap-
ping and unintentional degradation of an mRNA transcript. In yeast 
the Dcs2p protein can directly interact with and modulate the cata-
lytic activity of the Dcs1p enzyme18. Recently there has been grow-
ing interest in the scavenger decapping enzyme as a target for the 
treatment of spinal muscular atrophy (SMA)19,20.
DcpS is an 80-kDa homodimeric enzyme for which the human 
complex has been crystallized in its ligand-free form, in the presence of 
minimal cap substrates (such as m7GpppG) (Supplementary Fig. 1) 
and in complex with pharmaceutically relevant inhibitors19,21–23. 
DcpS is composed of a large 50-kDa dimeric C-terminal domain that 
is flexibly connected by a hinge region to a smaller domain-swapped 
30-kDa dimeric N-terminal lid-like domain (Supplementary 
Fig. 1b). In the substrate-free form, the enzyme has a symmetric con-
formation with few contacts between the two domains21. Upon inter-
action with substrate, however, the complex adopts an asymmetric 
conformation in which one substrate molecule is sandwiched 
between the N- and C-terminal domains on one side of the dimer 
(referred to as the closed site)21,22. In this binding site, the catalytic 
triad is assembled to promote hydrolysis of the substrate17,24. The 
other side of the dimeric enzyme adopts an open and catalytically 
incompetent conformation (referred to as the open site) that can 
interact with a second substrate molecule.
These static structures21,22 together with results from biochemical 
experiments25 and molecular dynamics simulations26 have led to the 
view that DcpS undergoes large domain rearrangements during the 
catalytic cycle to both interact with substrate and release products. 
Presumably the N-terminal lid domain flips over during catalysis, 
which then results in an opening of the closed site and a simulta-
neous closing of the open site22. This mechanism suggests that the 
dimeric nature of the enzyme and its domain motions enhance cata-
lytic efficiency because a substrate molecule can be positioned in 
the open binding site as catalysis is taking place at the closed bind-
ing site. However, several lines of evidence are in conflict with this 
model. First, single point mutations that enhance DcpS activity have 
been identified, showing that the wild-type enzyme does not func-
tion at the maximally possible catalytic rate21,22. Second, the DcpS 
enzyme is substrate inhibited, as it is more active under low sub-
strate concentrations than under high substrate concentrations25. 
This phenomenon is suggested to be due to a change in the rate-
limiting step of the reaction from substrate binding (under single-
turnover conditions) to a conformational change in the enzyme 
(under multiple-turnover conditions)25. Quantitative data to test 
these hypotheses are not available, and a more elaborate model that 
accurately explains the behavior of the enzyme is required.
To gain insights into the catalytic cycle of the scavenger decap-
ping enzyme and its regulation, we combined methyl-group NMR 
spectroscopy, X-ray crystallography and isothermal titration calo-
rimetry (ITC) studies. This enabled us to obtain an unexpected view 
of how interdomain motions directly regulate catalytic turnover and 
to provide a unique example for the fact that regulatory mechanisms 
can be hidden in static structures. We show that the domain-flipping 
motions in the scavenger decapping enzyme are important for sub-
strate binding and product release. We also show that these motions 
increase with increasing substrate concentration and can reach 
frequencies that are two orders of magnitude faster than those of 
1Max Planck Institute for Developmental Biology, Tübingen, Germany. 2Interfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany. 
3Present addresses: Max Planck Institute for Colloids and Interfaces, Potsdam, Germany (U.N.); FluidSolids AG, Zürich, Switzerland (B.S.).  
*e-mail: remco.sprangers@tuebingen.mpg.de
an excess of catalytically required motions 
inhibits the scavenger decapping enzyme
ancilla neu1, ursula neu2,3, anna-Lisa Fuchs1, Benjamin schlager1,3 & remco sprangers1*
The scavenger decapping enzyme hydrolyzes the protective 5′ cap structure on short mRNA fragments that are generated from 
the exosomal degradation of mRNAs. From static crystal structures and NMR data, it is apparent that the dimeric enzyme has 
to undergo large structural changes to bind its substrate in a catalytically competent conformation. Here we studied the yeast 
enzyme and showed that the associated opening and closing motions can be orders of magnitude faster than the catalytic 
turnover rate. This excess of motion is induced by the binding of a second ligand to the enzyme, which occurs at high substrate 
concentrations. We designed a mutant that disrupted the allosteric pathway that links the second binding event to the dynam-
ics and showed that this mutant enzyme is hyperactive. Our data reveal a unique mechanism of substrate inhibition in which 
motions that are required for catalytic activity also inhibit efficient turnover when they are present in excess. 
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substrate turnover. Unexpectedly, these excessive flipping motions 
ultimately inhibited substrate hydrolysis. In agreement with that, 
we showed that the hyperactivity of the K126A mutant enzyme 
is because of the reduced motions of the lid domain. In addition, 
our data establish a unique mode of substrate inhibition for DcpS 
in which high substrate concentrations induce excessive conforma-
tional changes in the enzyme that are too fast to permit catalysis.
ReSulTS
The ligand-free scavenger decapping enzyme is symmetric
To gain detailed information on the structure and dynamics of 
the scavenger decapping enzyme along the catalytic pathway, we 
first studied the ligand-free complex in solution by NMR spec-
troscopy. Methyl-TROSY NMR techniques27 are ideally suited to 
probe motions in protein complexes and are applicable to large and 
complex systems28–31. In this study, we used the scavenger decap-
ping enzyme Dcs1p from Saccharomyces cerevisiae, as the human 
enzyme for which X-ray structures are available did not provide the 
long-term stability required for detailed NMR studies. In our NMR 
experiments, we observed that the ligand-free form of the yeast DcpS 
enzyme displayed only a single set of resonances (Supplementary 
Fig. 1d). This was consistent with both protein chains of the dimer 
being in an identical chemical environment, which occurs only in 
the case of a symmetric homodimeric complex. Furthermore, we 
observed that the methyl-TROSY spectra of the isolated dimeric 
N- and C-terminal domains superimposed very well with the full-
length protein (Supplementary Fig. 1d). This showed that there 
are no close contacts between the dimeric N-terminal domain and 
the dimeric C-terminal domain. In summary, we established that 
the substrate-free enzyme from yeast is symmetric in solution and 
that the N- and C-terminal domains behave as independent units. 
These results are in full agreement with X-ray21 and computational 
studies26 of the ligand-free human enzyme that show that although 
the angle between the N- and C-terminal domains can change, the 
domains themselves move as rigid bodies.
Dcs1p interacts with substrates in a sequential manner
High-resolution structures are a prerequisite for the analysis of 
NMR studies that probe dynamics and interactions. The partially 
low sequence identity between the yeast and human DcpS enzymes 
precluded the generation of a reliable homology model for the yeast 
protein. We therefore used X-ray crystallography to determine the 
structure of the yeast Dcs1p enzyme in complex with m7GDP. To 
prevent hydrolysis of the substrate during measurements, we used a 
catalytically inactive variant of the enzyme (Dcs1pH268N)22. We chose 
m7GDP as a ligand because it mimics the substrate and is not hydro-
lyzed efficiently32. We solved the structure of the yeast enzyme at 
a resolution of 2.3 Å (Supplementary Table 1) and found that it 
featured the same architecture as the structure of the human DcpS 
enzyme bound to an m7GpppG substrate (1.8 Å r.m.s. deviation over 
all Cα atoms in common secondary structure elements) (Fig. 1a and 
Supplementary Fig. 1c). As in the human protein, Dcs1p adopted 
an asymmetric conformation such that the ligand was placed 
between the N- and C-terminal domains in the closed binding site, 
whereas the other side of the dimer adopted an open conformation 
(Fig. 1a,b). It is worth noting that the second site is occupied with 
substrate in the structure of the human enzyme22 but was empty in 
our yeast enzyme structure (our enzyme was crystallized at a lower 
substrate concentration). This finding indicates that both binding 
sites in the asymmetric form of the enzyme differ substantially in 
substrate affinity.
To probe the binding mechanism between Dcs1pH268N and its sub-
strate m7GpppG in solution, we used methyl-TROSY NMR spectros-
copy to directly follow structural changes in the enzyme upon stepwise 
addition of the substrate (Fig. 2). To map the residues involved in this 
interaction, we assigned numerous isoleucine and methionine methyl 
resonances that were close to the active site or that could potentially 
probe conformational changes during the catalytic cycle33,34 (see 
Supplementary Fig. 2). Notably, our NMR titration experiments dis-
played a two-step mechanism for substrate binding to Dcs1p. First, 
we observed that a large number of methyl resonances split into two 
signals upon addition of an equimolar amount of m7GpppG (such as 
those for I12, I36, I150, M153 and I219). This demonstrated that the 
initially symmetric ligand-free enzyme was converted into an asym-
metric dimer upon complex formation with the substrate (Figs. 1 
and 2b). It is worth noting that the change in chemical environment 
between the symmetric and asymmetric conformation is much larger 
for the closed side than for the open side. We therefore attributed 
methyl resonances that displayed large chemical shift perturbations 
(CSPs) upon substrate addition to residues in the closed binding site, 
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Figure 1 | Structure of the yeast DcpS–substrate complex. (a) 2.3 Å resolution crystal structure of the Dcs1p enzyme from S. cerevisiae in complex with 
m7GDP. The dimeric enzyme adopts an asymmetric conformation with one closed and one open binding site. The protein chains are colored blue with 
magenta side chains and green with yellow side chains, respectively, and the substrate is colored red. The boxed region is shown in panel b in a similar 
orientation. A cartoon representing the conformation of the enzyme is indicated, and the red dot refers to the substrate. (b) The substrate is tightly bound in 
the closed binding site. Residues Y94 and W161 highlight the high asymmetry of the enzyme in the ligand-bound form; these aromatic rings come within  
5 Å of each other in the closed binding site but are more than 22 Å apart in the open binding site. Without conformational changes, the substrate or product 
is not able to dissociate from the enzyme.
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whereas residues in the open side remained, in many instances, unaf-
fected (Fig. 2b). The fact that the observed CSPs are in slow exchange 
on the NMR time scale strongly suggested that this first binding 
event occurs with high affinity. Upon addition of hyperstoichiomet-
ric concentrations of m7GpppG, we observed additional CSPs for 
residues that were exclusively located in the open binding site of the 
asymmetric enzyme (Fig. 2c). Hence we can conclude that this sec-
ond binding event takes place in the open side of the asymmetric 
dimer. Taken together, our NMR data are consistent with a sequential 
binding mechanism in which the first substrate molecule that binds 
to the enzyme induces an asymmetric conformation of the enzyme 
and forms a closed binding site. At higher substrate concentrations, 
the second binding site on the open side of the asymmetric dimer can 
then be occupied, albeit with a lower affinity.
Dcs1p contains a high- and a low-affinity binding site
To quantify the affinities associated with these two binding events, 
we performed accurate NMR titration experiments (Fig. 2d and 
Supplementary Fig. 3a). We then used the intensities of the reso-
nances that reported on the first binding event (those of I12 and I36; 
Fig. 2b) and the positions of the resonances that reported on the 
occupancy of the second binding site (those of I42 and M153; Fig. 2c) 
to extract dissociation constants for both binding events. To that 
end we fitted the spectral properties of these four methyl groups 
using a sequential binding model (Supplementary Fig. 3a). From 
this analysis we extracted a high-nanomolar-affinity value for the 
first binding event (68 ± 255 nM) and a three-orders-of-magnitude 
weaker (micromolar) value for the second binding event 
(105 ± 20 μM) (Table 1). A high-affinity binding event was previ-
ously reported for the human enzyme25,35, whereas the low-affinity 
binding event has not been observed before. To independently vali-
date the sequential binding of substrate molecules to the enzyme and 
the large difference in binding affinities for the two binding events, 
we turned to ITC measurements (Supplementary Fig. 3a). In the 
ITC thermograph, a first binding event was observed in the nano-
molar range, whereas the affinity for the second binding site was 
determined reliably to be 324 ± 67 μM, in agreement with our 
NMR data. Taken together, our NMR and ITC data demon-
strate that the scavenger decapping enzyme interacts with two 
substrates in a sequential manner, in which the second binding 
site emerges only after interaction of the enzyme with the first 
substrate molecule.
The c-terminal domain binds the second substrate molecule
To characterize the second binding site in more detail, we per-
formed ITC and NMR experiments with the isolated C-terminal 
domain of the yeast Dcs1p enzyme and m7GpppG. Using ITC we 
showed that the isolated C-terminal domain of the enzyme interacts 
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Figure 2 | The scavenger decapping enzyme binds to two substrate molecules in a sequential manner. (a–c) Methyl-TRoSY NMR spectra of the yeast 
enzyme (0.25 mM dimer concentration) without (a) or with (b,c) substrate. Cartoons indicate the states of the complexes. (a) ligand-free, symmetric Dcs1p. 
Assignments for a number of isoleucine and methionine residues that are close to the active site are indicated (see also Supplementary Fig. 2). (b) Dcs1p 
after addition of one molar equivalent of m7GpppG (0.25 mM) to the dimeric enzyme. A number of resonances that report on the symmetric to asymmetric 
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open binding site shift, indicating that a second substrate molecule interacts in the open binding site of the enzyme. The insets on the right are expansions of the 
boxed regions in c and show a detailed view of the sequential binding process. Sym refers to the symmetric ligand-free protein. (d) Plot of the changes in the peak 
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(see a–c and boxed regions in the spectra in b,c). The errors (s.d.) in the extracted binding constants were based on Monte Carlo simulations for a simultaneous 
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with m7GpppG with an affinity that is comparable to that of the 
second binding event in the full-length complex (Supplementary 
Fig. 3c). Together with the structure of the human DcpS enzyme22 
(Supplementary Figs. 1b and 3c), this shows that the second ligand 
interacts predominantly with the C-terminal domain in the open 
binding pocket. To structurally characterize substrate binding to the 
open site of the yeast enzyme, we performed NMR titration experi-
ments using the isolated dimeric C-terminal domain and compared 
these results to those from the titration experiment performed with 
the full-length enzyme. For the isolated C-terminal domain, we 
observed that the same residues experienced CSPs upon addition 
of substrate as those in the full-length protein that was incubated 
with hyperstoichiometric amounts of substrate (Supplementary 
Fig. 3c). Notably, despite the fact that the second ligand mainly con-
tacts the C-terminal domain, we observed that occupation of the 
second binding site in the full-length protein resulted in CSPs in 
the N-terminal domain (such as those for I42; Fig. 2c). Based on 
the structure of the human protein in complex with m7GpppG sub-
strate, the distance between the second substrate and I42 in the yeast 
enzyme is expected to be over 12 Å. This long-range effect points 
toward an allosteric mechanism that can relay the substrate-binding 
event in the open binding pocket to the N-terminal lid domain and 
potentially further toward the closed binding pocket.
Activity requires the asymmetric form of the complex
Both X-ray (Fig. 1) and NMR (Fig. 2) data strongly suggested that 
the scavenger decapping enzyme needs to adopt an  asymmetric 
form to be catalytically competent. In yeast Dcs1p (Fig. 1), this 
closed conformation is mediated by a network of interactions that 
involves contacts between the 7-methyl group of the substrate 
and the aromatic ring of Tyr94. To assess the importance of these 
interactions for stable domain closure, we recorded methyl 
NMR spectra of the Dcs1pH268N Y94A enzyme in the presence of 
m7GpppG and spectra of the Dcs1pH268N enzyme in presence of the 
unmethylated ligand GpppG (Supplementary Fig. 4a). In both cases 
we observed no resonances that corresponded to the asymmetric 
conformation (Supplementary Fig. 4a) like the ones we observed 
for the Dcs1pH268N enzyme with m7GpppG (Fig. 2b). However, we 
did observe small CSPs in the same region where we had observed 
CSPs for substrate binding to Dcs1pH268N (Fig. 2 and Supplementary 
Fig. 4a). This showed that impairing the interaction between Dcs1p 
Y94 and the 7-methyl group results in a situation where the enzyme-
substrate complex is no longer able to form a stable asymmetric 
conformation.
To directly test the importance of the asymmetric conforma-
tion for catalytic activity, we monitored the hydrolysis of m7GpppG 
and GpppG by the WT yeast enzyme and the Y94A mutant, respec-
tively, using a time series of one-dimensional 31P NMR spectra. 
The WT enzyme hydrolyzed m7GpppG into m7GMP and GDP 
(Supplementary Figs. 1a and 4b); however, we did not detect 
enzymatic turnover for the Y94A enzyme with m7GpppG or for the 
WT enzyme with GpppG (Supplementary Fig. 4b). In summary, 
we show that the formation of a sufficiently long-lived closed 
active site is crucial for catalytic activity, which underscores the 
importance of conformational changes in the catalytic cycle of the 
scavenger decapping enzyme.
Figure 3 | Quantification of domain-flipping motions in the scavenger decapping enzyme. (a) longitudinal exchange experiment that directly reports on 
motions (the open binding site closes and the closed binding site opens) in the enzyme. The cyan- and pink-colored resonances result from the closed and 
open sites, respectively. The arrows point to the resonances that appear as a result of the domain-flipping motions. The spectrum shown here is recorded 
with a mixing time of 75 ms in the presence of a 20-fold excess of substrate over the dimeric enzyme. The cartoons represent the flipping motion detected 
in the NMR spectra. (b) Quantification of the exchange process in the presence of a 20-fold excess of ligand. The circles indicate resonance intensities 
of the cross and auto peaks. The error bars (which are within the circles) represent uncertainties in the resonance intensities. The drawn lines are a best 
global fit to the data and yield an exchange rate of 35.4 (± 4.8) s−1. The error (s.d.) in the extracted parameters is based on 100 Monte Carlo simulations. 
I and I0 refer to the signal intensities of the exchange and reference experiment, respectively. Tmix indicates the length of the exchange delay in the NMR 
experiment. (c) The flipping motions (a,b) depend on the m7GpppG ligand excess. Higher excess of ligand results in higher occupation of the open, second 
binding site and in faster exchange rates. This correlation between exchange rates and binding site occupancy shows that the flipping motions are directly 
induced by the presence of the second ligand in the open binding site.
Table 1 | Summary of the measured affinities, domain-flipping rates and turnover rates
Wt dcs1pK126a
Kd substrate (m7GpppG)d Closed site (Dcs1pH268N): 68 ± 255 nMa,b Closed site (Dcs1pH268N K126A): 112 ± 390 nMa,b; 240 ± 90 nMc
open site (Dcs1pH268N): 105 ± 20 μMa; 324 ± 67 μMc open site (Dcs1pH268N K126A): 196 ± 31 μMa; 280 ± 30 μMc
Flipping rated Dcs1pH268N: from 8 Hz (low substrate excess) to 34 Hz 
(high substrate excess)
Dcs1pH268N K126A: <1 Hz under high and low substrate excess
Turnover rate WT: 0.27 s−1 under high substrate excess Dcs1pK126A: 0.48 s−1 under high substrate excess
aDetermined using NMR. bThe high uncertainty in the determined Kd of the closed binding site results from the limited number of data points that define the transition. cDetermined using ITC. dInactive 
mutant (H268N) background.
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A conformational change results in product release
The reaction products, m7GMP and GDP, are formed in the closed 
pocket of the scavenger decapping enzyme after hydrolysis of the 
m7GpppG substrate. Using methyl NMR spectroscopy, we observed 
that binding of the m7GMP product to the enzyme preserves the 
asymmetric form of the complex (Supplementary Fig. 5a). During 
the next step in the catalytic cycle, the enzyme complex needs to 
open to release the product. To determine the affinity of the product 
for the closed binding site, we performed ITC measurements and 
found that the m7GMP product binds to yeast Dcs1p in a single-step 
process (Kd = 1.1 ± 0.6 μM) (Supplementary Fig. 5b). The product 
thus interacts with the closed binding site four times more weakly 
than the substrate does. Notably, using ITC and NMR we were not 
able to detect an interaction between the m7GMP product and the 
second, open binding site. This suggests a scenario in which hydro-
lysis of the substrate in the closed binding site and a flipping motion 
of the enzyme result in a situation where the product occupies the 
open binding site. In that case, m7GMP would be efficiently released 
from the enzyme. To test this hypothesis we used methyl-TROSY 
NMR spectroscopy, in which we added an m7GpppG substrate to 
the m7GMP–Dcs1p complex. This resulted in the efficient release 
of product and the formation of an m7GpppG–Dcs1p complex and 
shows that the enzyme can indeed spontaneously change from a 
product-bound state into a substrate-bound state upon addition of 
substrate (Supplementary Fig. 5c). In summary, our results indi-
cate that the first and second binding sites can concomitantly open 
and close during the catalytic cycle.
Dcs1p undergoes spontaneous domain-flipping motions
To observe whether the scavenger decapping enzyme undergoes 
domain-flipping motions in conditions of excess m7GpppG sub-
strate, we performed longitudinal exchange experiments29,33,36 on 
highly deuterated methyl-labeled samples. In these experiments the 
conversion of an open binding site into a closed one and vice versa 
can be observed directly because the exchange process results in 
cross peaks at resonance frequencies where one dimension corre-
sponds to the open (or closed) state and the other dimension corre-
sponds to the closed (or open) state. These experiments are possible 
because NMR is unique in the fact that it can distinguish between 
the open and closed states within one enzyme complex (Fig. 2b,c). 
Here we observed exchange peaks for all of the residues that dis-
play a different chemical shift in the open as compared to the closed 
state, indicating that the enzyme undergoes continuous domain-
flipping motions (Fig. 3a). Measurements using a number of differ-
ent exchange delays in these experiments allowed for the extraction 
of the exchange rates and the associated populations. For all of the 
residues that displayed well-resolved resonances for the auto and 
cross peaks, we determined very similar exchange parameters, 
indicating that the process we detect results from a global 
conformational change of the type associated with the N-terminal 
domain flipping on the C-terminal domain. In addition, the extracted 
populations of the open and closed states were, as expected, equal, as 
the number of open and closed sites in the enzyme is by definition 
1:1. To further analyze the data, we thus used a global fit, in which 
all residues were fitted to one exchange process and in which the 
open- and closed-state populations (pclosed and popen) were fixed to 
0.5. In the presence of a 20-fold excess of substrate over enzyme, we 
extracted a domain-flipping rate of 35.4 ± 4.8 s−1 (Fig. 3b). Notably, 
the flipping motions that we detected are not a result of enzymatic 
turnover and subsequent product release because we used an inac-
tive (H268N) mutant. Rather, the motions report on a situation in 
which an occupied closed binding site turns into an occupied open 
binding site and vice versa.
The second substrate induces domain-flipping motions
The second (open) binding site in Dcs1p is saturated with substrate 
(Fig. 2d) under the conditions in which we observed N-terminal 
domain–flipping motions. To probe whether the substrate in 
the open binding site induced these motions, we measured the 
domain-flipping rates at decreasing substrate concentrations. 
Notably, the domain-flipping rates decreased with reduced occu-
pation of the second binding site (Fig. 3c). These results display 
the presence of an allosteric pathway that links both binding sites 
in the enzyme. Such an allosteric pathway has previously been 
suggested on the basis of biochemical experiments25, but the 
molecular basis underlying the cross-talk between the active sites 
was not known. Here we demonstrate that substrate binding in 
the open binding site of the enzyme directly induces domain rear-
rangements and causes the closed binding site to open and the 
open binding site to close.
The catalytic rates are slower than the flipping rates
To assess whether the substrate-induced flipping motions in 
the enzyme correlated with catalytic turnover, we determined the 
activity of Dcs1p in conditions of excess substrate. To that end, 
we continuously recorded phosphorus NMR spectra during enzy-
matic turnover. The initial spectra (t = 0) displayed the phosphorus 
resonances of m7GpppG and the final spectra displayed resonances 
of the products, m7GMP and GDP (Fig. 4a). From these data we 
extracted a turnover rate (kcat) of 0.27 s−1 (Fig. 4b), which agreed 
with the turnover rate (under high substrate concentrations) that 
was previously determined for the human enzyme complex25. 
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Figure 4 | Turnover rates of the enzyme are much slower than the flipping rates. (a) 31P NMR spectra that report on the Dcs1p-mediated degradation  
(50 nM enzyme) of the (0.5 mM) m7GpppG substrate (top, red) into m7GMP and GDP products (bottom, yellow). NMR spectra (18 min each) were 
recorded successively until completion of the reaction. (b) Progression curves of the reaction. Crosses correspond to the mean concentrations of  
the substrate and product signals and are derived from the peak intensities of all 31P signals. The drawn line corresponds to the best fit of the data.  
The extracted turnover rates are indicated. (c) longitudinal exchange experiment of Dcs1pH268N K126A in the presence of a 20-fold excess of substrate  
and using a mixing time of 75 ms (at which the exchange peaks have maximum intensity for the Dcs1pH268N protein). left, exchange peaks were not 
observed (arrows in the traces), demonstrating that the K126A enzyme does not undergo unproductive flipping motions. Right, signal intensities of  
the resonances at different exchange delays (see also Fig. 3b).
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However, it is important to note that the turnover rates at high sub-
strate excess are two orders of magnitude slower than those of the 
domain-flipping motions (35.4 s−1) that we have measured (Fig. 3).
A point mutation interferes with fast flipping motions
As detailed above, we have determined that the N-terminal domain 
senses the presence of substrate in the open binding pocket 
(Fig. 2c). The structure of the enzyme (Fig. 1) features positively 
charged amino acids (such as K126) in the hinge region. We 
reasoned that these residues could be part of the allosteric pathway 
that links the occupation of the open binding site to a conforma-
tional change. To assess this hypothesis, we mutated K126 to an 
alanine and used longitudinal exchange experiments to probe 
whether the domain-flipping motions in this mutant enzyme were 
altered. Indeed, under conditions of substrate excess, the domain 
motions that we detected in the Dcs1pH268N enzyme were no longer 
detectable in the Dcs1pH268N K126A mutant enzyme (Fig. 4c). Taking 
into account the detection limits of the longitudinal exchange exper-
iment, the domain-flipping motions were reduced from 35.4 s−1  
in the Dcs1pH268N protein to <1 s−1 in the Dcs1pH268N K126A mutant. It 
is important to note that Dcs1pH268N K126A behaved like Dcs1pH268N 
with respect to the formation of an asymmetric conformation and 
interaction with substrate (Supplementary Fig. 3c). Indeed, the 
affinity for the substrate did not change substantially when the 
K126A mutation was introduced into the enzyme (Table 1). We 
thus found that a single point mutation in Dcs1p is able to uncou-
ple the binding of substrate in the second (open) binding pocket 
from fast domain rearrangements.
Reduced domain-flipping motions lead to hyperactivity
To probe whether reduced conformational exchange influences 
enzymatic activity, we measured the activity of the K126A enzyme and 
found that it displayed two-fold higher activity (Fig. 4b) compared 
to the WT enzyme. It is important to note that the increased catalytic 
efficiency is not due to changes in substrate binding (Supplementary 
Fig. 3a,b and Table 1). In addition, potential changes in product 
release are likely not the cause of the observed hyperactivity because 
for the human enzyme it has been established that product release is 
not the rate-limiting step in the catalytic cycle25.
Hyperactive mutants of DcpS have been described for the human 
enzyme22; however, the molecular basis for this hyperactivity has 
remained elusive. Here we show that unproductive domain-flipping 
motions decrease the catalytic efficiency of the enzyme. Interference 
with the underlying allosteric pathway through mutations reduces 
the unproductive motions and results in hyperactivity. Hence, 
domain-flipping motions in the enzyme that are important for the 
catalytic cycle (Supplementary Figs. 4 and 5) can reduce activity 
when they are too fast (Figs. 3 and 4).
DiScuSSiON
The correlation between enzyme motions and catalytic activity 
remains poorly understood despite the fact that this relationship 
was proposed decades ago37.
Here we studied the dynamic changes that occur during the 
catalytic cycle of the yeast scavenger decapping enzyme. Static 
structures of the enzyme21,22 (Fig. 1 and Supplementary Fig. 1) 
suggest that domain rearrangements are important for substrate 
binding and product release. We showed that the formation of a 
stable asymmetric conformation is indispensable for activity (Fig. 2 
and Supplementary Figs. 4 and 5). In addition, we established that 
the interaction of substrate with the second (open) binding pocket 
of the dimeric enzyme induces unproductive motions that impair 
catalytic efficiency (Figs. 3 and 4).
At high substrate concentrations the hinge motions interfered 
with efficient catalysis (Fig. 5a) because the time the substrate 
spends in the closed active site (life time) is on average too short 
to allow for efficient hydrolysis: before catalysis can take place, the 
enzyme rearranges into its mirror form (Fig. 5). This implies that 
the rate-limiting step in the catalytic cycle is after the formation of 
the closed binding site (such as structural rearrangements in the 
substrate). Previous studies indicate that, for the human enzyme, 
such a conformational change is relevant for the activation of cap 
hydrolysis22.
Using a designed mutant enzyme (K126A), we uncoupled 
the second substrate-binding event from the induction of unpro-
ductive motions, which resulted in hyperactivity (Fig. 4 and 
Supplementary Fig. 6). Mechanistically, we propose that electro-
static interactions between the positively charged residues in the 
hinge region (K126 and K125) and the negatively charged phosphate 
groups of the substrate in the open binding site induce motions of 
the N-terminal domain. The conservation of positively charged 
residues in the hinge region points toward a preserved electrostatic 
mechanism that regulates the activity of the scavenger decapping 
enzyme family. In agreement with that, mutations of positively 
charged hinge residues in the human enzyme (such as K138) also 
lead to hyperactivity22.
It has previously been shown that the human DcpS enzyme 
is more active at low substrate concentrations than it is at high 
Figure 5 | cartoon representation of the substrate inhibition mechanism of the scavenger decapping enzyme. (a) Under conditions of substrate excess, 
both binding sites in the enzyme are occupied. These result in fast, nonproductive flipping motions (horizontal dashed arrow) and low turnover rates 
(curved dashed arrows). Substrate and product are indicated by red and yellow circles, respectively. Determined flipping and turnover rates are indicated. 
(b) Under single-turnover conditions, only one of the two binding sites in the enzyme is occupied. The unproductive motions (crossed out horizontal line) no 
longer take place and the catalytic turnover is increased (curved dashed arrow). The indicated turnover rate corresponds to that of the human enzyme25 and 
may differ for the yeast complex. Note that under these conditions part of the catalytic cycle is not sampled (indicated in a light color for reference only).
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substrate concentrations25. The physiological relevance of sub-
strate inhibition has been demonstrated for a variety of enzymes, 
including phosphofructokinase, tyrosine hydroxylase and 
acetylcholinesterase38. DcpS is part of a complex enzymatic network 
that eliminates mRNA cap structures39, and substrate inhibition 
could play a role in a regulatory feedback loop. In addition, sub-
strate inhibition of DcpS might be required to limit cellular levels 
of the product m7GMP, which can be misincorporated into RNA18. 
The model of the catalytic cycle of DcpS that we introduced here 
(Fig. 5) provides the molecular explanation for the observed 
substrate-mediated inhibition of DcpS activity (Fig. 5b). At low 
substrate concentrations, the second DcpS binding site is not 
occupied (Fig. 2) and the domain-flipping motions are sig-
nificantly reduced or absent (Figs. 3 and 5b). This results in an 
increase in the catalytic turnover rate that can reach 1.2 s−1 in the 
human enzyme25. To our knowledge, this is the first time that a 
mechanism for substrate inhibition through an excess of protein 
motions has been described.
The substrate-induced molecular motions provide an additional 
layer of regulation for the activity of the scavenger decapping 
enzyme. In that regard it is worth mentioning that the enzyme has 
been reported to interact with a number of partners, including the 
exosome complex in humans16 and Xrn1 (ref. 40) and Dcs2p (ref. 18) 
in S. cerevisiae. Dcs2p has been reported to inhibit Dcs1p activity 
by heterodimerization, which potentially influences the dynamics 
in the complex. Currently, efforts to pharmaceutically inhibit DcpS 
are under way19,20. We demonstrate here that DcpS operates in 
a narrow range of dynamics. Thus both small compounds that 
block interdomain motions and those that accelerate them can 
impair activity. Finally, DcpS displays different activities toward 
substrates of various RNA lengths. The mechanism by which the 
enzyme discriminates short substrates from longer ones35 may 
be through the modulation of domain motions by the RNA body. 
Our results provide the conceptual framework to address these 
questions in detail.
In summary, we present here an example of an enzyme in 
which conformational changes that are required for activity can be 
detrimental for catalysis in the event they are too fast. This insight 
could not have been obtained from knowledge of static structures 
alone and underscores the need for studies that localize and quantify 
motions in large biomolecular assemblies. We expect these studies 
to elucidate more instances of complex inter-relationships between 
dynamics and activity and thus greatly advance our understanding 
of biomolecular function. 
received 19 December 2014; accepted 1 June 2015; 
published online 10 august 2015
MeTHODS
Methods and any associated references are available in the online 
version of the paper.
Accession codes. PDB: the coordinates for Dcs1p in complex with 
m7GDP are deposited under accession code 5BV3.
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ONliNe MeTHODS
Protein preparation. The DCS1 gene from S. cerevisiae was amplified from 
genomic DNA and cloned into a modified pET vector that contained an 
N-terminal His6-NusA-His6 tag that could be removed using TEV protease. 
Mutations were introduced using standard quick-change methods. BL21 
(DE3) codon plus cells (Stratagene) were transformed with the respective 
plasmid and grown in rich or minimal medium in the presence of kanamycin 
and chloramphenicol. Minimal medium was made using 100% D2O and con-
tained [2H12C]glucose as a carbon source. Isoleucine and methionine labeling 
was achieved by addition of 50 mg/liter α-ketobutyric acid and 250 mg/liter 
of [methyl-13CH3]methionine, respectively, 1 h before induction with 1.0 mM 
IPTG at a cell density (OD600) of 0.8 and a temperature of 25 °C. 12 h after 
induction the cells were lysed in buffer A (50 mM NaPO4 pH 8.0, 150 mM 
NaCl and 5 mM imidazole) supplemented with 0.1% Triton, 1 mM EDTA and 
100 μg/ml lysozyme. Subsequently the cell lysate was centrifuged at 50,000g 
for 20 min to remove insoluble debris. The supernatant, supplemented with 
2 mM MgCl2, was applied to Ni-NTA resin and the column was washed using 
10 column volumes of buffer A. The protein was eluted from the resin using 
buffer A supplemented with 200 mM imidazole. The affinity and solubility tag 
was removed from the protein by TEV cleavage during dialysis into 25 mM Tris 
pH 8.0, 75 mM NaCl, 1 mM DTT. The cleaved tag was removed from the target 
protein using a second Ni-NTA step in dialysis buffer. Finally a size exclusion 
chromatography purification step in buffer B (25 mM HEPES pH 8.0, 25 mM 
NaCl) using a Superdex 200 column yielded pure protein. For NMR, the final 
protein samples were exchanged by successive concentration and dilution steps 
into buffer B that was made using 100% D2O (NMR buffer).
Crystallography. Dcs1p in complex with m7GDP crystallized at a concentra-
tion of 10 mg/ml in 100 mM HEPES pH 7.5, 100 mM NaCl, 1.6 M (NH4)2SO4 
after several weeks. Diffraction data were collected at 100 K using a wavelength 
of 1 Å and a PILATUS 6 M detector at beamline PXII of the Swiss Light Source 
(PSI, Villigen, Switzerland). Data were processed using XDS41 and molecular 
replacement was performed using Phaser42 with the crystal structure of the 
human protein in complex with m7GDP (1XMM)21 as a search model. The 
structure was finalized by iterative manual modeling with Coot43 and refine-
ment with Phenix44 and Refmac45. The crystalized protein contained a cysteine 
bridge in a loop region of the N-terminal domain (Cys72-Cys78). This crys-
tallization artifact does not interfere with the data analysis, as the activity 
of the enzyme does not change between oxidizing and reducing conditions 
(Supplementary Fig. 7). All figures displaying protein structures were gener-
ated using PyMOL (http://www.pymol.org/).
NMR. NMR spectra were recorded at 27 °C on Bruker AVIII-600 and AVIII-
800 spectrometers with room temperature probe heads. All NMR samples 
contained buffer made in 100% D2O. For degradation experiments 0.5 mM 
m7GpppG substrate was mixed with 50 nM Dcs1p in NMR buffer and suc-
cessive phosphorus experiments were recorded over a time of several hours. 
Proton-carbon–based experiments exploited the methyl-TROSY principle 
and were recorded using a carbon chemical shift evolution of typically 40 ms. 
Longitudinal exchange experiments were recorded on samples containing 
0.25 mM Dcs1p (dimer concentration) in the presence of a 1:1, 1:2.5, 1:5 or 
1:20 molar ratio of m7GpppG using mixing times ranging from 3 to 1,000 ms, 
depending on the exchange rate. NMR data were processed using the NMRPipe-
NMRDraw software suite46 and figures displaying NMR spectra were produced 
using NMRView (onemoonscientific.com). NMR binding affinities were deter-
mined as described in the legend of Supplementary Figure 3a. All data points 
of the titration were simultaneously fitted to one sequential binding event. The 
extracted Kd values indicate that the first binding event takes place in the high-
nanomolar range and that the second binding event has a dissociation constant 
of 105 ± 20 μM. The error bars represent uncertainties in the peak intensity 
or peak position. The extracted Kd values represent mean values ± s.d. and are 
based on Monte Carlo simulations where the data points were randomly varied 
according to their errors. The large uncertainty in the Kd value for the first 
binding event results from the limited number of titration points that define 
the event.
Isothermal titration calorimetry (ITC). Binding constants were determined 
using a NanoITC instrument (TA Instruments) at 25 °C. m7GpppG or m7GMP 
were injected into a 0.5 mM Dcs1p (all variants carried the H268N mutation) 
solution (either full-length or C-terminal domain only). Data were processed 
using the in-house–written scripts (see legend to Supplementary Fig. 3a). 
Errors in the extracted Kd values were derived on the basis of Monte Carlo 
simulations in which the individual heat emissions were randomly varied 
depending on the noise level in the experiment.
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  Figure	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  of	  the	  human	  DcpS	  and	  spectra	  of	  the	  
isolated	  yeast	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  (a)	  Chemical	  structure	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  an	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  with	  a	  5’	  protecting	  cap.	  The	  nomenclature	  of	  the	   sugars,	   base	   and	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   backbone	   are	   indicated	   in	   red,	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   and	   green	  respectively.	   The	   methyl	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   in	   the	   cap	   structure	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   a	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  sphere.	  The	  scavenger	  decapping	  enzyme	  hydrolyses	  the	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  5’	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  at	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  the	  m7GpppG	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   in	   this	   study	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   the	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   (base	   1)	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   a	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   The	   products	   of	   the	   hydrolysis	   of	   m7GpppG	   (m7GMP	   and	   GDP)	   are	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(b)	  The	  human	  DcpS	  enzyme	  contains	  two	  protein	  chains	  that	  form	  a	  dimeric	  N-­‐terminal	  lid	  domain	  and	  a	  dimeric	  C-­‐terminal	  domain.	  The	  ligand	  free	  protein	  is	  symmetric	   (left)1.	   In	   the	   substrate	   bound	   protein	   the	   lid	   domain	   undergoes	   a	  large	  conformational	  change	  (right)2.	  In	  the	  structure	  of	  the	  human	  protein	  two	  substrates	  are	  bound	  to	  one	  dimeric	  enzyme	  (one	   in	   the	  open	  binding	  site	  and	  one	  in	  the	  closed	  binding	  site).	  (c)	  Superposition	  of	  the	  structures	  of	  the	  human	  (1ST0)2	  and	  yeast	  (this	  study)	  scavenger	  decapping	  enzymes	  in	  complex	  with	  ligand.	  For	  clarity	  the	  ligands	  are	  not	  displayed	  in	  the	  ribbon	  diagram.	  (d)	  Methyl	   TROSY	   spectra	   of	   the	   yeast	   full	   length	   enzyme	   (left	   panel)	   and	   the	  isolated	   N-­‐	   and	   C-­‐	   terminal	   domains	   (middle	   panels).	   A	   superposition	   of	   the	  spectra	  in	  the	  first	  three	  panels	  is	  shown	  on	  the	  right.	  The	  spectra	  of	  the	  isolated	  domains	  overlay	  very	  well	  with	  the	  spectrum	  of	  the	  full-­‐length	  protein	  indicating	  that	  the	  two	  domains	  behave	  as	  independent	  units	  in	  the	  full-­‐length	  protein.	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Supplementary	   Figure	   2	   |	   Assignment	   of	   methyl	   groups	   in	   the	   yeast	  
scavenger	  decapping	  enyme.	  (a)	  Example	  of	  the	  mutational	  approach	  for	  the	  methyl	  group	  assignments.	  Single	  Ile	  or	  Met	  residues	  were	  mutated	  into	  closely	  related	  amino	  acids.	  Spectra	  of	  the	  WT	  and	  mutant	  protein	  where	  then	  compared.	  An	  overlay	  of	  the	  spectra	  of	  the	  WT	   (black)	   and	   I311	   (red)	   Dcs1p	   allows	   for	   the	   assignment	   of	   I311	   in	   the	  symmetric	  (left)	  and	  asymmetric	  (right)	  conformation	  of	  the	  enzyme.	  (b)	  Structure	  of	  the	  yeast	  Dcs1p	  enzyme	  (see	  also	  Figure	  1),	  where	  all	  Isoleucine-­‐δ1	   and	  methionine	  methyl	   groups	   are	   shown	   as	   spheres.	   The	   assigned	  methyl	  groups	  are	  coloured	  orange.	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Supplementary	   Figure	   3a|	   Determination	   of	   the	   affinities	   of	   the	   first	   and	  
second	   binding	   event	   for	   the	   interaction	   between	  WT	   (H268N)	  DcpS	   and	  
m7GpppG	  substrate.	  	  Top:	   Selected	   regions	   of	   NMR	   spectra	   during	   the	   NMR	   titration	   (regions	   are	  indicated	  with	  a	  box	  in	  Figure	  2b	  and	  2c).	  The	  m7GpppG:DcpS	  (dimer)	  ratios	  are	  indicated	  in	  the	  spectra.	  The	  spectra	  on	  the	  left	  report	  on	  the	  fist	  binding	  event	  (that	   is	   in	   slow	  exchange	  on	   the	  NMR	  chemical	   shift	   timescale),	   the	   spectra	  on	  the	  right	  report	  on	   the	  second	  binding	  event	  (that	   is	   fast	  on	   the	  NMR	  chemical	  shift	  timescale).	  	  	  Middle:	  Identical	  to	  Figure	  2	  of	  the	  main	  paper,	  shown	  her	  for	  completeness.	  Plot	  of	  the	  changes	  in	  the	  peak	  intensities	  for	  residues	  I12	  and	  I36	  (open	  and	  closed	  resonances)	   and	   the	   changes	   in	   the	   peak	   position	   for	   residues	   M153	   (CSP	   in	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carbon)	  and	  I42	  (CSP	  in	  protons)	  for	  15	  titration	  points	  (see	  a-­‐c).	  All	  data	  points	  of	   the	  titration	  were	  simultaneously	   fitted	  to	  one	  sequential	  binding	  event	  (see	  below).	  The	  extracted	  kD	  values	  indicate	  that	  the	  first	  binding	  event	  takes	  place	  in	   the	   high	   nano-­‐molar	   range	   and	   that	   the	   second	   binding	   event	   has	   a	  dissociation	  constant	  of	  105	  (±20)	  μM.	  The	  large	  uncertainty	  in	  the	  kD	  value	  for	  the	   first	   binding	   event	   results	   from	   the	   limited	  number	  of	   titration	  points	   that	  define	  the	  event.	  For	  clarity	  the	  scale	  of	  the	  x-­‐axis	  is	  shown	  different	  below	  and	  above	  the	  1:1	  m7GpppG:DcpS	  ratio,	  as	  is	  indicated	  by	  the	  waveform.	  	  	  Bottom:	   The	   ITC	   thermograph	   of	   the	   interaction	   between	   the	   yeast	   scavenger	  decapping	  enzyme	  (H268N)	  and	  m7GpppG	  substrate	  displays	  three	  events.	  One	  of	  these	  events	  could	  be	  a	  result	  of	  protein	  aggregation	  in	  the	  ITC	  cell	  (indicated	  with	   a	   red	   circle);	   note	   that	   no	   protein	   aggregation	   or	   precipitation	   has	   been	  observed	   in	   any	   of	   our	   NMR	   experiments.	   The	   red	   line	   in	   the	   right	   panel	  corresponds	  to	  the	  best	  fit	  of	  the	  data	  using	  a	  model	  of	  sequential	  binding.	  This	  third	   event	   prevents	   the	   extraction	   of	   accurate	   binding	   values	   for	   the	   first	  binding	   event	   (indicated	  with	   a	   red	  dotted	  box	   around	   the	   indicated	   extracted	  values).	   The	   kD	   for	   the	   second	   binding	   event	   extracted	   using	   NMR	   is	   in	  agreement	   with	   the	   one	   extracted	   from	   the	   ITC	   experiment.	   Note	   that	   n=1	  corresponds	   to	   the	   stoichiometry	   of	   the	   first	   and	   of	   the	   second	   binding	   event,	  that	  both	  have	  an	  occupancy	  of	  1.	  	  	  In	  order	  to	  extract	  affinities	  from	  the	  ITC	  data,	  we	  performed	  baseline	  correction	  and	  peak	  integration	  using	  the	  NanoAnalyze	  program	  (TA	  instruments)	  and	  used	  in	  house	  written	  scripts	  to	  extract	  the	  associated	  binding	  affinities	  (the	  software	  provided	  by	  the	  manufactures	  did	  not	  include	  the	  sequential	  binding	  model).	  	  	  In	   the	   case	   of	   sequential	   binding,	   a	   mixture	   of	   free	   protein,	   protein	   with	   one	  ligand	  bound	  and	  protein	  with	  two	  ligands	  bound	  can	  be	  formed.	  The	  associated	  fractions	  (F0,	  F1	  or	  F2)	  are	  given	  by:	  	  	   𝐹! =    1𝑃                   𝐹! = 𝐾!!  [𝐿]𝑃                     𝐹! = 𝐾!!𝐾!!  [𝐿]!𝑃             	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  in	  which	  [L]	  is	  the	  free	  ligand	  concentration	  and	  	  	   𝑃 = 1+   𝐾!!   𝐿 +   𝐾!!𝐾!!  [𝐿]!	  	  where	  Ka1	   and	  Ka2	   refer	   to	   the	   binding	   constants	   associated	  with	   the	   first	   and	  second	  binding	  event,	  respectively,	  that	  are	  defined	  according	  to:	  	   𝐾!! = [𝑃𝐿]𝑃 [𝐿]                   𝐾!! =    [𝑃𝐿!]𝑃𝐿 [𝐿]	  	  [P]	   is	   the	   concentration	   of	   free	   protein,	   [PL]	   is	   the	   concentration	   of	   singly	  occupied	  protein	  and	  [PL2]	  is	  the	  concentration	  of	  double	  occupied	  protein.	  The	  concentration	  of	  free	  ligand	  [L]	  is	  determined	  numerically	  and	  iteratively	  based	  on	  the	  binding	  constants	  and	  total	  ligand	  concentration	  Lt	  at	  a	  given	  point	  during	  the	  titration,	  where	  	   𝐿! = 𝐿 +   𝑃! ∗ (𝐹! + 2𝐹!)	  	  and	  Pt	  is	  the	  total	  protein	  concentration.	  	  In	   an	   ITC	   experiment	   the	   heat	   content	   at	   a	   certain	   time	  during	   the	   titration	   is	  given	  by:	  	   𝑄 = 𝑃!  𝑉!    [𝐹!  ∆𝐻!   +   𝐹!   ∆𝐻! +   ∆𝐻! ]    	  	  where	  V0	  is	  the	  volume	  of	  the	  ITC	  cell	  and	  ΔH1	  and	  ΔH2	  are	  molar	  heats	  of	  ligand	  binding	   for	   the	   first	   and	   second	   binding	   steps	   respectively.	   In	   the	   fitting	  procedure,	  the	  parameters	  ΔH1,	  ΔH2,	  Ka1,	  Ka2	  and	  n	  (the	  total	  number	  of	  binding	  events	  per	  step)	  are	  optimized	  to	  minimize	  the	  difference	  between	  the	  observed	  and	  calculated	  heat	  content	  at	  all	  steps	  of	  the	  titration.	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In	  the	  NMR	  titration	  experiments,	  the	  first	  binding	  event	  is	  slow	  on	  the	  chemical	  shift	   timescale.	  Thus,	   the	   intensity	  of	   the	  original	  peaks	  directly	   reports	  on	   the	  fraction	  of	   free	  protein	   (F0),	  whereas	   the	  newly	  appearing	  peaks	   report	  on	   the	  sum	   of	   the	   singly	   and	   double	   occupied	   protein	   (F1+F2)	   (in	   case	   the	   second	  binding	  event	  does	  not	  perturb	  the	  position	  of	  the	  newly	  appearing	  resonance).	  The	  second	  binding	  event	   is	   fast	  on	  the	  NMR	  timescale	  and	  therefore,	   the	  peak	  position	   reports	   on	   the	   fraction	   of	   doubly	   bound	   protein	   F2.	   To	   extract	   the	  affinities	  from	  the	  NMR	  titration	  experiments	  the	  peak	  intensities	  that	  report	  on	  the	  first	  binding	  event	  and	  the	  peak	  positions	  that	  report	  on	  the	  second	  binding	  event	   were	   simultaneously	   fitted.	   To	   that	   end	   the	   parameters	   Ka1,	   Ka2,	   n,	   the	  resonance	  position	  of	  the	  fully	  bound	  second	  binding	  site	  and	  a	  scaling	  factor	  for	  each	  of	  the	  two	  slow	  exchanging	  resonances	  (to	  correct	  for	  potential	  differences	  in	   line-­‐width	   of	   the	   methyl	   resonances	   in	   the	   closed	   and	   open	   sites)	   were	  optimized	   to	   minimize	   the	   difference	   between	   the	   observed	   and	   calculated	  spectral	  properties	  at	  all	  steps	  of	  the	  titration.	  	  Errors	  in	  all	  fits	  are	  based	  on	  100	  MC	  (Monte	  Carlo)	  simulations	  where	  the	  data	  points	  used	   for	   the	   fitting	  were	   randomly	  varied	  based	  on	   the	  uncertainties	   in	  the	  experimental	  data.	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Supplementary	   Figure	   3b|	  Determination	   of	   the	   affinities	   of	   the	   first	   and	  
second	   binding	   event	   for	   the	   interaction	   between	   K126A	   (H268N)	   DcpS	  
and	  m7GpppG	  substrate.	  	  Top:	   Regions	   of	   the	   NMR	   spectra	   during	   the	   NMR	   titration	   experiment.	   See	  legend	  to	  figure	  S3a.	  Middle:	  Fit	  of	  the	  peak	  intensities	  and	  positions	  result	  in	  a	  kD	  of	  the	  first	  binding	  event	  that	  is	  in	  the	  high	  nano-­‐molar	  range	  and	  a	  kD	  for	  the	  second	  binding	  event	  that	  is	  196	  (±31)	  μM.	  	  Bottom:	   ITC	   thermogram	   for	   the	   interaction	   of	   Dcs1p	   (H268N,	   K126A)	   with	  m7GpppG	  that	  displays	  a	  sequential	  interaction	  mode.	  The	  red	  line	  corresponds	  to	   the	   fit	   of	   the	  data;	   the	  extracted	  binding	   constants	   are	   indicated	  next	   to	   the	  graph.	  Please	  note	  that	  the	  third	  event	  that	  we	  observed	  in	  the	  ITC	  experiments	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with	   the	  WT	   protein	   is	   not	   observed	   in	   the	   ITC	   experiment	   using	   the	   K126A	  mutant.	  As	  a	  result,	  the	  kD	  for	  the	  first	  binding	  event	  can	  be	  extracted	  from	  the	  ITC	  data	  for	  the	  K126A	  mutant.	  	  	  It	  is	  important	  to	  note	  that	  the	  affinities	  of	  m7GpppG	  for	  the	  WT	  (H268N)	  and	  the	  K126A	  (H268N)	  enzymes	  are	  very	  similar.	   In	  addition,	   the	  NMR	  spectra	  during	  the	  titration	  of	  the	  substrate	  to	  both	  forms	  of	  the	  enzyme	  show	  exactly	  the	  same	  behaviour	   (compare	   Figures	   S3a	   and	   S3b).	   This	   establishes	   that	   both	   proteins	  use	   the	  same	  sequential	  binding	  mechanism	  and	   the	  K126A	  mutation	  does	  not	  change	  the	  mechanism	  of	  the	  enzyme.	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Supplementary	   Figure	   3c	   |	   Analysis	   of	   the	   interaction	   between	   the	   C-­‐
terminal	  domain	  of	  Dcs1p	  and	  m7GpppG.	  Top:	  ITC	  thermogram	  for	  the	  interaction	  of	  the	  C-­‐terminal	  domain	  of	  Dcs1p	  with	  m7GpppG	   substrate.	   The	   affinity	   of	   the	   substrate	   to	   the	   C-­‐terminal	   domain	   is	  comparable	   to	   the	  affinity	  of	   the	  substrate	   to	   the	  open	  (second)	  binding	  site	   in	  the	  full-­‐length	  enzyme.	  This	  confirms	  that	  the	  interaction	  of	  the	  substrate	  in	  the	  open	  binding	  site	  is	  mainly	  mediated	  through	  the	  C-­‐terminal	  domain.	  	  Bottom	  left:	  	  Methyl	  TROSY	  NMR	  spectrum	  of	  the	  C-­‐terminal	  domain	  of	  Dcs1p	  in	  the	  absence	  (red)	  and	  presence	  (blue)	  of	  a	  5-­‐fold	  excess	  of	  m7GpppG.	  The	  same	  residues	  experience	  chemical	  shift	  changes	  in	  the	  isolated	  domain	  and	  in	  the	  full-­‐length	  protein	  (Figure	  2c),	  indicating	  that	  the	  m7GpppG	  substrate	  interacts	  in	  the	  same	  manner	  with	  the	  isolated	  C-­‐terminal	  domain	  and	  the	  full	  length	  protein.	  	  Bottom	   right:	   To	   judge	   how	   the	   substrate	   structurally	   interacts	  with	   the	   open	  binding	  pocket	  of	  the	  yeast	  protein,	  we	  modeled	  the	  m7GpppG	  substrate	  into	  the	  empty	  open	  binding	  pocket	  of	  our	  yeast	  structure.	  The	  model	  is	  based	  the	  human	  Dcs1p	   enzyme	   (1ST0)	   that	   contains	   substrate	   in	   the	   open	   and	   closed	   binding	  sites.	  The	  N-­‐terminal	  domain	  is	  colored	  in	  blue,	  the	  hinge	  region	  in	  red	  and	  the	  C-­‐
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terminal	  domain	  is	  shown	  in	  green,	  the	  ligand	  m7GpppG	  in	  yellow.	  In	  our	  model,	  the	   distance	   between	   the	   Cδ1	   methyl	   group	   of	   I42	   (pink	   sphere)	   and	   the	  substrate	  (dashed	  line)	  is	  between	  12	  and	  17	  Å	  (depending	  on	  how	  the	  substrate	  is	  exactly	  modeled).	  The	  shift	  of	  I42	  in	  our	  NMR	  titration	  experiments	  can	  thus	  not	  be	  due	  to	  direct	  contacts	  between	  the	  substrate	  and	  the	  methyl	  group	  in	  the	  N-­‐terminal	   domain.	   Residue	   K126	   that	   alters	   the	   dynamics	   of	   the	   protein	   is	  located	   in	   the	  hinge	   region,	   in-­‐between	   the	  bound	  second	  substrate	  and	   I42	   in	  the	  N-­‐terminal	  domain.	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Supplementary	  Figure	  4	  |	  Asymmetry	  of	  the	  enzyme	  is	  required	  for	  activity.	  (a)	   The	   Y94A	  Dcs1p	   enzyme	   interacts	  with	  m7GpppG	   (left	   spectrum).	   The	  WT	  Dcs1p	   enzyme	   interacts	   with	   (non-­‐methylated)	   GpppG	   (two	   right	   spectra:	   Ile,	  respectively	  Met	  region).	  In	  both	  cases,	  the	  enzyme	  fails	  to	  adopt	  an	  asymmetric	  conformation.	  This	  can	  be	  clearly	  seen	  from	  e.g.	  residues	  I12	  and	  I36,	  that	  don’t	  experience	  peak	  splitting	  as	  we	  observed	  for	  the	  WT	  protein	  in	  the	  presence	  of	  m7GpppG	  (Figure	  2B).	   It	  should	  be	  noted	  that	  the	  affinity	  of	  the	  protein	  for	  the	  ligand	  is	  unaffected	  by	  the	  mutations	  as	  the	  extent	  of	  the	  chemical	  shift	  changes	  observed	  here	  is	  comparable	  to	  the	  chemical	  shift	  changes	  that	  are	  observed	  for	  the	  open	  binding	  site	  in	  WT	  protein	  with	  m7GpppG	  (compare	  e.g.	  M153	  in	  Figure	  S3a).	  (b)	   31P	   spectra	   of	   the	   m7GpppG	   or	   GpppG	   in	   the	   presence	   of	   the	   decapping	  enzyme.	   Upon	   hydrolysis,	   the	   phosphate	   spectrum	   of	   the	   ligand	   changes.	  m7GpppG	   is	   not	   hydrolysed	   by	   the	   Y94A	   enzyme	   (left)	   and	   GpppG	   is	   not	  hydrolysed	  by	  WT	  Dcs1p	  (middle).	  As	  a	  reference	  the	  spectra	  of	  m7GpppG	  in	  the	  presence	   of	   WT	   enzyme	   are	   shown	   on	   the	   right,	   where	   the	   substrate	   is	  hydrolysed	  completely	  within	  14	  hours.	  	   	  
a Dcs1p Y94A without and with 1:5 m7GpppG
1H (p.p.m.)
13
C
 (p
.p
.m
.)
Dcs1p without, with 1:5 GpppG
1H (p.p.m.)
m7GpppG
-24.0-12.0 0.0
31P (p.p.m.)
m7GpppG Time = 14h
GpppG Time = 0
-24.0-12.0 0.0
31P (p.p.m.)
GpppG Time = 14h
Time = 0Time = 0m7GpppG
m7GpppG _,a
m7GpppG `
-24.0-12.0 0.0
31P (p.p.m.)
Time = 14hm7Gp + ppG
m7GMP _
GDP `
GDP _
b m7GpppG  + Dcs1p Y94A m7GpppG  + Dcs1pGpppG  + Dcs1p 
-0.50.00.5
 9
11
13
15
17
-0.50.00.5
 9
11
13
15
17
 1.5 1.7 1.9 2.1
13
14
15
16
13
C
 (p
.p
.m
.)
M195
M153
I42I42
I294I294
ILE region MET region
I219 I219
I36
I12
I36
I12
Nature Chemical Biology: doi:10.1038/nchembio.1866
	   S14	  
	  
Supplementary	   Figure	   5	   |	   Substrate	   competes	   the	   product	   out	   of	   the	  
enzyme.	  (a)	  DcpS	  without	   and	  with	   the	  product	  m7GMP.	   In	   the	  presence	  of	  m7GMP	   the	  enzyme	  adopt	  an	  assymmetric	  conformtion	  as	  can	  be	  judge	  from	  the	  splitting	  of	  the	  resonances	  of	   I12	  and	  I36.	  Note	   that	   I12	  appears	  at	   lower	  carbon	  chemical	  shifts	  compared	  the	  other	  spectra	  shown	  in	  this	  paper	  due	  to	  a	  difference	  in	  the	  aliasing	  of	  the	  spectrum.	  (b)	  DcpS	  binds	  the	  m7GMP	  product	  with	  an	  affinity	  of	  1.05	  ±	  0.64	  μM	  in	  the	  first	  binding	   event.	   A	   second	   binding	   event	   is	   not	   observed,	   indicating	   that	   the	  product	  has	  no	  affinity	   for	   the	  open	  binding	  site.	  Using	  NMR	  spectroscopy	  and	  ITC	  we	   have	   not	   been	   able	   to	   detect	   any	   interaction	   of	   the	   GDP	   product	  with	  either	   the	   first	   or	   the	   second	   binding	   site	   (data	   not	   shown),	   underscoring	   the	  importance	  that	  the	  7-­‐methyl	  group	  plays	  in	  the	  recognition	  process	  between	  the	  nucleotides	  and	  the	  enzyme	  (see	  Figure	  S4).	  (c)	  The	  substrate	   is	  able	   to	  compete	   the	  product	  out	  of	   the	  closed	  binding	  site.	  	  The	  NMR	  spectra	  of	  the	  WT	  protein	  bound	  to	  m7GMP	  and	  bound	  to	  m7GpppG	  are	  very	  similar	  and	  in	  order	  to	  be	  able	  to	  clearly	  distinguish	  if	  substrate	  or	  product	  is	  bound	  in	  the	  closed	  binding	  pocket,	  we	  introduced	  a	  reporter	   isoleucine	  into	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the	   enzyme	   (Leucine	   279	   to	   Isoleucine).	   The	   enzyme	   containing	   this	   reporter	  isoleucine	  was	  converted	  into	  an	  asymmetric	  conformation	  by	  the	  addition	  of	  the	  product	   m7GMP.	   Subsequently,	   we	   added	   m7GpppG	   substrate	   in	   a	   stepwise	  manner.	  During	  the	  addition	  of	  the	  substrate	  the	  reporter	  isoleucine	  shifts	  from	  the	  m7GMP	  bound	  position	  to	   the	  m7GpppG	  bound	  position.	  This	   indicates	   that	  the	   asymmetric	   product	   bound	   form	   of	   the	   enzyme	   is	   transferred	   into	   an	  asymmetric	  substrate	  bound	  form.	  In	  other	  words,	  interaction	  of	  substrate	  in	  the	  second	  binding	  site	  results	  in	  an	  opening	  of	  the	  first,	  product	  filled	  binding	  site.	  As	   a	   result	   the	   product	   can	   rapidly	   leave	   the	   enzyme,	   as	   this	   exhibits	   no	  detectable	  interaction	  with	  the	  open	  binding	  pocket.	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Supplementary	   Figure	   6	   |	   Cartoon	   representation	   of	   the	   K126A	   mutant	  
enzyme.	  	  	  The	  K126A	  mutation	  decouples	  the	  occupation	  of	  the	  second	  binding	  site	  from	  domain	   flipping	   motions.	   Unproductive	   motions	   are	   reduced	   or	   absent	  (horizontal	   dashed	   line)	   and	   catalytic	   turnover	   increases	   (curved	   dashed	  arrows).	  The	  K126A	  mutation	  is	  indicated	  with	  a	  cross.	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Supplementary	   Figure	   7	   |	   Activity	   assays	   under	   reducing	   and	   oxidizing	  
condition.	  The	  activity	  of	  Dcs1p	  is	  not	  influenced	  by	  the	  formation	  of	  a	  disulphate	  bond	  in	  the	   N-­‐terminal	   domain	   (that	  we	   observe	   in	   the	   crystal	   structure).	   	   Shown	   are	  three	   different	   time	   points	   from	   a	   degradation	   series	   in	   the	   absence	   (top)	   or	  presence	   (bottom)	   of	   1	  mM	   DTT	   (in	   the	   bottom	   spectra	   1	  mM	   DTT	   has	   been	  present	  during	   the	   complete	  purification).	   The	   spectra	   are	   identical	  within	   the	  noise,	  proving	  that	  the	  activity	  is	  independent	  of	  the	  formed	  disulphate	  bond.	  In	  both	  spectra	  200	  nM	  WT	  Dcs1p	  was	  mixed	  with	  0.5	  mM	  m7GpppG	  substrate	  at	  20°C.	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Supplementary	  Table	  1	  |	  Data	  collection	  and	  refinement	  statistics	  	  
Data	  collection	   	  Space	  group	   19	  Cell	  dimensions	  	  	   	  	  	  	  	  a,	  b,	  c	  (Å)	   87.99,	  104.52,	  189.96	  	  	  	  	  a,	  b,	  g	  	  (°)	  	   90.0,	  90.0,	  90.0	  Resolution	  (Å)	   20	  (2.25)	  
Rsym	  or	  Rmerge	   6.7	  (71.6)	  
I	  /	  sI	   12.04	  (2.35)	  Completeness	  (%)	   99.5	  (98.9)	  Redundancy	   3.3	  (3.3)	  
	   	  
Refinement	   	  Resolution	  (Å)	   2.25	  No.	  reflections	   83812	  
Rwork	  /	  Rfree	   0.219/	  0.255	  No.	  atoms	   	  	  	  	  	  Protein	   10338	  	  	  	  	  Ligand/ion	   98	  	  	  	  	  Water	   129	  
B-­‐factors	   	  	  	  	  	  	  Protein	   54.63	  	  	  	  	  Ligand/ion	   53.01	  	  	  	  	  Water	   43.02	  R.m.s.	  deviations	   	  	  	  	  	  Bond	  lengths	  (Å)	   0.01	  	  	  	  	  Bond	  angles	  (°)	   1.36	  Values	  in	  parentheses	  are	  for	  highest-­‐resolution	  shell.	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